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Abstract 
 
Sortases are a family of enzymes responsible for the covalent anchoring of proteins to the cell wall of 
Gram-positive bacteria via a transpeptidation reaction. These cysteine transpeptidases specifically recog-
nize and cleave a five amino acid long sorting motif on the target proteins and then catalyzed the formation 
of a new peptide bond between the C-terminus of the cleaved sorting motif and the free amino group of a 
cell wall component. The transpeptidation activity of the well-characterized class A sortase from Staphy-
lococcus aureus (SaSrtA) and evolved variants thereof continues to see increasing use in a wide range of 
biotechnological applications (Sortagging). Due to low activity, sortases from classes other than class A 
are not currently used for this purpose and, with the exception of SaSrtA, laboratory evolution of other 
sortases has not been performed. 
In the first part of this work, we report on the exploration of the natural diversity of sortases and describe 
the in-depth characterization of a sortase enzyme that belongs to the not-yet-investigated class F, sortase 
F from Propionibacterium acnes (PaSrtF). We showed that PaSrtF exhibits similar behaviour to the wild 
type SaSrtA in terms of catalytic activity and sequence specificity and demonstrated its usefulness for 
protein engineering applications.  
In the second part of the work, the development of a novel assay for the screening of sortase variants with 
improved properties is described. Hydrogel bead-based microreactors, suitable for high-throughput 
screening using a large particle flow cytometer, were prepared and evaluated for their capability to act as 
individual evolutionary units that link sortases activity with a fluorescent readout.  
The microreactor-based assay, developed and optimized with the wild type SaSrtA, was successfully val-
idated with the newly characterized PaSrtF and can, therefore, be used for its directed evolution.  
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List of abbreviations 
 
 
Å                                   Ångström 10-10 m  
A                                    adenine 
A, Ala                            alanine 
ADCs                             antibody-drug conjugates 
BaSrtB                           sortase B from Bacillus anthracis 
BaSrtD                           sortase D from Bacillus anthracis 
C                                    cytosine 
C, Cys                            cysteine 
CaSrtD                           sortase D from Clostridium acetobutylicum  
CBM                               carbohydrate-binding motif  
COPAS                          complex object parametric analysis and sorting 
CpSrtD                           sortase D from Clostridium perfringens 
CV                                 column volume 
CWSS                            cell wall sorting signal 
D, Asp                           aspartic acid 
Dabcyl                           4-{[4-(dimethylamino) phenyl]azo}benzoic acid 
dATP                             deoxyadenosine triphosphate 
dCTP                             deoxycytidine triphosphate 
dGTP                             deoxyguanosine triphosphate 
dTTP                             deoxythymidine triphosphate 
dNTP                             deoxynucleoside triphosphate 
DMF                              N,N-dimethylformamide  
DMSO                           dimethyl sulfoxide  
DNPNTGDE                 aspartic acid-asparagine-proline-asparagine-threonine-glycine-aspartic acid-glutamic acid 
E, Glu                            glutamic acid 
EDANS                         5-[(2-aminoethyl)amino] naphthalene-1-sulfonic acid 
ep-PCR                          error-prone polymerase chain reaction 
DNA                              deoxyribonucleic acid 
eSaSrtA                         evolved sortase A from Staphylococcus aureus 
eSrtA/D                         chimeric sortase (evolved sortase A from S. aureus/sortase D from B. anthracis) 
FITC                              fluorescein isothiocyanate 
G                                    guanidine 
G, Gly                            glycine 
GCABs                          gel-core alginate microbeads  
GC-CAMs                     gel-core chitosan-coated alginate microcapsules 
GFP                               green fluorescence protein 
Gn-SrtA                         N-terminally glycine-modified sortase A from Staphylococcus aureus 
Gn-SrtB                         N-terminally glycine-modified sortase B from Bacillus anthracis 
Gn-SrtF                          N-terminally glycine-modified sortase A from Propionibacterium acnes 
HC-CAMs                     hollow-core chitosan-coated alginate microcapsules 
His10                             polyhistidine tag 
HPLC                             high performance liquid chromatography 
IPTG                              isopropyl β-D-1-thiogalactopyranoside 
K, Lys                            lysine 
kDa                                kilo Dalton 
L, Leu                            leucine 
LB                                  lysogeny broth 
LC-MS                           liquid chromatography-mass spectrometry 
LPXTG                          leucine-proline-any amino acid-treonine-glycine 
LPETGE                        leucine-proline-glutamic acid-treonine-glycine- glutamic acid 
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M, Met                           methionine 
MES                               2-(N-morpholino)ethanesulfonic acid 
mRNA                            messenger ribonucleic acid  
MkSrtE                           sortase E from Methanopyrus kandleri 
MTT                               3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
N, Asn                            asparagine 
NMR                              nuclear magnetic resonance 
OD600                           optical density at 600 nm 
P, Pro                             proline 
PAH                               poly-allylamine hydrochloride 
PaSrtF                            sortase F from Propionibacterium acnes 
PCR                               polymerase chain reaction 
PI                                   propidium iodide 
PSS                                poly-styrene sulfonate 
Q, Gln                            glutamine 
R, Arg                            arginine 
Rs                                                      Stokes radius 
S, Ser                             serine 
SaSrtA                           sortase A from Staphylococcus.aureus 
ScSrtE                            sortase E from Streptomyces coelicolor 
SDS-PAGE                    sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
SrtA                                sortase A 
SrtB                                sortase B 
SrtF                                 sortase F 
T                                     thymine 
T, Thr                             threonine 
TB                                  terrific broth 
TOF                                time of flight 
V, Val                             valine 
VvGT5                           Vitis vinifera glycosyltransferase 5 
WCE                              whole cell extract 
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1.1  Biology and function of sortases  
 
The cell wall of Gram-positive bacteria displays a wide subset of proteins that enable each microbe to 
communicate and interact with the surrounding environment. Among the strategies evolved by bacteria 
to immobilize proteins on the cell surface, the covalent anchoring of proteins to the cell wall is executed 
by sortase enzymes (Navarre and Schneewind, 1994).  
Sortases are a family of membrane-anchored cysteine transpeptidases that either “sort” proteins by attach-
ing them to the cell wall or participate in the construction of pili, proteinaceous filaments that extend from 
the cell surface. 
The first and still the best characterized sortase family member sortase A from Staphylococcus aureus 
(SaSrtA) was identified in 1999 by Mazmanian and colleagues following the functional complementation 
of S. aureus mutants defective in the anchoring of surface proteins (Mazmanian et al., 1999).  
The sortase A-mediated transpeptidation starts when the precursor of the target protein containing an N-
terminal signal peptide and a C-terminal cell wall sorting signal (CWSS) is exported from the cytoplasm 
through the secretory (Sec) pathway. The CWSS consists of a conserved five amino acid long sorting 
motif LPXTG (where the third amino acid X can be variable) followed by a hydrophobic stretch and a C-
terminal positively charged tail. The hydrophobic stretch and the positively charged tail presumably func-
tion by retaining the translocated polypeptide in the bilayer membrane and positioning the LPXTG motif 
for processing by the sortase enzyme (Ryan G Kruger et al., 2004; Navarre and Schneewind, 1994; 
Schneewind et al., 1992). Once sortase A binds the LPXTG sorting motif the thiol group of the cysteine 
in the active site nucleophilically attacks the carbonyl carbon of the threonine residue (T) cleaving the 
peptide bond between the threonine and the glycine (G) and creating an intermediate in which the sortase 
and the target protein are linked together through a thioester linkage. The intermediate is then resolved 
when the free amino group of the first glycine residue of the pentaglycine stretch of the cell wall precursor 
lipid II nucleophilically attacks the thioester linkage forming a new peptide bond between the target pro-
tein and the lipid II molecule (Ton-That et al., 1999) (Figure 1.1). 
 
 
 
Figure 1.1. Mechanism of S. aureus sortase A-mediated surface protein anchoring to the cell wall.  
(Reproduced with permission from Guimaraes et al. 2013). 
10 
 
1.2 Classification of sortases 
 
At present 9205 gene sequences encoding sortase enzymes have been identified within 3118 species most 
of them being Gram-positive bacteria. Only a handful of sortases have been found in Gram-negative bac-
teria or archaeal species (Comfort and Clubb, 2004; Finn et al., 2016; Pallen et al., 2001).  
Based on their amino acid sequence and their function, Clubb and co-workers. (Spirig et al., 2011) divided 
sortases into six classes called class A to F. Although the nomenclature has considerably changed in the 
past (Comfort and Clubb, 2004; Dramsi et al., 2005) this system is now reflected in the conserved domain 
database of the NCBI, which, however, splits the sortase D class into two separate classes (D1 and D2). 
Most Gram-positive bacteria express more than one class of sortases that, in the course of the evolution, 
may have evolved different specificity for the pentapeptide sorting motif. Consequently, by recognizing 
their class-specific sorting motif, sortases belonging to different classes are predicted to operate non-
redundantly to display or assemble distinct proteins on the cell surface (Comfort and Clubb, 2004). The 
phylogeny of the sortases along with their predicted recognition sequences is depicted in figure 1.2. 
 
 
 
 
Figure 1.2. Neighbour-joining phylogenetic tree showing the evolutionary relationship among sortases. The tree 
was constructed from a multiple sequence alignment of representative structures of sortases from classes A, B, C, 
D1, D2 and E and additional sortase sequences of the classes D1, D2 and F. Leaves of the tree were labeled with the 
PDB code (green) or the species. For each class the bootstrap support and the consensus recognition sequence are 
indicated. Highlighted in red are positions differing from the sortase A recognition sequence (Di Girolamo et al., 
2019). 
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Class A sortases are considered housekeeping enzymes as in different bacteria they anchor to the cell wall 
a large number of functionally distinct proteins. As an example, sortase A from L. monocytogenes was 
found to process up to 43 proteins (Boekhorst et al., 2005; Marraffini et al., 2006). Consistent with this 
observation is the fact that genes encoding for sortases A are generally not clustered with any of its sub-
strates (Pallen et al., 2001). Proteins anchored by class A enzymes contain the LPXTG motif and possess 
several functions including bacterial adhesion, nutrient acquisition, host cell invasion, and immune system 
evasion (Navarre and Schneewind, 1999).  
Sortases belonging to class B are less abundant then class A homologues and genes encoding for members 
of this class were found located within operons that also encode their substrates. For instance, genes en-
coding for sortase B from Staphylococcus aureus (Sa-SrtB) and for sortase B from Bacillus anthracis 
(Ba-SrtB) reside within the isd (iron-responsive surface determinant) locus, which also contains genes 
encoding for proteins involved in the heme uptake. Unlike class A sortases, specificity of class B members 
is less well-defined and recognition sequences NPKTG and NPQTN were reported for Ba-SrtB and Sa-
SrtB respectively (Maresso et al., 2006; Mazmanian et al., 2003).  
Class C sortases have a more specialized function and are used by Gram-positive bacteria to link pilin 
subunits via lysine–isopeptide bonds to construct pili that promote microbial adhesion and biofilm for-
mation (Mandlik et al., 2008; Ton‐That and Schneewind, 2003). More recently class B members were 
also found that assemble pili (Kang et al., 2011; Shaik et al., 2015). As for class B sortases, the genes 
encoding class C sortases are often located in gene clusters with their substrates and are often present in 
several copies per genome (Hendrickx et al., 2011). Similarly to class A sortases, sortases belonging to 
class C are predicted to process proteins harboring sorting signal with the LPXTG motif (Comfort and 
Clubb, 2004).  
Less is known on sortases of the classes D and E. At present only two class D sortases have been charac-
terized in Bacillus anthracis and Clostridium perfringens for which atomic structures have also been re-
ported. Sortase D1 form B. anthracis (Ba-SrtD1, also known as Ba-SrtC) is required for the formation of 
infectious spores and it has been shown to specifically cleave proteins bearing the LPNTA motif and to 
attach them to the amino group of diaminopimelic acid in the envelope of sporulating cells (Marraffini 
and Schneewind, 2006, 2007; Scott A. Robson et al., 2012). 
Sortase D2 from C. perfringens (CpSrtD2) was shown to be catalytically distinct from Ba-SrtD1 as it 
cleaves substrates bearing the LPQTGS recognition sequence. Interestingly, its catalytic activity was 
found enhanced in presence of magnesium making CpSrtD2 one of the two known sortases (the other 
being SaSrtA) whose activity is modulated by metal ions (Suryadinata et al., 2015). 
Class E sortases share limited primary sequence homology to other sortases and are thought to also have 
a general housekeeping role. In fact, genes encoding class A and E sortases are never found in the same 
organism and, similar to class A sortases, genes encoding class E enzymes are not positioned adjacent to 
those encoding potential protein substrates (Comfort and Clubb, 2004). So far, two class E sortases have 
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been studied in more detail and their structures have been recently determined. Sortase E from Strepto-
myces coelicolor has been shown to anchor chaplin proteins to the cell surface that promote the transition 
from vegetative growth to aerial hyphae formation and appeared to prefer LAXTG substrates over 
LPXTG substrates (A. Duong et al., 2012; M. D. Kattke et al., 2016). Similarly, sortase E from S. aver-
mitilis preferentially transpeptidates substrates with an LAXTG motif using nucleophiles with an N-ter-
minal glycine residue (Das et al., 2017). Class F sortases are mainly present in the orders Actinomycetales 
and Bacillales but at present, none of them has been biochemically or structurally characterized. An over-
view of the sortase enzyme family is given in table 1. 
 
 
Table 1: Overview of the sortase enzyme family. Sortases are grouped according to their sequence homology. The 
conserved domain (CD) code as well as the protein data base (PBD) code of representative structures are reported. 
The most common sorting motifs (with positions differing from sortase A sorting motif highlighted in red) and the 
function of the sortases are also given. 
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1.3 Sortases structure and mechanism of action  
 
Shortly after its discovery, the three-dimensional structure of the conserved domain of sortase A from S. 
aureus (SaSrtAΔN59) was determined with NMR spectroscopy (Ilangovan et al., 2001). The structure re-
vealed a unique eight-stranded β-barrel core formed by the interaction of two anti-parallel β sheets that 
includes two helices and several loops with the putative active site at the end of a hydrophobic depression 
that could accommodate the LPXTG substrate peptide. In addition, comparison of NMR spectra in the 
presence and absence of calcium allowed the positioning of the calcium binding site in proximity of the 
active site (Ilangovan et al., 2001). The overall structure of SaSrtAΔN59 is depicted in figure 1.3. 
 
 
 
Figure 1.3. Overall structure of SaSrtA. SrtAΔN59 adopts a three-dimensional β-barrel structure formed by the 
interaction of two anti-parallel β sheets (Ilangovan et al., 2001). The structure was generated from the atomic coor-
dinates of 1T2P (Zong et al., 2004) using the program UCSF Chimera (Pettersen et al., 2004).  
 
 
 
To better describe the substrate binding pocket, the X-ray structure of SaSrtAΔN59 non-covalently com-
plexed with its substrate was subsequently solved (Zong et al., 2004). Analysis of the complex structure 
revealed that the peptide bond between the threonine and the glycine residues of the ligand peptide was 
positioned between the conserved residues Cys184 and Arg197 but far from the His120 side chain that 
was thought to form along with Cys184 the catalytic thiolate-imidazolium ion pair found in the superfam-
ily of cysteine proteases.  
Although the conserved His120 and Arg197 were shown essential for efficient enzymatic activity (Mar-
raffini et al., 2004; Ton-That et al., 2002), their role in catalysis remained controversial until detailed 
kinetic measurements supported a reverse protonation mechanism (Frankel et al., 2005). This mechanism 
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proposes that at any given time and at physiological pH only a small percentage (0.06%) of the total 
enzyme contains the Cys184 thiolate and His120 imidazolium forms and is competent for catalysis. 
The reverse protonation mechanism was confirmed by analyzing the NMR structure of the SaSrtAΔN59 
covalently bound to a substrate analog to mimic the thioacyl catalytic intermediate (Suree et al., 2009). 
His120 would protonate the amide leaving group as the T-G peptide bond is broken and would deproto-
nate and activate the incoming terminal amine group of lipid II for nucleophilic attack on the thioacyl 
intermediate. By donating hydrogen bonds Arg197 would stabilizes both the positioning of the LPXTG 
substrate in the active site and the tetrahedral intermediates of catalysis (figure 1.4) 
 
 
 
 
Figure 1.4. Proposed SrtA transpeptidation mechanism based on the structure of the SrtAΔN59 in complex with a 
substrate analog. (i) Active site of sortase A containing the flexible β6/β7 loop. (ii) The β6/β7 loop closes upon 
binding of the sorting motif whose positioning is stabilized through the formation of hydrogen bonds with Arg197. 
The thiolate group of Cys184 attacks the carbonyl carbon of the threonine forming a tetrahedral intermediate. (iii) 
His120 protonates the amide of the glycine residue as the peptide bond is broken. (iv) The free amino group of the 
pentaglycine cross-bridge peptide of lipid II enters the active site and, upon activation by His120, nucleophilically 
attacks the intermediate. (v) The formation of a second tetrahedral intermediate is followed by the rupture of the 
thioacyl linkage and the release of the transpeptidation product. (Reproduced with permission from Suree et al. 
2009). 
 
 
 
In addition, the NMR structure of SaSrtAΔN59 bound to a substrate analog allowed to elucidate the molec-
ular basis of substrate recognition. SaSrtA recognizes the LPXTG substrate through a large groove that 
leads into the active site. Residues in strands β4 and β7 form the floor of the groove, whereas the walls 
are formed by surface loops β6/β7, β7/β8, β3/β4, and β2/H1. 
Comparison of NMR structures in presence and absence of the substrate analog revealed that the binding 
of the sorting motif induces two main structural changes. One concerns a 10 Å displacement of the β6/β7 
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loop towards the active site that (i) lead to the formation of a 310 helix that appears to plays a key role in 
substrate recognition and (ii) allow the side chain of Glu171 (together with Glu105 and Glu108) to contact 
the calcium ion stabilizing the closed conformation (figure 1.5 A). The second structural change concerns 
a 13 Å displacement of  the β7/β8 loop that creates a new groove that expose the side chain of His120 and 
that might represent the entry point for the lipid II substrate into the active site (Suree et al., 2009) (figure 
1.5 B). 
 
 
 
 
Figure 1.5. Binding of the sorting motif induces two main changes in the structure of SrtA. (A) Expanded view of 
the superposition of the average NMR structures of SrtAΔN59 and of SrtAΔN59 bound to a substrate analog showing 
that the displacement of β6/β7 loop towards the active site upon substrate binding causes the formation of a 310 helix 
and allows the positioning of the calcium ion calcium into the calcium binding pocket. (B) Expanded view as in (A) 
showing that the substrate-dependent structural change in the β7/β8 loop unmasks a groove that might represent the 
entry point of the lipid II substrate. (Reproduced with permission from Suree et al. 2009). 
 
 
At present, in addition to SaSrtA, structures have been reported for other class A sortases and for members 
of class B, C, D and E. Structural analysis have shown that sortases from different classes share a similar 
overall structure but with variable number of peripheral α-helices and other variations that likely effect 
the function and modulate the substrate specificity. For instance, an extended β6/β7 loop in sortase B from 
S. aureus is involved in recognizing the NPQTN sorting signal substrate (Jacobitz et al., 2014) while the 
two short additional N-terminal helices may play a role in anchoring substrates to buried portions of the 
cell wall (Marraffini and Schneewind, 2005). Still, in class C sortases, an elongated N-terminal region has 
been shown to work as a lid that occlude the active site and that might regulate the enzyme activity 
(Mandlik et al., 2008; Manzano et al., 2009, 2008).  
Structural and computational studies of sortase A from B. anthracis and sortase B from S. aureus in com-
plex with their sorting signals peptides have shown that class A and B sortases recognize their substrates 
and catalyze the transpeptidation reaction in a similar manner (Chan et al., 2015; Jacobitz et al., 2014). 
These results suggest that all the sortases may function using a similar mechanism of action.  
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1.4 Sortases as targets for anti-infective agents development 
 
Many of the LPXTG bearing proteins attached to the cell wall of S. aureus by sortase A belong to the 
MSCRAMMs (microbial surface components recognizing adhesive matrix molecules). These proteins are 
virulence factors that play significant roles during staphylococcal infections including bacterial attach-
ment to the extracellular matrix of host tissues, biofilm formation and immune response evasion (Foster 
et al., 2014). Over the last two decades, several studies have demonstrated the link between sortase A 
activity and S. aureus pathogenesis. In a pioneer study, Mazmanian and colleagues (Mazmanian et al., 
2000) showed that gene knockout mutants of srtA resulted in defective surface expression of various 
LPXTG motif proteins and a defect in establishing renal abscesses and acute infection in mice. The re-
duced ability of an S. aureus srtA deletion mutant to infect the host was also demonstrated in several 
animal models (Weiss et al., 2004). SrtA activity was shown to promote S. aureus survival inside macro-
phages following phagocytosis, as srtA deletion mutants were found to be more susceptible to killing by 
macrophages (Kubica et al., 2008) and to promote biofilm formation as loss of SrtA in clinical isolates 
significantly reduced their ability to form biofilms (O’Neill et al., 2008). Similarly, the link between sort-
ase activity and pathogenicity has been confirmed for others Gram-positive species such as L. monocyto-
genes (Bierne et al., 2002), S. pneumonia (Kharat and Tomasz, 2003), Enterococcus faecalis (Kemp et 
al., 2007) and Streptococcus suis (Vanier et al., 2008). All together, these studies have highlighted the 
potential of sortase inhibition for the treatment of Gram-positive related infectious diseases and, for this 
reason, the search of molecules that could inhibit sortase activity became an intensive area of research. 
The screening of natural or synthetic compound libraries as well as molecular modeling, pharmacophore 
hypotheses, 3D-QSAR models and virtual screening approaches allowed the identification and the char-
acterization of a consistent number of reversible and irreversible SaSrtA inhibitors (Cascioferro et al., 
2015). However, most of these compounds showed activity in the high micromolar range and because of 
this low potency, none of them has been developed as drug. 
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1.5 In vitro activity and specificity of sortases 
 
Soon after its discovery, the proteolytic activity of SaSrtA towards peptides bearing the LPXTG motif 
and its transpeptidation reaction in presence of the nucleophile NH2-Gly3 were demonstrated by Ton-
That and colleagues in two subsequent studies (Ton-That et al., 2000, 1999). In these studies, the authors 
also showed that SaSrtA cleaves the LPXTG motif between the threonine and the glycine and that in the 
absence of a nucleophile, the thioacyl intermediate is hydrolyzed, resulting in the cleavage of the LPETG 
motif without the formation of a new peptide bond. Later, beside determining the SaSrtA 3D structure, 
Ilangovan and colleagues found that the SaSrtA activity was increased by 8-fold in presence of calcium 
ions (Ilangovan et al., 2001). To determine the kinetic parameters of SaSrtA, FRET-based assays, that 
make use of sorting signal peptides containing donor and quencher fluorophores at each end, were initially 
employed (Ilangovan et al., 2001; Ton-That et al., 2000). However, limitations associated with the fluo-
rescence inner filter effect quenching at high substrate concentration led to the development of HPLC-
based methods enabling more accurate measurements (Frankel et al., 2005; Ryan G Kruger et al., 2004). 
Although published values for SaSrtA show a wide variation depending on the substrate sequence used, 
according to Frankel and colleagues transpeptidation occurs with a kcat = 0.28 ± 0.02 s−1, and Km values 
for the LPXTG and the Gly5 nucleophile of 7.33 ± 1.01 mM and 196 ± 64 μM, respectively. In the absence 
of the nucleophile SaSrtA works as a protease that hydrolyze the sorting motif with a kcat = 0.086 ± 
0.015 s−1 (Frankel et al., 2005). 
Since the characterization of SaSrtA, the in vitro enzymatic activity of several other sortases has been 
investigated. However, none of them has shown to be as active as SaSrtA which catalyzes transpeptidation 
~20–500-fold faster than other characterized sortases (Jacobitz et al., 2017).  
Due to the low reaction rate and long incubation time required for reaction product analysis, sequence 
specificities of most sortases have been barely determined. Apart from SaSrtA, for which the substrate 
specificity was experimentally determined in detail, (Ryan G. Kruger et al., 2004) recognition sequences 
of other sortases are mainly predicted by bioinformatics means.  
Moreover, as the composition of the peptidoglycan cell wall differs from strain to strain, sortases from 
different species are expected to have a different specificity with respect to the nucleophile substrate that 
resolve the thioacyl intermediate. For instance, sortase A from Streptococcus pyogenes (SpSrtA) was 
shown to accept dialanine as nucleophile, the simplest form of cross-bridge subunits in the peptidoglycan 
of S. pyogenes (Kang et al., 2011), while sortases from Bacillus species, which were shown to attach 
proteins to the diaminopimelic acid cross-bridges in the cell wall (Marraffini and Schneewind, 2007), are 
expected to accept this molecule in vitro.  
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1.6 Sortases as protein engineering tools 
 
The demonstration that sortase A from S. aureus could break a peptide bond within the LPXTG motif and 
then reform a new bond with an incoming oligo-glycine nucleophile in vitro (Ton-That et al., 2000) paved 
the way for the development of sortases as valuable tools for protein engineering. The transpeptidation 
reaction catalyzed by sortases, also referred to as “sortagging” (Popp et al., 2007), has attracted increasing 
attention and has been exploited to site-specifically link fluorescent dyes, carbohydrates and other moie-
ties to protein substrates and to the surface of cells (Antos et al., 2017, 2016). Sortase-mediated transpep-
tidation reactions have also been used for protein-protein ligation (Levary et al., 2011), protein immobi-
lization on solid supports (Chan et al., 2007; Raeeszadeh-Sarmazdeh et al., 2015) and peptide and protein 
cyclization (Antos et al., 2009b; Zhang et al., 2015).  
The majority of sortagging applications use sortases to modify proteins of interest either at the C or at the 
N-terminus. For C-terminal labeling target proteins carrying the LPXTG motif at their C-terminal are 
reacted with oligo-glycine-modified probes in presence of the sortase enzyme. Conversely, for N-terminal 
labeling, target proteins contain at least one glycine residue at the N-terminus and are reacted with mo-
lecular probes modified with the LPXTG motif. (Figure 1.6).  
 
 
 
 
Figure 1.6. Schematic representation of protein labeling at the C-terminus (left) and at the N-terminus (right) us-
ing sortases. Reproduced with permission from Guimaraes et al. 2013 an Theile et al. 2013. 
 
 
 
Site-specific conjugation of molecules has also been demonstrated to internal lysine residues of proteins 
by exploiting the non-canonical isopeptide ligation of SaSrtA (Bellucci et al., 2015). By using SaSrtA in 
combination with sortase A from S. pyogenes (SpSrtA) that recognizes and cleaves the LPXTA motif and 
accepts alanine-based nucleophiles, Ploegh and co-workers developed a strategy for the biorthogonal con-
jugation of two different probes to a single protein (Antos et al., 2009a). 
Sortase-mediated transpeptidation proceeds site-specifically, under mild conditions and in a single step 
and overcomes some of the limitations associated with conventional chemical conjugation methods. For 
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instance, sortases have been successfully used for the site-specific conjugation of drugs to antibodies to 
produce antibody-drug conjugates (ADCs), a new class of biopharmaceutical drugs designed for the tar-
geted treatment of cancer. Unlike chemical conjugation methods, the use of sortase enzymes allowed to 
control precisely the conjugation site and the conjugation ratio of toxins to antibodies. Sortases enabled 
the production of homogeneous preparations of ADCs which displayed in vitro cell killing activities in-
distinguishable from conjugates obtained through chemical conjugation methods (Beerli et al., 2015; 
Stefan et al., 2017). 
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1.7 Optimizing SaSrtA performance 
 
Although the biotechnology community soon recognized the potential of the sortase-mediated transpep-
tidation reaction, the widespread use of sortases showed some notable limitations. The intrinsic poor en-
zymatic efficiency of wild type SaSrtA requires equimolar concentration of enzyme and substrate and 
long reaction time to achieve sufficient conjugation yields limiting its use to small-scale bioconjugates 
synthesis. A second limitation concerns the narrow substrate scope of SaSrtA that restricts sortagging to 
substrates naturally containing the LPXTG sequence or those engineered to display this motif. Still, the 
strong Ca2+ dependency of SaSrtA prevents its use in low Ca2+ concentrations conditions like in the cyto-
plasm of living cells or in presence of Ca2+-chelating compounds, such as phosphate, carbonate, and eth-
ylenediaminetetraacetic acid (EDTA). 
The use of SaSrtA as a valuable tool for site-specific protein modification gained significance after the 
development, by directed evolution, of an enhanced version of SaSrtA. By integrating yeast display, sort-
ase-mediated bioconjugation, and fluorescence-activated cell sorting (FACS), Liu and co-workers iso-
lated an enhanced SaSrtA pentamutant variant (eSaSrtA) showing a 140-fold increase in activity as com-
pared to the wild type counterpart (Irwin Chen et al., 2011). This work showed for the first time the 
potential of directed evolution to increase the enzymatic activity of a sortase enzyme and led to the devel-
opment of additional directed evolution strategies to further improve the catalytic activity or to alter the 
sequence specificity of SaSrtA. Using a fluorescence resonance energy transfer (FRET)-based screening 
assay, Chen and co-workers identified additional beneficial mutations that resulted in a 3-fold improve-
ment in catalytic efficiency over the pentamutant (Chen et al., 2016). Similarly, using a directed evolution 
approach based on a DHFR protein complementation assay, Suliman and colleagues identified SaSrtA 
variants with increased catalytic efficiencies (Suliman et al., 2017). More recently, a SaSrtA variant dis-
playing improved catalytic activity and increased resistance towards the organic co-solvent DMSO was 
isolated  (Zou et al., 2018). 
The first evidence that sortase specificity could be altered originated from a domain swapping experiment 
in which the β6-β7 loop in SaSrtA was replaced by the homologous binding loop from SaSrtB (Bentley 
et al., 2007). Although at the expense of the catalytic activity, the resulting chimeric enzyme showed 
altered specificity in hydrolysis reactions, preferring substrates containing NPQTN over the LPETG mo-
tif. However, this variant was unable to perform transpeptidation. By randomizing the amino acid se-
quence of the β6-β7 loop and by using a directed evolution platform based on a phage display system, 
Schwarzer and co-workers were able to  isolate a SaSrtA variant with a promiscuous specificity at the 
first residue of the sorting signal (Piotukh et al., 2011a). Some years later, the yeast display assay, used 
to improve the catalytic properties of the wild type SaSrtA, was applied to reprogram the sequence spec-
ificity of eSaSrtA resulting in the isolation of two orthogonal SaSrtA variants recognizing either LPXSG 
or LAXTG with minimal loss of activity relative to eSaSrtA (Dorr et al., 2014). More recently, the above 
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mentioned phage display system allowed to identify SaSrtA mutants that accept APXTG and FPXTG 
motifs but with a catalytic activity similar to the wild-type enzyme (Schmohl et al., 2017).  
In addition to protein engineering, a complementary approach to broaden substrate scope of sortases relies 
on exploiting sortase homologs that are characterized of different substrate specificity. To date, apart from 
above mentioned sortase A from S. pyogenes, only few others SaSrtA homologs have been characterized 
that recognize sorting motifs different than LPXTG (Matsumoto et al., 2012; Nikghalb et al., 2018; 
Schmohl et al., 2017). Nevertheless, their use still remains hampered by the very low catalytic activity.  
To allow sortase-mediated conjugation in living systems or at low calcium concentration, calcium-inde-
pendent SaSrtA variants were also developed. By introducing mutations at residues of the calcium binding 
pocket Glu105 and Glu108, to mimic the calcium-independent equivalent sortases from S. pyogenes and 
B. anthracis, Nagamune and co-workers obtained a calcium-independent SaSrtA which, however, suf-
fered from reduced catalytic activity (Hirakawa et al., 2012). By combining these two mutations with the 
beneficial mutation previously identified (Irwin Chen et al., 2011), Guimaraes and co-workers developed 
a heptamutant SaSrtA that demonstrated high catalytic efficiency in the absence of Ca2+ (Wuethrich et al., 
2014). Using a similar approach, other groups have also developed calcium-independent variants of 
SaSrtA and demonstrated their efficacy in various applications (Glasgow et al., 2016; Hirakawa et al., 
2015; Jeong et al., 2017; Witte et al., 2015). Moreover, a calcium-independent SaSrtA variant with twelve 
mutations, characterized of slightly higher activity relative to the wild type SaSrtA in presence of calcium, 
was recently identified by a directed evolution strategy based on in vitro compartmentalization (IVC) 
(Gianella et al., 2016).  
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1.8 Directed evolution of sortases within hydrogel microcompartments 
 
In the last years, several efforts have been made to improve the activity and to alter the specificity of 
sortase enzyme through a variety of directed evolution strategies. However, apart from SaSrtA, in vitro 
evolution of other sortase enzymes have not yet been reported. 
Although the yeast surface display assay developed by Liu and co-workers was successfully applied for 
directed evolution of SaSrtA (Irwin Chen et al., 2011), the relative low number of enzyme molecules 
displayed on the cell surface (up to 100.000) might be insufficient to generate a readily detectable output 
signal when sortases with lower catalytic activity than SaSrtA are assayed. In addition, the single turnover 
nature of the yeast display system does not allow for output signal amplification thereby limiting the 
sensitivity of the assay and, consequently, the capability to detect and evolve poorly active sortases.  
To improve the assay sensitivity and achieve a downward extension of the dynamic range of the screening 
system, one possibility is to increase the amount of the enzyme assayed during the screening procedure. 
If microtiter plate-based screening assays are employed, this can be easily achieved by expressing the 
protein of interest in the cytoplasm of proliferating cells in liquid cultures and by performing the enzy-
matic reaction in cell lysates. However, screening platforms that rely on the use of microtiter plates require 
a significant investment in terms of money, time, and space and although advancements have been made, 
the throughput of these methods is typically limited to 103–104 variants per screen. 
A more powerful method, that enable selection of enzymes for multiple-turnover at high-throughput, re-
lies on the use of artificial microcompartments. Compared to robotic microtiter plate-based systems, di-
rected evolution platforms that rely on microcompartments allow the screening of libraries with a 1.000 
fold-increase in speed and 1-million-fold reduction in volume (Agresti et al., 2010). Compartmentaliza-
tion into artificial microcompartments enables the linkage of the genotype (the nucleic acid sequence that 
encodes the catalysts) and the phenotype (the optical readout that originates from catalysis), an essential 
feature of any directed evolution strategy. 
The potential of miniaturized reaction within artificial compartments for directed evolution of catalysts 
was first demonstrated by Tawfik and Griffiths who introduced the term “in vitro compartmentalization” 
(IVC) (Tawfik and Griffiths, 1998). In IVC, members of a library are spatially separated into water-in-oil 
emulsion droplets with volumes as small as a femtoliter, where ach droplet acts as an independent micro-
reactor. Typically, protein catalysts produced by cells or in vitro translation are co-compartmentalized 
with a fluorogenic substrate whose conversion and specific retention allow the faithful analysis and se-
lection of catalysts with improved functional properties. Directed evolution campaigns that rely on the 
use of bulk water-in-oil emulsions were initially developed and applied for the evolution of DNA poly-
merases  (Ghadessy et al., 2001), β-galactosidase (Mastrobattista et al., 2005) or thiolactonases (Aharoni 
et al., 2005). However, the polydispersity of these emulsions made it difficult to carry out quantitative 
assays and to control single cell or individual DNA molecule compartmentalization. To overcome this 
limitations microfluidics-based technologies, that allow to generate emulsion droplets with uniform size, 
were implemented and incorporated into in vitro evolution assays to screen for peroxidase, arylsulfatase 
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and cellulase activities (Agresti et al., 2010; Kintses et al., 2012; Ostafe et al., 2014). A microfluidic 
device was employed by Hollfelder and co-workers to screen for phosphotriesterase activity from single 
cell lysates compartmentalized within emulsion droplets containing agarose and alginate (Fischlechner et 
al., 2014). The stepwise deposition of the polymers poly-allylamine hydrochloride (PAH) and poly-sty-
rene sulfonate (PSS) (known as layer-by-layer assembly) on the surface of the droplets, yielded robust 
microspheres that were suitable for fluorescence-activated cell sorting (FACS) and that were character-
ized of a size-selective shell. Unlike emulsion droplets, the semipermeable nature of the shell enables gel-
shell beads to exchange buffer or small exogenous molecules facilitating for instance the execution of 
multistep reactions or the execution of reactions that require external substrate supply. 
Although directed evolution platforms using microdroplets have been integrated with different protein 
expression systems like in vitro transcription and translation (Fallah-Araghi et al., 2012), cell display 
(Agresti et al., 2010; Irwin Chen et al., 2011), cell secretion (Beneyton et al., 2017) and cell lysis (Kintses 
et al., 2012), screening procedures based on cells typically involve the compartmentalization and the anal-
ysis of a single cell. To date, only few examples of cell proliferation within emulsion droplets are reported 
in literature (Beneyton et al., 2014; Wang et al., 2014). Although the low solubility of oxygen in the oil 
phase of the emulsion droplets to support aerobic cell growth can be overcome by the use of fluorinated 
oils, proliferation of single cells within emulsion droplets rely on the limited amount of growth medium 
contained in the aqueous phase of the droplet that prevents high cell density cultivations.  
An alternative strategy to encapsulate and cultivate single cells without limitations of oxygen or nutrients 
supply rely on the use of hydrogel microdroplets. Hydrogels are three-dimensional networks of hydro-
philic polymer in which water is the dispersion medium. Due to their many advantageous features, hy-
drogels have attracted increased attention in the scientific community and have been used for many bio-
logical and biomedical applications including drug delivery, single molecule and cell analysis and tissue 
engineering (Ahmed, 2015; Peppas et al., 2006). Among the polymers used to prepare hydrogels, alginate 
has received much attention in literature and has been widely used for cell encapsulation (Goh et al., 2012; 
Rathore et al., 2013). Alginate is a naturally occurring anionic polymer isolated from brown algae that 
enables the formation of hydrogels in the presence of divalent cations like Ca2+. The porosity of the algi-
nate gel allows the diffusion of nutrients to support cell growth and reagents to perform reactions but 
prevents the diffusion of cells or colonies that remain immobilized within the alginate hydrogel matrix. 
Cell encapsulation using alginate can be carried out under very mild conditions and is therefore suitable 
for cellular screening applications that require single cells surviving and proliferating. In addition, the 
mechanical strength of alginate hydrogels enables the accumulation of a large number of cells without 
affecting hydrogels stability. To date, several technologies have been developed that allow to encapsulate 
single cells within uniform alginate microspheres at high-throughput (Leong et al., 2016) and, depending 
on the particle size, clone processing technologies such as FACS (fluorescence activated cell sorter) or 
COPAS (complex object parametric analysis and sorting) have been used for particles analysis and sort-
ing. 
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2      Aim of the work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
Over the last decades, there has been an increasing demand for technologies that allow the specific incor-
poration of novel functionalities in proteins useful for a wide range of applications.  
While early methods of protein modification relying on the reactivity of either lysine, cysteine or other 
residues on the target protein still have a widespread utility, the development of chemoenzymatic tech-
nologies for the site-specific protein modification represented a breakthrough in this field as allow to 
overcome limitations associated with conventional chemical ligation methods (Rabuka, 2010; Rashidian 
et al., 2013) 
Sortases are a class of enzymes that are responsible for the covalent attachment of secreted proteins to the 
cell wall of Gram-positive bacteria. Over recent years, the transpeptidation reaction catalyzed by sortases, 
and in particular by sortase A from S. aureus (SaSrtA), has been extensively studied and it has seen an 
increasing use in the construction of novel protein derivatives as well as to perform demanding conjuga-
tion processes. Several strategies have been developed that allow optimizing sortase performance and to 
expand the range of substrates compatible with sortase-based approach. However, at present, the vast 
majority of the protocols rely on the use of the well-characterized sortase A from S. aureus (SaSrtA) and 
on evolved variants thereof.  
Although evolved versions of SaSrtA have clearly shown enhanced reaction rates over the wild-type en-
zyme, recent studies have suggested that are not optimal for all applications. For instance, it was shown 
that the wild-type SaSrtA gives higher overall yields in the ligation of GFP to polystyrene beads as com-
pared to evolved versions (Heck et al., 2014a). In another study, the pentamutant SaSrtA was seen more 
prone to higher levels of side products (Heck et al., 2014b). Efforts to broaden substrate scope has led to 
the directed evolution of few SaSrtA variants with altered specificity and to the identification of naturally 
occurring SaSrtA homologs that also prefer alternative sorting sequence over the canonical LPXTG motif. 
However, while these evolved sortases have yet to see widespread use, sortase A homologs suffer again 
of poor catalytic efficiency.  
Due to their inherent low activity, sortases from classes other than class A are not currently used for 
sortagging applications and with the exception of SaSrtA other sortases have not been evolved. This can 
be likely attributed to the fact that directed evolution strategies developed so far are not sensitive enough 
to detect the activity of poorly active sortases. 
In this context, the aim of this thesis was to identify novel sortase enzymes that would further expand the 
use of sortase-based ligation methods and to develop a directed evolution strategy compatible with sort-
ases with low activity. 
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3      Results and discussion  
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3.1  Identification and characterization of novel sortase enzymes 
 
3.1.1 Sampling sortase diversity 
 
With the goal to expand the number of available sortase variants that can be used for protein engineering 
applications such as in biorthogonal conjugation of antibody-drug conjugates, the natural diversity of 
sortases was explored. Seven sortases from classes with a predicted recognition sequence different from 
the LPXTG of SaSrtA, including one member of the non-yet-characterized class F, were selected as target 
enzymes for in vitro transpeptidation activity analysis (Table 3.1). Depending on the specificity and the 
activity of the newly identified sortases, in vitro evolution to improve their activity should be performed. 
Sortase B and sortase D1 from Bacillus anthracis (BaSrtB and BaSrtD respectively) with putative recog-
nition sequences NPXTG and LPXTA respectively were chosen because their structure was determined 
and therefore expression of soluble enzyme was previously known. Two additional class D2 sortases, 
sortase D from Clostridium perfringens (CpSrtD) and sortase D from Clostridium acetobutylicum 
(CaSrtD) were chosen because in various clostridia, sortase-like proteins have been identified, but none 
of them was characterized until October 2014 (Leeuwen et al., 2014). The first of the two selected class E 
sortases, sortase E from Streptomyces coelicolor (ScSrtE2), is responsible in this organism for aerial hy-
phae development and has been shown to cleave LAXTG-containing peptides in vitro (Andrew Duong et 
al., 2012). The second selected class E enzyme (MkSrtE) is the single sortase-like protein found in the 
archaeon Methanopyrus kandleri and represents one of the few identified but not-yet-characterized sort-
ases from non-Gram-positive bacteria. As M. kandleri is a hyperthermophile and a thriving halophile, the 
potential transpeptidation activity of MkSrtE at high temperature and high salt concentrations makes this 
enzyme very attractive as it would further expand the scope of sortase-mediated ligations. The class F 
sortase was selected from Propionibacterium acnes (PaSrtF) because in its genome a single sortase gene 
is annotated and because a previous study provided indirect evidence that a sortase is active in this organ-
ism (Lodes et al., 2006). Class C sortases were not taken into consideration because, similar to class A 
enzymes, members of this class recognize proteins with sorting signals that contain the consensus LPXTG 
(Comfort and Clubb, 2004).  
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3.1.2 Recombinant expression and purification  
 
Prior to gene synthesis, amino acid sequences of target sortases were subjected to an in silico analysis 
with Predict protein, Phobius, Signal P and TM pred to delineate signal peptide sequences and to identify 
transmembrane regions. Genes encoding for the putative soluble domain were codon optimized for ex-
pression in Escherichia coli, custom-synthetized and subsequently cloned into an expression vector to 
yield proteins with a 3C protease cleavage site and a histidine tag at the C-terminus.  
Following expression analysis in a small-scale test, recombinant target sortases were expressed in four 
liters’ cultures and subsequently purified by metal affinity chromatography. An overview of selected sort-
ases along with their purification results is given in Table 3.1.  
 
 
Table 3.1: Overview of selected sortases and relative purification results; red letters in the sorting motif 
indicate positions differing from the SaSrtA motif LPXTG where the X in third position designates no 
preference for a specific amino acid sidechain. 
 
 
 
 
 
Three of the selected sortases namely BaSrtBΔ37, BaSrtDΔ24 and CpSrtDΔ22, showed good solubility and 
were purified with high yield (≥ 40 mg per liter of culture) and purity (> 95%) by using an identical 
purification strategy (Figure 3.1). By contrast, the remaining sortases exhibited very low solubility and 
could not be purified. In the attempt to improve their solubility, a series of solubility studies were carried 
out using different expression strains in combination with different expression conditions and several 
extraction buffers. Moreover, additional variants of CaSrtDΔ23 and ScSrtE Δ157 consisting of the conserved 
domain only, were constructed by removing the N-terminal linker segment that connects the catalytic 
domain to the putative transmembrane anchor (CaSrtDΔ66 and ScSrtEΔ193 respectively). Although under 
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certain conditions protein solubility was improved, MkSrtEΔ66 and the two length variants of CaSrtD ap-
peared quite unstable and were lost during the purification procedure (E. Calà and M. Castiglione master 
thesis). Unexpectedly, in contrast to two other studies, in which the purification and the crystallization of 
a four amino acid shorter variant at the N-terminus (ScSrtEΔ161, residues Thr162-Ser352) were reported (An-
drew Duong et al., 2012; Michele D. Kattke et al., 2016), in our hands ScSrtEΔ157 (residues Gln158-Ser352) 
showed very low solubility and could not be isolated under similar conditions. Same results were observed 
with the shorter variant ScSrtEΔ193. 
Positive outcomes were instead obtained with PaSrtFΔ34. In this case, increased ionic strength significantly 
improved the solubility of the enzyme that was isolated and subjected to preliminary activity analysis. 
Later on, having realized the potential of this sortase, the purification procedure of PaSrtF was further 
optimized. Total purification yield was improved by using a C-terminal twin streptavidin tag while satis-
factory purity was achieved by performing, in addition to affinity chromatography, a step of ion exchange 
chromatography (Figure 3.2). 
  
 
 
 
Figure 3.1. SDS-PAGE analysis of BaSrtB (A), BaSrtD (B) and CpSrtD (C) purification by metal affinity 
chromatography. M: Protein Ladder; WCE: whole cell extract; S12: Clarified cell lysate at 12,000g; FT: Flow 
through; W1: Column wash with 10 mM imidazole; W2: Column wash with 20 mM imidazole; E: Eluate  
 
 
 
 
Figure 3.2. SDS-PAGE analysis of PaSrtF purification by affinity chromatography (A) followed by anion 
exchange chromatography (B) M: Protein Ladder; WCE: Whole cell extract; S12: Clarified cell lysate at 
30,000g; FT: Flow through; W1-W3: Washes; E1-E9: Elution fractions; Pool: Pool of elution fractions E2-E9 
from A; A12-B10: Elution fractions. 
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3.1.3 Activity and specificity analysis of BaSrtB, BaSrtD and CpSrtD 
 
Part of the results discussed within this section are the cumulative work of the authors Chasper Puorger, 
Salvatore Di Girolamo and Georg Lipps and have been published in 2017 (Puorger et al., 2017). RP-
HPLC, LC/MS and relative data analysis were performed by Dr. Chasper Puorger. 
 
 
Following purification, the activity of BaSrtB, BaSrtD and CpSrtD was analyzed through a high perfor-
mance liquid chromatography (HPLC)-based assay. As depicted in figure 3.3 A, FITC-labeled recogni-
tion peptides, specific for different classes of sortases, were individually mixed with a biotinylated GGGK 
nucleophile and the transpeptidation reaction started by the addition of each of the purified sortase en-
zyme. By determining with reverse phase-HPLC (RP-HPLC) the transpeptidation product yields of each 
reaction, the activity of target sortases was estimated in comparison to the evolved variant of the well-
characterized sortase A from S. aureus (eSaSrtA) (Table 3.2). Among the purified sortases, only BaSrtB, 
reacted with the class B specific peptide substrate DNPXTGDE, yielded sufficient amounts of transpep-
tidation product that allowed the subsequent determination of its sequence specificity. By contrast, only 
trace amount of products was detected when BaSrtD and CpSrtD were reacted with their putative recog-
nition peptides making their sequence specificity determination impossible. 
 
 
Table 3.2. Overview on the product yield for the different sortases as determined with RP-HPLC  
 
 
+++++: >60 % product; ++++: 30 – 60 % product; +++: 10 – 30 % product; ++: 5 – 10 % product; +: < 5% product; 
+/-: trace amounts of product; -: no activity found; n. d.: not determined 
a Enzyme concentrations used in the reactions; b Reaction time 
 
 
Sequence specificity of BaSrtB was determined by using a newly developed liquid chromatography-mass 
spectrometry (LC-MS)-based method. The method relies on reacting mixtures of FITC-labeled recogni-
tion peptides with one randomized position at a time and the biotinylated GGGK nucleophile in presence 
of the designated sortase as described above. Following the reaction, biotinylated transpeptidation prod-
ucts are isolated from the reaction mixture with streptavidin-coated magnetic beads and analysed via LC-
MS (Figure 3.3). 
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Figure 3.3. Overview of the method for sequence specificity determination using recognition peptide libraries. 
(A) In vitro transpeptidation reaction scheme for RP-HPLC analysis. The X in the substrate peptide designates 
one of the 20 amino acids (B) Depiction of the transpeptidation product isolation procedure used to obtain 
samples for LC-MS analysis (Puorger et al., 2017) 
 
 
 
For method development, the highly active eSaSrtA was employed. The LC-MS analysis of the transpep-
tidation products obtained by reacting mixture of recognition peptides with individual variable positions 
and the biotinylated nucleophile in presence of eSaSrtA allowed to identify which sequences from the 
mixture are preferentially recognized by this sortase (Figure 3.4 A). The results were in good agreement 
with previously published data (I. Chen et al., 2011; Ryan G. Kruger et al., 2004) demonstrating the 
validity of the. Once established for the eSaSrtA the method was successfully applied to determine the 
sequence specificity of BaSrtB (which was found about 104-fold less active than eSaSrtA) (Figure 3.4 
B), and, as discussed below, of PaSrtF (section 3.1.5).  
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Figure 3.4. Logo representations of the sequence specificity of (A) eSaSrtA and (B) BaSrtB. Both sortases show 
no specificity at position 3, while the other positions are more stringent. Uncharged polar amino acids are colored 
green, basic amino acids blue, hydrophobic amino acids black, and acidic amino acids red; proline is colored 
orange, and cysteine and methionine are colored yellow. J (purple) represents isoleucine and leucine, which 
could not be distinguished in the LC−MS analysis because of their identical masses. Glycine at position 5 in the 
recognition sequence of BaSrtB is colored gray since it could not be determined directly because of the low rate 
of substrate turnover (Puorger et al., 2017). 
 
 
 
Besides elucidating for the first time the detailed sequence specificity of a non-class A sortase, we showed 
that BaSrtB catalyzes a transpeptidation reaction in vitro and that it can accept oligo-glycine-modified 
molecules as nucleophile. For this reason, BaSrtB was selected as the first valuable target for directed 
evolution purposes. By contrast, due to the limited product formation, BaSrtD and CpSrtD were no further 
characterized nor considered as targets for directed evolution. 
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3.1.4 Structure determination of sortase D2 from C. perfringens 
 
As the class D1 sortase from B. anthracis (BaSrtD) was the sole class D member for which the molecular 
structure was reported (Scott A. Robson et al., 2012), the structure determination of the sortase D2 from 
C. perfringens (CpSrtD) was attempted by the research group of Prof. Dr. Timm Maier (Biozentrum, 
University of Basel) using X-ray crystallography. The structure of the protein was successfully deter-
mined at 2.3 Å resolution. Unexpectedly, the crystal structure of CpSrtD was published by Suryadinata et 
al. (Suryadinata et al., 2015). Nevertheless, our protein model was very similar to the published CpSrtD 
model. As shown in figure 3.5, the only notable difference concerns the conformation of the β3-α4 loop 
(residues 106-116) that cause the different orientation of the conserved histidine residue (His109). 
 
 
 
 
Figure 3.5. (A) CpSrtD protein crystals. (B) Superposition of the published CpSrtD structure (blue; PDB entry 
4d70) and the CpSrtD structural model as determined in this work (orange). The only notable difference con-
cerns the conformation of the β3-α4 loop. 
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3.1.5 Characterization of sortase F from Propionibacterium acnes 
 
The results discussed within this section are the cumulative work of the author Salvatore Di Girolamo, 
Chasper Puorger, Mara Castiglione, Maren Vogel, Rémy Gebleux, Manfred Briendl, Tamara Hell, Roger 
Beerli, Ulf Grawunder, Georg Lipps and have been published in 2019 (Di Girolamo et al., 2019). 
RP-HPLC, LC/MS and relative data analysis were performed by Dr. Chasper Puorger. 
 
 
While biochemical analysis and structures have been reported for at least one member of class A, B, C, 
D and E sortases, at present, class F enzymes remained to be studied.  
Genome analysis of the completely sequenced type strain P. acnes KPA171202 (Brüggemann et al., 2004) 
revealed that, in this Gram-positive bacterium, only a single sortase gene is annotated. According to the 
conserved domain database of the NCBI, the sortase gene encodes for a sortase that belongs to the class 
F subfamily. Since a previous study provided indirect evidence that in P. acnes a sortase enzyme is active 
(Lodes et al., 2006) and since data from an RNA-sequencing experiment showed that the gene is expressed 
under normal growth conditions, an in-depth characterization of this sortase was performed.  
The analysis of the amino acid sequence of PaSrtF with SignalP (Petersen et al., 2011) allowed to delin-
eate a 24 amino acid long signal peptide suggesting that the sortase is, as expected, targeted to the secre-
tory pathway. Unlike other sortases, PaSrtF lacks the hydrophobic region that should anchor the protein 
to the cell membrane. We suggest that, in this sortase, the signal peptide is not cleaved but the enzyme 
remains attached to the membrane by the hydrophobic core of the signal peptide. C-terminal to the signal 
peptide is a region expected to be unordered which may constitute a flexible linker that connects the 
conserved catalytic domain (residues 65-215) to the bacterial cell membrane. For recombinant protein 
production, the signal peptide and ten residues from this flexible linker were omitted. The resulting PaSrtF 
variant (PaSrtFΔ34) was purified and subsequently subjected to biochemical characterization. 
In order to identify the sorting motif preferred by PaSrtF a gel-based conjugation assay was set up. A 
panel of FITC-labeled peptides carrying sorting motifs recognized by different sortase classes were incu-
bated with an N-terminally hexa-glycine-modified protein serving as nucleophile (Gly6-AlgQ2, see sec-
tion 3.2.3.1 for details) in presence of the purified PaSrtF. Following SDS-PAGE, the gel was scanned 
with a fluorescence scanner to verify the presence of fluorescent transpeptidation products. As can be 
seen in figure 3.6, only the peptide carrying the sortase A/C motif LPXTG was transferred to the protein 
serving as nucleophile demonstrating catalytic activity of PaSrtF towards the class A sorting motif. 
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Figure 3.6. PaSrtF recognizes the LPXTG sorting motif for transpeptidation. Recombinant PaSrtF (10 µM) was 
mixed with 10 µM Gly6-AlgQ2 and 10 µM of each FITC-labeled recognition peptide and incubated for 6 hours 
at 25 °C in 50 mM sodium phosphate, pH 8.5 and 500 mM NaCl, 5 mM DTT. The formation of transpeptidation 
products was analyzed by SDS-PAGE gel fluorescence scanning (right panel). Equal protein loading was assessed 
by staining the gel with Coomassie (left panel). Lane M designates the protein ladder. The peptide substrates were 
from left to right LPXTGE (sortase A/C substrate), DNPNTGDE (sortase B substrate 1), ENPXTNAGT (sortase 
B substrate 2), KLPXTASN (sortase D substrate), and ALAXTGSE (sortase E substrate).  
 
 
 
Next, by using FITC-LPXTGE peptides, the gel-based conjugation assay was employed to determine 
the pH optimum of PaSrtF reaction in the pH range from 4 to 12. As can be seen in figure 3.7, similar to 
SrtA from S. aureus, PaSrtF is most active at a slightly alkaline pH between 8 and 9. The outcome was in 
excellent agreement with the results obtained by analyzing initial rates of the reactions with RP-HPLC 
(Figure 3.8 A). Moreover, analysis of the product yield after 24 hours, showed highest product formation 
at slightly lower pH (between 7 and 8) probably due to the partial inactivation of PaSrtF at basic pH during 
prolonged incubation times (Figure 3.8 B).  
 
 
 
 
Figure 3.7. PaSrtF is most active between pH 8 and 9. The activity of PaSrtF was measured at different pH values 
in a 0.2 M boric acid/0.05 M citric acid/0.1 M phosphate buffer system (Carmody, 1961) supplemented with 500 mM 
NaCl. Reactions were carried out with 2.5 µM enzyme, 10 µM FITC-LPXTGE and 10 µM Gly6-AlgQ2 for 6 hours 
at 25 °C. 
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Figure 3.8. (A) Initial rates of transpeptidation assay carried out with 5 µM PaSrtF, 250 µM FITC-LPQTGE and 
1 mM GGGK-biotin, analyzed with RP-HPLC. (B) Analysis of amounts of transpeptidation products after 24 hours. 
 
 
 
Similarly, the gel-based conjugation assay served to evaluate the influence of the ionic strength on 
PaSrtF activity. Surprisingly, PaSrtF prefers high salt concentrations with the highest activity found be-
tween 0.5 and 1 M NaCl (Figure 3.9). Interestingly, at salt concentration higher than 1 M NaCl another 
nucleophile, possibly a degradation product of the Gly6-AlgQ2 protein, was preferentially labeled over 
the whole protein. Similar behavior was observed when the NaCl dependence of PaSrtF activity was 
analyzed with RP-HPLC. The outcome confirmed that PaSrtF remains active even at 3 M NaCl and that 
it less active at NaCl concentration below 500 mM. In addition, comparable product yields between 0.75 
and 3 M NaCl after 24 hours, suggest that the enzyme is stabilized at high salt concentration during long 
reaction times (data not shown). Hence, the high salt tolerance of PaSrtF would potentially broaden the 
scope of sortagging approaches. 
 
 
 
 
Figure 3.9. PaSrtF activity at different ionic strengths. PaSrtF shows highest activity between 0.5 and 1 M NaCl. 
The NaCl concentration was varied between 0 and 3 M in 50 mM sodium phosphate, pH 8.5, 5 mM DTT. The gel-
based conjugation assay was carried out with 2.5 µM enzyme, 10 µM FITC-labeled recognition peptide and 10 µM 
Gly6-AlgQ2 after 6 hours incubation at 25 °C. 
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Previous studies have shown that SaSrtA is strongly activated by calcium ions (Ilangovan et al., 2001; 
Naik et al., 2006). More recently, the activity of CpSrtD was found enhanced in presence of magnesium 
(Suryadinata et al., 2015). At present, the above-mentioned enyzmes are the only two reported sortases 
whose activity is modulated by metal ions. 
To evaluate whether metal ions have a stimulatory effect on PaSrtF activity, a number of bivalent cations 
such as Zn2+, Mg2+, Ni2+, Ca2+ and Mn2+ were screened using a FRET-based cleavage assay. The assay 
makes use of a peptide carrying the LPXTG motif, labeled with the fluorophore-quencher pair EDANS-
Dabcyl (SrtA substrateII, Anaspec). When the peptide is cleaved by the sortase, the fluorophore-quencher 
pair is broken up causing an increase in fluorescence that can be continuously monitored by using a fluo-
rescence reader. As can be seen in figure 3.10, none of the screened metal ions stimulated PaSrtF activity 
compared to the “cation-free” reaction (reaction performed without additional bivalent ions) suggesting 
that PaSrtF activity is independent of bivalent ions. This, would enable the direct use of SrtF for in vivo 
and cell-based applications. Interestingly, as previously described also for CpSrtD (Suryadinata et al., 
2015), PaSrtF is strongly inhibited by the presence of zinc ions.  
 
 
 
 
Figure 3.10. PaSrtF activity measured in presence of different metal bivalent cations (10 mM). Reaction rates 
were determined by measuring reactions of 5 µM PaSrtF with 20 µM of the quencher-fluorophore peptide 
and 2 mM Gly3 in a fluorescence spectrophotometer in 50 mM Tris-HCl, 500 mM NaCl, pH 8.5 at 25 °C for 
1 hour. 
 
 
 
To determine the optimal temperature at which PaSrtF achieves maximal transpeptidation activity, the 
FRET-based cleavage assay was performed at different temperatures. The results showed a broad tem-
perature optimum around 25 °C with a significant decline of the activity above 40 °C (Figure 3.11)  
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Figure 3.11. PaSrtF activity measured in the temperature range from 15 to 45 °C. Rates were determined by 
measuring reactions of 5 µM PaSrtF with 20 µM quencher-fluorophore peptide and 2 mM Gly3 in a thermostatized 
cuvette in a fluorescence spectrophotometer in 50 mM Tris-HCl, 500 mM NaCl, pH 8.5. 
 
 
 
Next, the detailed sequence specificity of PaSrtF was determined by using the LC-MS-based method as 
described above for BaSrtB. As shown in figure 3.12, compared to eSaSrtA, PaSrtF is less strict on the 
amino acid residue at the first position but it has a clearer preference for proline at position 2 and for 
threonine at position 4. As for SaSrtA, PaSrtF has no preference at position 3 where all amino acids except 
Proline were found. For position 5 no product formation was observed with the corresponding peptide 
mixture. However, since peptides with a glycine at position 5 were used for investigation of all other 
positions, glycine is at least one of the most probable amino acids at this position.  
 
 
 
 
Figure 3.12. Comparison of the sortase specificity of PaSrtF (A) and eSaSrtA (B). The sortase specificity was 
investigated by incubating the sortases with peptide mixtures with one position variable at a time. Transpepti-
dation products were isolated and the identity of the variable amino acid at a given position was determined by 
LC-MS. The letter J stands for Leucine and Isoleucine, which are not distinguishable by mass.  
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Very important, determination of the Michealis-Menten kinetics parameters with RP-HPLC showed that 
kcat of PaSrtF (0.06 min-1) is comparable to kcat of the wild type SaSrtA (kcat = 0.04 min-1) making PaSrtF 
the first naturally occurring characterized sortase enzyme with an activity similar to the most thoroughly 
used wild type SaSrtA. Compared to the wild type SaSrtA, PaSrtF has a significantly lower Km value for 
the LPXTG-peptide (0.26 mM versus 7.6 mM) and a 10-fold higher Km value for the nucleophile (2.3 mM 
versus 0.14 mM) (Figure 3.13).  
 
 
 
 
Figure 3.13. Michaelis-Menten parameters determined for SrtF from P. acnes and for SrtA from S. aureus. 
 
 
 
To investigate the utility of the newly identified PaSrtF for protein engineering, a site-specifically conju-
gated antibody-drug conjugate (ADC) was prepared by NBE therapeutics AG using a similar approach to 
the one previously described for eSaSrtA (Beerli et al., 2015; Stefan et al., 2017). Determination of the 
drug content by RP-HPLC revealed that PaSrtF is capable to generate highly homogeneous ADCs, which, 
in a cell-killing assay have shown similar potency and specificity to ADCs developed using eSaSrtA. 
All together, these results make the newly identified PaSrtF a powerful alternative to the most frequently 
used SaSrtA for sortase-mediated ligations applications. Moreover, PaSrtF represented an ideal target for 
our directed evolution campaign. 
  
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
3.1.6  Analysis of sortase F length-variants 
 
Although PaSrtFΔ34 was purified and characterized, purification of this variant was quite challenging be-
cause of the low protein solubility. With the goal to optimize and improve PaSrtF purification and under-
stand whether the flexible linker that connects the conserved domain to the bacterial cell membrane is 
important for the enzymatic activity, two additional PaSrtF variants were analyzed: PaSrtFΔ47 and 
PaSrtFΔ60 obtained by further extending the deletion of the N-terminal region. A graphical representation 
of PaSrtF variants architecture is given in figure 3.14. 
Similar to PaSrtFΔN34, both SrtFΔ47 and SrtFΔ60 required high ionic strength (500 mM NaCl) for soluble 
extraction and were purified following the same protocol described for PaSrtFΔN34.  
After purification, a gel-based conjugation assay was performed to evaluate the activity of PaSrtFΔN47 
and PaSrtFΔ60 in comparison to PaSrtFΔ34. As shown in figure 3.15, while PaSrtFΔ34 and PaSrtFΔN47 dis-
played similar activities, PaSrtFΔ60 appeared about 70 % then less active than PaSrtFΔ34. Consistent results 
were obtained by determining the total product yields with RP-HPLC (data not shown). 
Although further investigations are required, these preliminary results indicate that the conserved domain 
alone may be not sufficient to achieve efficient transpeptidation and that residues of the flexible linker 
may play a role on binding the substrate peptide.  
 
 
 
 
 
Figure 3.14. Graphical representation of the architecture of the full-length PaSrtF (1), PaSrtFΔN34 (2), PaSrtFΔN47 (3) 
and PaSrtFΔN60 (4) showing the position of the conserved histidine (H124), cysteine (C195) and arginine (R208) 
residues within the conserved domain (residues 65-217). The N-terminal signal peptide and the flexible linker that 
connect the conserved domain to the bacterial cell membrane are depicted as a gray and striped box respectively. 
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Figure 3.15. Gel-based conjugation assay of PaSrtF length-variants. Recombinant PaSrtF variants (2.5 µM) were 
mixed with 10 µM Gly6-AlgQ2 and 50 µM fluorescent peptide substrate and incubated for 3 hours at 25 °C in 
50 mM sodium phosphate, pH 8.5 and 500 mM NaCl. The extent of the transpeptidation reaction was analyzed by 
SDS-PAGE gel fluorescence scanning (right panel) and quantified with imageJ. Equal protein loading was assessed 
by staining the gel with Coomassie (left panel). Lane M designates the protein ladder; Lane 1 negative control 
(No sortase); Lane 2: reaction with PaSrtFΔ34; Lane 3: reaction with PaSrtFΔ47; Lane 3: reaction with PaSrtFΔ60;  
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3.1.7 Construction and analysis of a chimeric sortase  
 
The development of a chimeric enzyme from two functionally related proteins has proved to be an effec-
tive strategy for improving or altering its activity and to gain valuable information on the structure-func-
tion relationship of the parent proteins. For instance, in a previous work, the construction of a chimeric 
sortase by domain swapping, allowed to get insights on how sortases enzymes discriminate between their 
substrates (Bentley et al., 2007). The replacement of the β6-β7 loop in sortase A from S. aureus (SaSrtA) 
with the corresponding loop from the sortase B from the same organism (SaSrtB) yielded a loop-swapped 
sortase A able to cleave NPQTN peptide substrates with a specificity profile change compared to SaSrtA 
by a factor of over 700,000. However, the chimeric enzyme was unable to perform transpeptidation onto 
the pentaglycine molecule used as nucleophile. 
In this work, with the goal to alter the sequence specificity of the highly active eSaSrtA, a chimeric sortase 
was constructed and investigated. Driven by the structure similarity between class A and class D1 sortases 
(S. A. Robson et al., 2012), we set out to create a hybrid protein (eSrtA/D) that ideally combines the high 
activity of eSaSrtA with the sequence specificity of BaSrtD. To this end, the SCHEMA algorithm (Voigt 
et al., 2002) was employed to identify fragments of parental sortases whose recombination is less likely 
to disrupt the three-dimensional structure of the resulting chimeric enzyme. The algorithm takes into ac-
count the 3D structures of parental proteins and generate a SCHEMA disruption profile whose minima 
represent crossover sites that preserve the maximum number of interactions between residues. According 
to the SCHEMA disruption profile for recombination of SaSrtA and BaSrtB, preferred recombination 
would occur at alignment position 187 and 233 (Figure 3.16 A). Recombination at position 187 produces 
a chimeric sortase that contains the N-terminal region of eSaSrtA for residues Gln59-Arg151, fused to the 
C-terminal region of BaSrtD for residues Thr143- Lys198 that include the β6-β7 loop (His153- Pro166) which 
is considered the main sequence specificity determinant (S. A. Robson et al., 2012). On the other hand, 
the chimeric sortase obtained by recombination at position 233 generates a chimeric enzyme that do not 
contains the β6-β7 loop but only the disordered β7-β8 loop which may rather play a role in binding the 
nucleophile (S. A. Robson et al., 2012) (Figure 3.16 B). For this reason, only the first chimeric variant 
was investigated. Primary and secondary structures of recombinant chimeric eSrtA/D are depicted in fig-
ure 3.16 C.  
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Figure 3.16. (A) SCHEMA disruption profile for recombination of sortase A from S. aureus (1T2W) and sortase D 
from B. anthracis (2LN7). Similar results are obtained when the order of proteins in the chimera is swapped (blue 
line and green line). Suitable recombination sites (corresponding to minima in the schema profile) are at alignment 
positions 187 and 233 (abscissa, red circles). (B) Structural model of chimeric enzymes obtained by recombination 
at position 187 (left) and 233 (right); Cyan: SaSrtA, Gold: BaSrtD. (C) Primary and secondary structures of recom-
binant chimeric eSrtA/D; In blue and red the eSaSrtA and BaSrtD primary sequences respectively. Conserved cata-
lytic residues are underlined. Highlighted in yellow are the cloning scars; in violet the 3C protease cleavage site and 
in green the polyhystidine tag. Secondary structure elements are shown in green for β-strands (arrows) and helices 
(cylinders).  
 
 
 
The DNA sequence encoding for the chimeric eSrtA/D, was codon optimized for expression in Esche-
richia coli, custom-synthetized and cloned into an expression vector to yield a protein with a 3C protease 
cleavage site and a histidine tag at the C-terminus. Although, at first, the chimeric enzyme appeared poorly 
soluble, a solubility study using different extraction buffers allowed to improve its solubility (Figure 3.17 
A). Purification was performed by affinity chromatography (Figure 3.17 B). 
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Figure 3.17. (A) SDS-PAGE analysis of insoluble (P) and soluble (S) fractions obtained by using different extrac-
tion buffers. Protein extraction in 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.5 M Urea helped improving protein 
solubility (red circle). M: Protein Ladder, IND: Post-induction sample; UNI: Pre-induction sample; P1-P4: Insoluble 
fractions; S1-S4 soluble fractions. Extraction buffers were: 1) 20 mM Tris, 150 mM NaCl, 0.2% NP40 pH 7.5; 2) 
50 mM Tris, 150 mM NaCl, 0.5 M Urea, pH 7.5; 3) 50 mM Tris, 2 M NaCl, pH 7.5; 4) 50 mM Tris, 150 mM NaCl, 
pH 7.5. (B) SDS-PAGE analysis of fractions from chimeric eSrtA/BaSrtD purification. M: Protein Ladder; WCE: 
Whole cell extract; S12: Clarified cell lysate at 50,000g; FT: Flow through; W1: Column wash with 10 mM imid-
azole; W2: Column wash with 20 mM imidazole: E: Eluate  
 
 
 
First, to assess whether the chimeric eSrtA/D was active and showed specificity towards class D recogni-
tion substrate peptides, a gel-based conjugation assay was performed. The purified enzyme was incu-
bated with the FITC-labeled peptide carrying the class D sorting motif LPXTA (KLPXTASN) in presence 
of the N-terminally hexa-glycine-modified protein Gly6-AlgQ2 as nucleophile (see section 3.2.3.1 for 
details). As control, reactions were performed with parental enzymes eSaSrtA and BaSrtD. Unfortunately, 
the SDS-PAGE and gel fluorescence scanning revealed that the chimeric eSrtA/D is unable to transfer the 
fluorescent peptide to Gly6-AlgQ2 suggesting that the enzyme lost its transpeptidation activity (Fig-
ure 3.18). Next, to confirm these results and evaluate whether the chimeric eSrtA/D retained the ability 
to cleave the recognition peptide substrate, the formation of both cleavage and transpeptidation products 
was analyzed with RP-HPLC. In this case, the fluorescent peptide substrate specific for SaSrtA (FITC-
LPETGE) was also tested. The HPLC analysis demonstrated the total lack of activity of the chimeric 
eSrtA/D (data not shown). The construction and analysis of chimeric enzymes was discontinued. 
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Figure 3.18. Gel-based conjugation assay of chimeric eSrtA/D; 10 µM chimeric sortase was mixed with 20 µM 
Gly6-AlgQ2 and 20 µM class D fluorescent peptide substrate (FITC-KLPNTASN) and incubated for 18 hours at 
30 °C in 25 mM Tris/HCl pH 8.3, 150 mM NaCl, 10 mM CaCl2. As control, reactions were performed with parental 
sortases: eSaSrtA (1 µM, 1 hour at 30 °C) and BaSrtD (10 µM, 18 hours, 30 °C). The formation of transpeptidation 
products was analyzed by SDS-PAGE gel fluorescence scanning (right panel). Equal protein loading was assessed 
by staining the gel with Coomassie (left panel). Lane M designates the protein ladder. 
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3.2 Establishment of a microreactor-based assay for directed evolution of 
sortases with low activity 
 
With the goal to develop a directed evolution strategy compatible with sortases with low activity, the 
utility of a microreactor-based assay was investigated. The assay relies on the use of alginate-based mi-
crocompartments as miniature sized culture and reaction vessels suitable for high-throughput screening 
and sorting using the large particle flow cytometer COPAS (Complex Object Parametric Analyzer and 
Sorter). Compared to single-cell screening system, proliferation of cells within microcompartments, fol-
lowed by cell lysis, enables a larger amount of enzyme to be assayed thereby increasing the likelihood to 
detect the activity of poorly active enzymes. Moreover, in comparison to traditional microtiter plate 
screens, the use of miniaturized cell lysate compartments in combination with COPAS provides higher 
throughput enabling a deeper exploration of an enzyme’s sequence space in less time. Hence, microcom-
partments encapsulating microcolonies, here referred as microreactors, were developed and investigated 
as individual evolutionary units for the functional screening of sortases with enhanced activity.  
As shown in figure 3.19, the original concept of the assay workflow consisted of different steps including 
cell encapsulation into polymer-based beads to spatially segregate clones carrying different enzyme se-
quences, cell growth, cell lysis, sortase-mediated conjugation reaction and eventually COPAS selection 
and genotype recovery.  
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Figure 3.19. Workflow of the microreactor-based assay for directed evolution of sortases. Polymer-based micro-
compartments encapsulating E. coli colonies that originate from individually compartmentalized cells from a library 
of mutants, express a sortase variant that, upon cell lysis, is released from cells but retained inside microcompart-
ments. Here, the sortase enzyme encounters and joins the two substrates: a fluorescent labeled recognition peptide, 
and an oligo-glycine-modified protein acting as nucleophile. After removal of the unreacted fluorescent substrate, 
retention of fluorescent transpeptidation products ensures that microcompartments harbouring the most active sort-
ases are distinguished and isolated on the basis of fluorescence intensity using a large particle flow cytometer (CO-
PAS). By dissolving the microcompartments, the genotype (plasmid) is recovered and if needed further randomized 
for a new round of evolution. 
 
 
 
3.2.1 Alginate bead-based compartments as miniature sized culture vessels 
 
Due to its unique characteristics, alginate is one of the most frequently used biomaterial in the field of cell 
microencapsulation. Encapsulation of living cells within alginate hydrogels can be carried out under mild 
and physiological conditions and is therefore suitable for applications in which cell viability is an essential 
requirement. In this work, three different types of alginate bead-based microcompartments were prepared 
and evaluated for the production of monoclonal microreactors suitable for the development of a high-
throughput platform for directed evolution of low active sortases using COPAS: 
 
1. Gel-core alginate microbeads (GCABs) 
2. Gel-core chitosan-coated alginate microcapsules (GC-CAMs) 
3. Hollow-core chitosan-coated alginate microcapsules (HC-CAMs) 
 
Gel-core alginate beads (GCABs), or simply alginate beads, were prepared by extrusion dripping and 
external gelation as described in materials end methods. Briefly, a 3 % low viscosity alginate solution was 
prepared and dispersed into alginate microdroplets through the “Prilling by vibration” technique (also 
known as laminar‐jet break‐up). Alginate microdroplets, extruded through a 150 µm nozzle, were pro-
duced at a rate of 2480 Hz and ionotropically cross-linked into a gelling bath containing calcium to obtain 
inhomogeneous alginate beads, or calcium and sodium to obtain homogeneous alginate beads. Homoge-
neity refers to the distribution of the alginate concentration throughout the bead cross section and can be 
controlled by adjusting the concentration and ratio of gelling to non-gelling cations in the gelling solution. 
Production of inhomogeneous beads with a polymer concentration at the surface being ten times higher 
than the concentration in the center have been reported (Skjåk-Bræk et al., 1989). The different distribu-
tion of alginate in inhomogeneous and homogeneous alginate beads can be seen in figure 3.20 A.  
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Typically, as indicated by light microscopy and COPAS analysis (Figure 3.20 A, B), uniform and mon-
odispersed alginate beads with a diameter of about 280 and 360 µm were obtained for inhomogeneous 
and homogenous beads respectively. In both cases, the size distribution (calculated by COPAS as coeffi-
cient of variation) ranged between 5 and 10% (Figure 3.20 B). Multiplets formation was rarely detected. 
 
 
 
 
Figure 3.20. (A) Bright field and fluorescent images of inhomogeneous (left) and homogeneous (right) alginate 
beads. Beads loaded with the fusion protein AlgQ2-GFP (see section 3.2.3.1 for details) show the distribution of 
alginate through the beads cross section. Inhomogeneous beads exhibit higher fluorescence intensity at the surface 
and lower in the centre reflecting the polymer concentration distribution. By contrast, due to the constant alginate 
concentration through the beads cross section, homogeneous beads show a constant fluorescent signal; the size bar 
corresponds to 100 µm. (B) Time-of-flight (TOF, relative estimate of the particle size) versus extinction dot‐plot 
of COPAS‐analyzed inhomogeneous alginate beads. 
 
 
Coating alginate beads with polymers was shown to improve their mechanical resistance and chemical 
stability. Due to its good biocompatibility, ease of use and low price, chitosan became one of the more 
common polymer used as coating material (Krasaekoopt et al., 2004; Serp et al., 2000) . 
Gel-core and hollow-core chitosan-coated alginate microcapsules were prepared through a modified two-
stage procedure as originally outlined by Lim and Sun (Lim and Sun, 1980) (Figure 3.21).  
The procedure comprises the formation of gel-core alginate beads (GCABs) as described above, followed 
by a membrane forming stage in which GCABs are immersed in a solution of the opposite charged poly-
mer chitosan. Adsorption of the positively charged chitosan onto the negatively charged alginate beads 
surface results in the formation of gel-core chitosan-coated alginate microcapsules (GC-CAM) with an 
alginate gel core and a polyelectrolyte complex membrane of increasing thickness with increasing incu-
bation time in the chitosan solution. Treatment of GC-CAM with a calcium-chelating agent such as so-
dium citrate causes the dissolution of the gel core template resulting in the production of hollow-core 
chitosan-coated alginate microcapsules (HC-CAMs). 
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Figure 3.21. Alginate bead-based microcompartments production scheme. Alginate solution is dispersed in mi-
crodroplets that are ionotropically cross-linked into a gelling bath containing calcium chloride. The resulting algi-
nate beads (GCABs) are incubated in a solution of the positively charged polymer chitosan that adsorbs onto the 
negatively charged alginate beads surface forming gel-core chitosan-coated alginate microcapsules (GC -CAMs). 
Treatment of GC-CAMs with sodium citrate causes the dissolution of the gel core template and leads to the for-
mation of hollow-core chitosan-coated alginate microcapsules (HC-CAMs). 
 
 
 
Previous studies have shown that long incubation times of alginate beads entrapping cells in the chitosan 
solution results in a lower cell survival rate (Chávarri et al., 2010; Krasaekoopt et al., 2004). For this 
reason, to ensure stable capsules formation while preserving cell viability, chitosan binding conditions 
were optimized to minimize the incubation time of alginate beads into the acidic chitosan solution. In 
agreement with Gåserød and colleagues (Gåserød et al., 1999, 1998) binding of chitosan was enhanced by 
using homogeneous alginate beads, by adding calcium chloride in the chitosan solution and by reducing 
the molecular weight of chitosan. Due to a lower alginate concentration at the surface, homogeneous algi-
nate beads have a more porous and open gel structure and show higher rate of binding of chitosan in 
comparison to inhomogeneous beads (Figure 3.22). Similarly, the presence of calcium chloride in the 
chitosan solution enabled a faster adsorption of chitosan onto the alginate bead surface. 
The molecular weight of the chitosan was also shown to affect both the rate and the extent of binding to 
the alginate beads with the smallest molecules showing a more rapid diffusion (Gåserød et al., 1998). 
Faster membrane formation was achieved by autoclaving the chitosan solution. The heat treatment most 
likely causes a reduction of the molecular weight of the chitosan used (Mw 50-190 kDa) allowing a better 
penetration of the chitosan molecules into the alginate gel network.  
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Under these conditions, stable gel-core chitosan-coated alginate microcapsules (GC-CAMs) with a poly-
electrolyte complex membrane thickness of about 15 µm are obtained in two minutes.  
When GC-CAMs were incubated in a solution of sodium citrate, the alginate core dissolved and the liq-
uefied alginate flowed out of the capsule generating hollow-core chitosan-coated alginate microcapsules 
(HC-CAMs). 
 
 
 
 
Figure 3.22. Effect of homogeneity degree on the binding of chitosan to the alginate beads. Shown are 
phase contrast images of hollow-core chitosan-coated alginate microcapsules obtained from inhomogene-
ous (A) and homogeneous alginate beads (B). Beads were coated with a 0.3% chitosan solution (not auto-
claved) for 15 min then treated with 50 mM sodium citrate. Due to a lower alginate concentration at the 
surface, homogeneous beads show higher rate of binding of chitosan than inhomogeneous beads which 
result in a ticker alginate-chitosan membrane. The size bar corresponds to 100 µm. 
 
 
 
Unlike alginate beads, chitosan-coated alginate microcapsules were found stable in absence of calcium or 
when exposed to either low concentrations of calcium chelating agents or high concentrations of compet-
ing ions like Na+. However, all three different types of alginate bead-based microcompartments produced 
were mechanically quite stable and appeared intact under the microscope after COPAS analysis suggest-
ing that they could support microbial cell growth and withstand the various external forces encountered 
during the whole assay. 
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3.2.2 Analysis of clones grown in alginate bead-based microcompartments 
 
For the production of microreactors, E. coli cells were suspended in the alginate solution and alginate 
bead-based microcompartments prepared as described above. Since the encapsulation method does not 
allow to strictly determine the number of cells per bead, the average bead occupancy, governed by the 
Poisson distribution, was controlled by changing the concentration of the cell suspension. Usually, to 
obtain a satisfactory fraction of colonized microreactors, an average number of two cells per bead was 
considered. 
As first step, growth of E. coli cells was qualitatively evaluated within GCABs. Microscopic analysis 
revealed that, after incubation of cells-entrapping beads in the growth-medium, cells proliferate to form 
colonies normally shaped as a sphere or an ellipsoid that occupy a small portion of the bead volume 
(Figure 3.23 A). The analysis also revealed that a colony growing near the edge of the bead causes its 
rupture with subsequent leakage of cells to the medium. During cell encapsulation, the chance that a single 
cell falls in the periphery is higher than ending up in the center of the alginate bead (Figure 3.23 B). As 
consequence, growing cells in GCBs implies a high risk of cell outgrowth, making such microreactors 
unsuitable for the development of the assay. For this reason, GCBs-based microreactors were not further 
investigated.  
 
 
 
 
Figure 3.23. Microscopic analysis of gel-core alginate beads harboring a single E. coli colony. The size bar 
corresponds to 100 µm (A) In gel-core alginate beads, E. coli cells grow to form colonies shaped as a sphere 
or an ellipsoid that occupies only a small portion of the bead volume. (B) A colony growing close to the bead 
surface causes its rupture with subsequent leakage of cells. 
 
 
 
Similar to cell growth within GCABs, cell growth within GC-CAMs resulted in the formation of a colony 
confined in a small area of the capsule. However, the presence of the polyelectrolyte membrane repre-
sented a physical barrier that prevented the rupture of the capsule when colonies grew in the bead periph-
ery (Figure 3.24 A). When GC-CAM entrapping E. coli cells were transferred into the growth medium 
supplemented with sodium citrate, the alginate gel core liquefied (forming HC-CAM) and the cells pro-
liferated to form colonies extended over the whole capsule core (Figure 3.24 B).   
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Figure 3.24. Microscopic analysis of gel-core (A) and hollow-core (B) chitosan-coated alginate bead-based micro-
reactors. The presence of the chitosan-alginate polyelectrolyte complex membrane confers on capsules high me-
chanical strength and prevents cell outgrowth. Similar to cell growth within alginate beads, cell growth within gel-
core chitosan-coated microcapsules generates colonies confined in a small area of the capsule. The addition of so-
dium citrate to the growth medium causes the dissolution of the alginate gel core and leads to the formation of 
colonies extended over the whole hollow core.  
 
 
 
Cell survival rates, determined by comparing the number of living cells encapsulated with the number of 
colonies detected in microcapsules after cell growth, showed that about 80-90 % of encapsulated cells 
survived the encapsulation procedure demonstrating that the encapsulation method, the chitosan coating, 
and the sodium citrate treatment only have a minor impact on cell viability.  
To evaluate whether the status of the core (gel or hollow) can affect the cell growth rate inside the micro-
capsules, the total number of cells grown in either gel-core or hollow-core-based microreactors was esti-
mated through an MTT reduction assay as described by Wang and colleagues (Wang et al., 2010). The 
assay relies on the reduction, by the dehydrogenase system of active cells, of the water-soluble yellow dye 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) to the water-insoluble purple form-
azan whose concentration, after dissolution in DMSO, is directly proportional to the number of metaboli-
cally active cells. 
After incubation in the growth medium for 18 hours at 28 °C the estimated final biomass in microcapsules 
with hollow-core was twice as high as in microcapsules with a gel-core indicating that the alginate gel 
matrix may provide mechanical resistance against cellular growth resulting in a slightly reduced growth 
rate. According to the MTT assay, a single hollow-core microreactor contains up to 1.5 million cells. As, 
for the strain BL21, one unit of absorbance at 600 nm was found to corresponds to about 2 x 108 cells/ml, 
a local cell density of 5×1010 cell/ml (OD600nm ≈ 250) was calculated. 
Microscopic inspection after COPAS analysis and sorting showed that cellular growth does not affect the 
stability of neither gel-core nor hollow-core-based microreactors making them both suitable for the de-
velopment of the directed evolution assay. However, due to the variability in colony size and shape, gel-
core-based microreactors provide less homogenous signals in comparison to HC-CAM-based microreac-
tors, which might result in a reduced accuracy of the optical readout during COPAS analysis and sorting. 
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In addition, due to the higher specific weight, hollow-core-based microreactors provide a much better and 
efficient gravity-driven separation of colonized microcapsules from the empty ones allowing a consider-
able reduction of working volumes and sorting analysis times (figure 3.25).  
For all the above-mentioned reasons, the hollow-core-based microreactors were preferred over the gel-
core’s. 
 
 
 
 
 
Figure 3.25. Scheme of gravity-driven separation of colonized and empty hollow-core microcapsules  
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3.2.3 Sortase-mediated conjugation within microreactors 
 
While the use of microreactors enable a large amount of enzyme variants to be analyzed at a miniaturized 
scale, the successful application of the assay for directed evolution of low active sortases however relies 
on a robust and efficient sortase-mediated conjugation reaction within the microreactors. Using the well-
characterized sortase A from S. aureus (SaSrtA) as a model, two different strategies were investigated 
with the goal to maximize the assay sensitivity and allow for detectable outputs when sortases with poor 
activity are assayed.  
Since alginate was chosen as polymer for the production of microreactors, the first strategy relied on the 
use of an alginate binding protein as the nucleophilic component of the sortase-mediated conjugation that 
takes place within microreactors. Upon cell lysis, the intracellularly expressed sortase is expected to rec-
ognize the small and free-to-diffuse exogenous fluorescent labeled recognition peptide and attach it to the 
N-terminus of the oligo-glycine-modified alginate binding protein. By interacting with the alginate bead 
matrix, the alginate binding protein would retain the fluorescent transpeptidation products inside micro-
reactors, ensuring a direct correlation between the sortase activity and the fluorescent output signal (Fig-
ure 3.26). 
 
 
 
 
Figure 3.26. Scheme of the sortase-mediated conjugation reaction within microreactors based on the use of an N-
terminally oligo-glycine-modified alginate binding protein. Upon cell lysis, the sortase enzyme recognizes the fluo-
rescent labeled recognition peptide and attach it to the N-terminus of the oligo-glycine-modified alginate binding 
protein co-expressed along with the sortase or supplied in solution. Beyond acting as nucleophile for the sortase-
mediated conjugation, the modified alginate binding protein would enable the retention of the transpeptidation prod-
ucts by interacting with the alginate contained in microreactors. 
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Distinct from the first strategy, the second strategy requires only two reaction components and relies on 
the expression of a sortase enzyme harboring a glycine tag at its N-terminus. It has been suggested that, 
in such a fusion construct, the N-terminus can access the active site in an intramolecular fashion and, due 
to the increased local substrate concentration, improve the sortase-mediated conjugation reaction rate 
(Amer et al., 2016; Piotukh et al., 2011b). In this case, in absence of a specific retention mechanism, 
transpeptidation products retention would be ensured by coating microreactors with a selective membrane 
made of the polyelectrolytes poly-allylamine hydrochloride (PAH) and poly-styrene sulfonate (PSS) (Fig-
ure 3.27). Microreactors with controlled permeability would allow the low molecular weight fluorescent 
recognition peptide (≈ 1 kDa) to diffuse inside and take part in the sortase-mediated conjugation reaction 
while would prevent the higher molecular weight transpeptidation products (≈ 20 kDa) from diffusing 
out. 
 
 
 
 
Figure 3.27. Scheme of the sortase-mediated conjugation within PSS-PAH-coated microreactors based on the use 
of an N-terminally oligo-glycine modified sortase. Upon cell lysis, the N-terminally oligo-glycine-modified sortase 
captures the fluorescent labeled recognition peptide through an intramolecular transpeptidation reaction. Transpep-
tidation products retention is ensured by the presence of a selective polyelectrolyte shell that surrounds microreac-
tors.  
 
 
Because of the lower affinity of SaSrtA for the recognition peptide substrate as compared to the oligo-
glycine nucleophile, the assay was formatted so that the fluorescent labeled recognition peptide substrate 
is supplied exogenously. By lowering the concentration of the peptide provided during each round of the 
directed evolution experiment, this format would allow to increase the evolutionary pressure and select 
for variants with improved peptide recognition capabilities and thus with higher catalytic efficiencies.  
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3.2.3.1 Conjugation and product capture strategy based on AlgQ2 
 
In this work, three putative alginate-binding proteins were selected and investigated as the nucleophilic 
component of the sortase-mediated conjugation reaction within microreactors.  
The first one, AlgQ2 from Sphingomonas species, was selected because its structure was previously de-
termined (Momma et al., 2002) and because it was shown to specifically bind alginate (Momma et al., 
2005). However, due to its size, AlgQ2 showed low expression rate, especially when co-expressed with 
the sortase enzyme. For this reason, two smaller putative alginate binding protein domains were probed 
as alternative to AlgQ2: (i) the C-terminal carbohydrate-binding domain of AlgX (AlgX-C) from Pseu-
domonas aeruginosa involved  in the biosynthesis of alginate (Riley et al., 2013) and (ii) the carbohydrate-
binding motif (CBM) of the “sugar binding protein” from Bacteroides thetaiotamicron that in addition 
carries an Alginate Lyase domain. 
In view of using the alginate binding proteins as nucleophiles in the sortase-mediated conjugation reac-
tion, 5 glycine residues were introduced at the N-terminus of the amino acid sequences used for gene 
synthesis. As the cloning method used in this work introduces a serine residue after the N-terminal me-
thionine (considered to be removed by the expression host enzyme methionine amino peptidase (Frottin 
et al., 2006), the “cloning scar” serine residue must be changed into another glycine residue in order to 
obtain alginate binding proteins with a glycine tag at the N-terminus.  
First, to evaluate the alginate binding ability of these three putative alginate binding proteins, the corre-
sponding genes were overexpressed in E. coli fused at the C-terminal with GFP. Unfortunately, among 
them, only the fusion construct AlgQ2-GFP was expressed in soluble form and could be purified through 
affinity chromatography. 
To analyze the alginate-binding ability of AlgQ2, homogeneous alginate microbeads were prepared and 
incubated with the purified AlgQ2-GFP (87 kDa). As negative control, alginate microbeads were incu-
bated either with GFP (30 kDa) or with a similar size protein also fused to GFP (VvGT5-GFP, 79 kDa) 
which should not display any alginate binding ability. Since the average pore size diameter for a 3 % 
alginate gels was found to be about 15 nm (Li et al., 1996), AlgQ2-GFP, with an estimated Stokes radius 
of approximately 3.8 nm (Erickson, 2009) is expected to diffuse out from alginate beads after washing 
unless it is retained through interaction with alginate. Fluorescence microscopy analysis revealed that 
only alginate beads incubated with AlgQ2-GFP retain fluorescence demonstrating that AlgQ2 indeed has 
alginate binding properties (Figure 3.28). 
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Figure 3.28. AlgQ2 displays alginate beads binding properties. About 2000 homogeneous alginate beads were 
incubated with 500 nM of either GFP, VvGT5-GFP or AlgQ2-GFP in 25 mM Tris/HCl pH 8.0, 10 mM CaCl2 
for 30 minutes then washed with the same buffer overnight. Shown are the beads in bright field and as fluores-
cence images (Exposure time 1/500s). Only alginate beads incubated with AlgQ2-GFP retain fluorescence. 
Molecular weight and Stokes radius (Rs) are reported for each protein. The size bar corresponds to 100 µm.  
 
 
 
Next, to establish whether the N-terminally oligo-glycine-modified AlgQ2 would work as nucleophile in 
a sortase-mediated conjugation reaction, sequence encoding for Gly5-AlgQ2 was transferred in an ex-
pression vector (p7XC3H) yielding AlgQ2 with the N-terminus SGGGGG (Ser-Gly5-AlgQ2). After, as 
mentioned above, the “cloning scar” serine was changed into another glycine residue to yield AlgQ2 with 
six glycine at its N-terminus (Gly6-AlgQ2). Upon expression and purification, Gly6-AlgQ2 was incu-
bated with the FITC-labeled peptide substrate bearing the recognition motif LPXTG in presence of the 
enhanced version of sortase A (eSaSrtA) (Figure 3.29 A). After separation of reaction components by 
SDS-PAGE, the fluorescence scan of the gel revealed the presence of a strong linkage between the fluo-
rescent peptide and Gly6-AlgQ2 but not with either BSA or Ser-Gly5-AlgQ2 used as negative controls 
(Figure 3.29 B). Beyond showing that Gly6-AlgQ2 works as nucleophile in the sortase-mediated conju-
gation and it is therefore suitable for the development of the microreactor-based assay, this experiment 
confirmed the importance of the presence of the N-terminal glycine residue to achieve efficient conjuga-
tion. 
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Figure 3.29: AlgQ2 acts as a nucleophile in a sortase-mediated conjugation reaction. (A) Reaction scheme for 
the sortase-mediate conjugation of the fluorescent recognition peptide to the N-terminally oligo-glycine mod-
ified AlgQ2. (B) Gel-based conjugation assay; eSaSrtA (1 µM) was mixed with 2 µM FITC-LPXTGE and 
2 µM of either Gly6-AlgQ2, bovine serum albumin (BSA) or Ser-Gly5-AlgQ2 in 25 mM Tris/HCl pH 8.2, 
150 mM NaCl, 10 mM CaCl2 and incubated in for 1 hour at 30 °C. The formation of transpeptidation products 
was analyzed by SDS-PAGE gel fluorescence scanning (right panel). Equal protein loading was assessed by 
staining the gel with Coomassie (left panel). Lane 1: eSaSrtA alone; lane 2: Gly6-AlgQ2 alone; Lane 3: 
No eSrtA; lane 4: No Gly6-AlgQ2; lane 5: reaction with BSA; lane 6: reaction with Ser-Gly5-AlgQ2; lane 7: 
reaction with Gly6-AlgQ2.  
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3.2.3.1.1 Sortase-mediated conjugation within alginate beads 
 
A requirement for the use of microreactors for directed evolution purposes is that the sortase enzyme, 
released from colonies upon cell lysis, retains activity in the environment of the alginate bead matrix and 
efficiently catalyzes the conjugation of the fluorescent labeled recognition peptide to the N-terminally 
oligo-glycine modified molecule. The capability of eSaSrtA to conjugate the fluorescent peptide to Gly6-
AlgQ2 within alginate beads was therefore examined. To this end, homogeneous gel-core alginate beads 
(GCABs) were prepared and incubated with recombinant eSaSrtA and Gly6-AlgQ2 for protein loading. 
After washing the alginate beads to remove unbound proteins, the reaction was initiated by the addition 
of FITC-LPXTGE. Following one-hour incubation, beads were washed to remove unreacted substrate 
peptides thereby terminating the reaction. As the fluorescent recognition peptides linked to Gly6-AlgQ2 
were supposed to remain inside the alginate beads, fluorescent beads were expected if the sortase-medi-
ated conjugation reaction takes place. As revealed by fluorescence microscopy analysis, high fluorescent 
signals were obtained with beads loaded with both Gly6-AlgQ2 and eSaSrtA incubated with the fluores-
cent specific peptide (Figure 3.30 A1). Conversely, beads loaded only with Gly6-AlgQ2 or beads loaded 
with both proteins but incubated with a fluorescent labeled peptide not recognized by eSaSrtA (FITC-
NPNTG) appeared not fluorescent demonstrating that the reaction is dependent both on the SaSrtA activ-
ity and on its substrate specificity and that the fluorescent recognition peptide can freely diffuse through 
the alginate bead matrix. (Figure 3.30 A2, A3). In addition, SDS-PAGE analysis of the bead samples 
followed by fluorescence scanning of the gel confirmed the linkage between Gly6-AlgQ2 and the fluo-
rescent recognition peptide proving the feasibility of the sortase-mediated conjugation reaction within the 
alginate bead environment (Figure 3.30 B) 
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Figure 3.30. (A) SaSrtA-mediated conjugation within alginate beads. (1) About 1000 alginate beads were incubated 
with 2 µM eSaSrtA and 8 µM Gly6-AlgQ2 for 30 min then washed to remove unbound proteins. The reaction was 
initiated by adding 10 µM FITC-LPXTGE. After 1 hour incubation at 30 °C, beads were washed to remove unreacted 
peptide and then analyzed by fluorescence microscopy (Exposure time 1/50s). Beads loaded with Gly6-AlgQ2 only 
(2) or reacted with the class B-specific peptide FITC-DNPNTGDE (3) were used as negative controls. (B) Coo-
massie staining and fluorescence scan of the SDS-PAGE gel of the bead sample 1 (S1) depicted in A1 showing the 
linkage between SaSrtA and the fluorescent recognition peptide. 
 
 
 
When alginate beads loaded only with eSaSrtA were incubated with FITC-LPXTGE, fluorescent beads 
were observed (Figure 3.31 A). Interestingly, the fluorescence analysis by SDS-PAGE/fluorescence scan-
ning, revealed a linkage between the fluorescent peptide and the eSaSrtA itself (Figure 3.31 B).  
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Figure 3.31. (A) About 1000 alginate beads were incubated with 2 µM eSaSrtA for 30 min then washed to 
remove unbound protein. After 1-hour incubation with 10 µM FITC-LPXTGE at 30 °C, beads were washed to 
remove unreacted peptide and then analyzed by fluorescence microscopy (Exposure time 1/50s). (B) Fluores-
cence scan of the SDS-PAGE gel of the bead sample (S) depicted in A1 showing the linkage between SaSrtA 
and the fluorescent recognition peptide. 
 
 
 
Previous studies have reported that in absence of a dedicated nucleophile SaSrtA forms a stable thioacyl 
intermediate with the recognition peptide substrate (Bellucci et al., 2015; Dasgupta et al., 2011). However, 
the progressive upshift of the band corresponding to SaSrtA along with a decreasing fluorescence inten-
sity, strongly suggested that one or more fluorescent peptides have been linked to the SaSrtA molecule. 
As SaSrtA was shown to transfer LPXT motifs to the ε amino-group of lysine residues through a non-
canonical isopeptide ligation (Bellucci et al., 2015; McConnell et al., 2018) it is likely that, in addition to 
the thioacyl intermediate, species in which one or more the fluorescent peptides are linked to exposed 
lysine residues of the SaSrtA protein can be formed. 
To confirm this hypothesis and evaluate the occurrence of stable thioacyl intermediates formation, SaSrtA 
was reacted with FITC-LPXTGE in absence of Gly6-AlgQ2 and the resulting fluorescent SaSrtA product 
subsequently purified from the excess of fluorescent peptide by using a desalting column (Figure 3.32 
A). When the fluorescent SaSrtA product was incubated for 18 hours in absence of nucleophile, a slightly 
reduction of the fluorescent signal was observed in comparison to samples incubated for one hour (Figure 
3.32 B). This reduction, which, correspond to about 30 and 17 % of the total product in presence and in 
absence of calcium respectively, is most likely associated to the resolution of the thioacyl intermediate by 
the hydrolysis side reaction. As consequence, the remaining fluorescent product might therefore consist 
of SaSrtA possibly linked to one or more fluorescent peptide molecule at lysine residues level.  
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Notably, no fluorescent signal reduction was observed when Gly6-AlgQ2 was added to enforce the thio-
acyl intermediate resolution further confirming that in addition to the thioacyl intermediate, stable link-
ages between fluorescent peptides and lysine residues of SaSrtA may occur through an intermolecular 
isopeptide ligation. 
 
 
 
 
 
 
 
Figure 3.32. (A) Reaction scheme for thioacyl intermediate formation and purification. Recombinant eSaSrtA was 
incubated with FITC-LPXTGE in absence of nucleophile and the resulting fluorescent product purified from the 
fluorescent peptide by using a desalting column (B) The purified product (2 µM) was incubated in 25 mM Tris/HCl 
pH 8.2, 150 mM NaCl for 1 or 18 hours, with or without CaCl2 (10 mM), and in the absence or in presence of the 
nucleophile Gly6-AlgQ2 (8 µM). Intermediate-solving reactions were analyzed by SDS-PAGE gel fluorescence 
scanning (right panel). Band signal intensities were quantified with ImageJ. Fluorescent signals were normalized to 
total protein loading assessed by staining the gel with Coomassie (left panel). 
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3.2.3.1.2 Analysis of the fusion protein Gly6-AlgQ2-eSaSrtA 
 
 
With the goal to reduce the diffusion of eSaSrtA from alginate beads and enhance the sensitivity of the 
sortase-mediated conjugation assay within alginate beads, the fusion protein Gly6-AlgQ2-eSrtA was con-
structed by linking the C-terminus of the Gly6-AlgQ2 alginate binding protein with the N-terminus of the 
eSaSrtA enzyme via a GSGS linker. 
When alginate beads, loaded with the purified Gly6-AlgQ2-eSrtA (without any further nucleophile addi-
tion) were incubated with FITC-LPXTGE for one hour, alginate beads appeared highly fluorescent. The 
analysis of the beads content by SDS-PAGE and fluorescence scanning revealed a linkage between the 
construct Gly6-AlgQ2-eSrtA and the FITC-labeled recognition peptide and raised the question whether 
the conjugation reaction occurs intra or inter-molecularly (Figure 3.33).  
 
 
 
 
 
 
 
Figure 3.33. (A) About 1000 alginate beads were incubated with 2 µM Gly6-AlgQ2-eSrtA for 30 min then washed 
to remove unbound protein. After 1 hour incubation with 10 µM FITC-LPXTGE at 30 °C, beads were washed to 
remove unreacted peptide and analyzed by fluorescence microscopy (Exposure time 1/50s). (B). Coomassie-staining 
and fluorescence scan of SDS-PAGE gel of the bead sample (S) depicted in figure A showing the linkage between 
Gly6-AlgQ2-SrtA and the fluorescent recognition peptide. 
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To establish whether the conjugation reaction occurs intra or inter-molecularly, a gel-based conjugation 
assay was set up in which Gly6-AlgQ2-eSrtA was reacted at three different concentrations (10, 1 and 
0.1 µM) with an excess of the fluorescent substrate peptide (FITC-LPXTGE) and subsequently analysed 
by SDS-PAGE for fluorescence quantification (Figure 3.34 A). When, after 2 and 10 min incubation, 
equal amounts of Gly6-AlgQ2-eSrtA were analysed by SDS-PAGE and gel fluorescence scanning, com-
parable amounts of labeled protein were observed for the three reactions (Figure 3.34 B). If the interme-
diate resolving step of the reaction is rate-limiting and occurs intermolecularly, we would expect a 100-
fold lower fluorescent signal intensity for the reaction at the lowest protein concentration (0.1 µM) com-
pared to the reaction at the highest protein concentration (10 µM) as observed for the unmodified SaSrtA 
(see figure 3.38 B). Still, as shown in figure 3.35, in comparison to the reaction performed with equimolar 
concentration of Gly6-AlgQ2 and eSaSrtA (10 µM), the reaction performed with Gly6-AlgQ2-eSrtA 
showed increased reaction rate therefore suggesting that Gly6-AlgQ2-eSrtA labels itself intramolecularly. 
These results were in agreement with a recent study by Amer and colleagues who showed that in a fusion 
construct involving SaSrtA the glycine tag at the N-terminus can access the enzyme active site in an 
intramolecular fashion (Amer et al., 2016). As suggested in this study, the presence of the oligo-glycine 
nucleophile substrate and the sortase enzyme within the same polypeptide might improve the reaction rate 
by increasing the effective nucleophile concentration in proximity of the active site of the enzyme. 
 
 
 
 
 
 
 
Figure 3.34. (A) Reaction scheme for the fusion Gly6-AlgQ2-eSrtA-mediated conjugation (B) Gel-based conjuga-
tion assay; the fusion protein Gly6-AlgQ2-SrtA was incubated at three different concentrations (10, 1 or 0.1 µM) in 
25 mM Tris/HCl pH 8.2, 150 mM NaCl, 10 mM CaCl2 with an excess of FITC-LPXTGE (40 µM) for 2 and 
10 minutes. Equal amounts of Gly6-AlgQ2-eSrtA (3 pmol) from each reaction were analyzed by SDS-PAGE gel 
fluorescence scanning (right panel). Equal protein loading was assessed by staining the gel with Coomassie (left 
panel). Comparable amounts of labeled protein detected for the three reactions suggest that Gly6-AlgQ2-eSrtA la-
bels itself intramolecularly. 
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Figure 3.35. (A) Comparison of the eSrtA-mediated conjugation performed with 10 µM Gly6-AlgQ2-eSrtA 
(lane 1) or 10 µM of Gly6-AlgQ2 and 10 µM eSaSrtA (lane 2) for 5 minutes. 
 
 
 
Beyond providing improved reaction rates, the use of fusion construct Gly6-AlgQ2-eSrtA set the stage 
for a new two-components conjugation platform that allows to overcome limitations associated with the 
supply of the oligo-glycine nucleophile substrate within microreactors. For instance, when Gly6-AlgQ2 
was co-expressed with the wild type SaSrtA, very poor expression yields were observed for both proteins 
making co-expression an inadequate approach for the nucleophile supply (Figure 3.36). Since even lower 
expression yields would be expected when Gly6-AlgQ2 is co-expressed with the construct Gly-AlgQ2-
eSrtA (needed to prevent the diffusion of the sortase enzyme from microreactors), the use of the fusion 
construct Gly6-AlgQ2-SrtA was preferred over the use of the two separate proteins for the validation of 
the strategy based on the use of the alginate binding protein AlgQ2. However, while the use of two sepa-
rate proteins would allow for multiple turnover kinetics the use of the fusion protein Gly6-AlgQ2-SrtA 
limits the reaction to single turnover. 
 
 
 
 
Figure 3.36. SDS-PAGE (left) and Western blot analysis (right) showing expression yields of SaSrtA alone (lane 
1), SaSrtA and Gly6-AlgQ2 (lane 2) and Gly6-AlgQ2-SrtA (lane 3) in E. coli BL21. Protein expression was achieved 
by the addition of 0.5 mM IPTG to exponential growing cells for 18 hours at 28 °C. Lane M designates the ladder. 
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3.2.3.2 Conjugation strategy based on N-terminally oligo-glycine-modified sortases 
 
Inspired by the intramolecular conjugation mechanism observed with Gly6-AlgQ2-SrtA and by the pre-
viously described phage-display assay by Schwarzer and co-workers (Piotukh et al., 2011b), five glycine 
residues were added at the N-terminus of the wild type sortase A (G5-SrtA), and the ability of this con-
struct to capture the fluorescent substrate peptide by an intramolecular reaction was subsequently evalu-
ated.  
Interestingly, when G5-SrtA was overexpressed in E. coli a significant reduction in protein expression 
was observed in comparison to the unmodified sortase A. In the attempt to explain this observation, the 
length of the sequence at the amino terminus was varied between one, two or three glycine residues (to 
achieve G1-SrtA, G2-SrtA and G3-SrtA respectively) and the expression-activity relationship of these 
modified sortases was analysed through the gel-based conjugation assay. Whole cell extracts (WCE) 
were incubated with the FITC-LPETGE and subsequently analysed by SDS-PAGE and fluorescence scan-
ning (Figure 3.37). As can be seen in the Coomassie-stained gel, the presence of one or more glycine 
residues at the N-terminus of SaSrtA results in a notable reduction of protein expression with G5-SrtA 
showing the lowest expression yield. However, the fluorescence scan of the gel revealed a massive im-
provement of the fluorescent signal intensity for single or multiple glycine-modified SaSrtA as compared 
to the unmodified enzyme. 
 
 
 
 
Figure 3.37 Expression-activity relationship of wild type unmodified (G0) and N-terminally glycine-modified 
SaSrtA (G1-G5). Whole cell extracts (WCE) in 25 mM Tris/HCl pH 8.2, 150 mM NaCl, 10 mM CaCl2 of E. coli 
cultures expressing SaSrtA variants were incubated with FITC-LPETGE for 3 hours at 30 °C and subsequently 
analysed by SDS-PAGE (left) and fluorescence scanning (right). The addition of one (G1) or more (G2, G3, G5) 
glycine residues at the N-terminus of SaSrtA causes a protein expression reduction. However, in comparison to 
wild type SaSrtA (WT), N-terminally glycine-modified SaSrtA variants show improved reaction rates. 
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To establish whether the observed reactions occur intra or inter-molecularly, the wild type SaSrtA with a 
single glycine at its N-terminus (G-SrtA) was purified and a gel-based conjugation assay was performed 
as described above for the fusion protein Gly6-AlgQ2-eSrtA (section 3.2.3.1.2). Similarly, when G-SrtA 
was incubated at at three different concentrations with an excess of the fluorescent substrate peptide and 
an equal amount of protein were analysed by SDS-PAGE followed by fluorescence scanning of the gel, 
comparable amounts of labeled protein were observed for the three reactions (Figure 3.38 A). Similar to 
what observed for Gly6-AlgQ2-eSrtA, the linkage of the fluorescent peptide to the amino-terminal glycine 
of the enzyme seems to occur intramolecularly. In support of this assumption is the different labeling 
behaviour observed with the unmodified eSaSrtA. In this case, the amount of protein labeled was propor-
tional to the protein concentration (Figure 3.38 B). However, it is not clear how, in absence of a flexible 
linker, the amino group of the glycine at the N-terminus reaches the active site of the enzyme (Figure 
3.38 C).  
As for the fusion construct Gly6-AlgQ2-eSrtA, the use of a N-terminally oligo-glycine-modified sortase 
allows for a two-component sortase-mediated conjugation platform that facilitate the execution of the 
microreactor-based assay. Moreover, due to the higher expression yield of G-SrtA as compared to Gly6-
AlgQ2-eSrtA, the assay based on the use of an N-terminally oligo-glycine-modified sortase is expected 
to provide higher sensitivity. 
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Figure 3.38. G-SrtA intramolecular labeling evaluation. (A) Gel-based conjugation assay; G-SrtA was incubated at 
three different concentrations (50, 5 or 0.5 µM) with FITC-LPETGE (200 µM) in 25 mM Tris/HCl pH 8.2, 150 mM 
NaCl, 10 mM CaCl2 for 5 and 30 minutes at 30 °C. Equal amounts of G-SrtA (10 pmol) from each reaction were 
analyzed by SDS-PAGE gel fluorescence scanning (right panel). Equal protein loading was assessed by staining the 
gel with Coomassie (left panel). Similar to Gly6-AlgQ2-SrtA, comparable amounts of labeled protein detected for 
the three reactions suggest that G-SrtA labels itself intramolecularly. The conjugation of the fluorescent peptide to 
the amino-terminal glycine of G-SrtA causes the upshift of the band corresponding to G-SrtA. (B) Gel-based con-
jugation assay as in A performed with the unmodified eSaSrtA for 5 minutes showing that the amount of labeled 
protein is proportional to the protein concentration. (C) The NMR-derived structural ensemble of SaSrtAΔN59 in 
complex with the peptide substrate shows the reduced flexibility of its N-terminal region and raise the question of 
how the glycine residue at the N-terminus of G-SrtA reaches the active site. 
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3.2.4 Layer-by-layer coating to control capsule permeability 
 
Although the use of an N-terminally oligo-glycine-modified sortase would represent an alternative to the 
use of the fusion Gly6-AlgQ2-sortase, this approach requires a different mechanism for preventing the 
enzyme and the relative fluorescent transpeptidation product to escape microreactors. To this end, inspired 
by the work of Hollfelder and co-workers, we decided to investigate the utility of a layer-by-layer (LBL) 
coating technique. LBL assembly of thin films made of polyelectrolytes of opposite charges onto template 
particles has been used to affect the permeability of microcapsules (Antipov and Sukhorukov, 2004), 
(Price et al., 2010). Among the polyelectrolyte coating pairs used, the pair PSS and PAH (poly-styrene 
sulfonate and poly-allylamine hydrochloride respectively; figure 3.39 C) is one of the most studied and 
has been successfully applied to produce stable and semipermeable microcapsules for high-throughput 
purposes with a molecular weight cut-off ranging from 2 to 6 kDa (Fischlechner et al., 2014; Mak et al., 
2008). Consequently, by using PSS and PAH for the coating, the fluorescent recognition substrate peptide 
with a molecular weight of about 1 kDa should be able to diffuse inwards and outwards from microreac-
tors while molecules with a molecular weight above the cut-off value should remain encapsulated. To test 
this, GFP-expressing HC-CAM-based microreactors were used as templates for the sequential deposition 
of PSS and PAH and, upon cell lysis, analyzed for their capability to retain the GFP (30 kDa). As can be 
seen in figure 3.39 A microreactors coated with one layer of either PSS or PAH were found highly per-
meable to GFP while microreactors coated with one layer of PSS and one layer of PAH already retained 
99% of GFP as compared to uncoated microreactors. When PAH was deposited as first layer followed by 
PSS more than 60% of GFP was found in solution indicating that efficient layer-by-layer coating of chi-
tosan-alginate microcapsules requires the interaction between the negatively charged PSS and the posi-
tively charged chitosan (Figure 3.39 B). Interestingly, when a PSS solution without calcium chloride was 
used for coating (PSS*), only 10 % of the GFP was retained inside microreactors suggesting that, as 
previously reported for chitosan, the presence of calcium chloride  possibly improves the deposition of 
PSS by increasing the porosity of the chitosan-alginate complex membrane. 
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Figure 3.39. (A) Analysis of PSS-PAH coating on capsule permeability. GFP-expressing HC-CAM-based microre-
actors were differently coated using the coating pair PSS and PAH and, upon cell lysis, evaluated for their capability 
to retain the GFP. Microreactors coated with one layer of PSS followed by one layer of PAH (PSS/PAH) retained 
99% of GFP as compared to uncoated microreactors. Assembly of the PSS-PAH shell is impaired when a PSS 
solution without CaCl2 (PSS*) is used. (B) Schematic illustration of PSS-PAH-coated HC-CAM. (C) Chemical 
structures of PSS and PAH. 
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3.2.5 Encapsulated cell lysis optimization 
 
In order to make the fluorescent labeled recognition peptide accessible to the intracellularly expressed 
sortase enzyme, a cell lysis step is required before the sortase-mediated conjugation reaction can take 
place in microreactors. Disruption of encapsulated cells was achieved by treating microreactors with Bug-
Buster (Merck Millipore), a mixture of non-ionic detergents capable of cell wall and membrane perfora-
tion. To determine the appropriate BugBuster concentration to obtain efficient cell lysis, microreactors 
lacking the PSS/PAH coating were treated with different concentrations of the detergents mixture and cell 
viability was evaluated through the MTT reduction assay (see section 3.2.2 for details).  
According to the MTT assay results, about 97% of encapsulated cells were not viable after treatment with 
0.25 X BugBuster for 30 minutes (Figure 3.40 A). Equivalent results were obtained with PSS/PAH-
coated microreactors, indicating that the presence of the shell does not affect cell lysis efficiency (data 
not shown). 
To ensure that the MTT assay outcome correlates with an efficient cell lysis, the release of GFP from 
GFP-expressing microreactors was also analysed. As shown in figure 3.40 B, after treatment with 0.25 X 
BugBuster for 5 and 30 minutes, microreactors released only about 17 and 29 % of GFP respectively. 
Although most of the cells appeared dead after treatment with 0.25 X BugBuster, the release of GFP was 
not efficient suggesting that cells were not completely lysed. On the other hand, when microreactors were 
treated with 0.5 X BugBuster about 82 % of the GFP was already present in the supernatant after 5 minutes 
incubation and about 93 % after 15-30 minutes. No significant improvement was observed at higher de-
tergent concentration.  
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Figure 3.40. Effect of BugBuster concentration on cell lysis. (A) Cell viability determination through the MTT 
reduction assay at increasing BugBuster concentrations. (B) Analysis of the relative GFP released in the supernatant 
from GFP-expressing microreactors at increasing BugBuster concentrations. 
 
 
 
In addition to BugBuster, the benefit of using the commercial autolytic strain XJb (DE3) to improve cell 
lysis efficiency was also analysed. In this strain, the arabinose-induced expression of the bacteriophage λ 
endolysin is supposed to weaken the cell wall allowing higher cell lysis efficiency. As shown in figure 
3.41, GFP-expressing microreactors prepared using this strain released in the supernatant about 97 % of 
GFP after treatment with 0.2 X BugBuster. By contrast, GFP-expressing microreactor prepared using the 
standard expression strain BL21 (DE3) released about four fold less protein at the same conditions. Alt-
hough the autolytic strain alone cannot be used as alternative to the chemical cell lysis, it allows to con-
siderably reduce the amount of BugBuster needed. 
 
 
 
 
Figure 3.41. Analysis of the GFP release in the supernatant from microreactors harboring GFP-expressing 
BL21 or XJb at increasing BugBuster concentrations. 
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3.2.6 Unreacted fluorescent substrate peptide washing optimization 
 
With the aim to detect even minimal fluorescence intensity changes between samples, the reduction of 
the fluorescent background after incubation of microreactors with the fluorescent substrate peptide was 
highly desirable. In order to achieve an efficient removal of unreacted fluorescent substrate peptides, a 
series of detergents were screened for their capability to break up electrostatic and hydrophobic interac-
tions that may occur between the fluorescent recognition peptide substrate and the cellular or capsule 
components.  
In a preliminary screen, microreactors expressing the inactive sortase A (SaSrtA-C184G) were treated 
with BugBuster for cell lysis and, after washing, incubated with the fluorescent labeled peptide FITC-
LPXTGE. Upon removal of the supernatant, microreactors were incubated with a washing solution con-
taining one of the detergents selected for the screen. Three non-ionic (Tween 20, TritonX-100, IGEPAL 
CA630) and one zwitterionic detergents (Zwittergent 3-14) were used because unlike ionic detergents are 
considered to be “mild” thereby allowing proteins to retain their native structure and function. Following 
washing steps without detergents, microreactors were examined for the residual fluorescence by fluores-
cence microscopy. The results of this screen showed that efficient peptide removal is possible by using 
washing solutions containing 0.1% Triton-X 100 or Zwittergent 3:14. 
To confirm these results and to further optimize peptide washing conditions, microreactors expressing 
either Gly6-AlgQ2-SrtA or the inactive Gly6-AlgQ2-SrtA-C184G were reacted with FITC-LPXTGE and 
subsequently washed with Triton-X 100 or Zwittergent 3:14 before COPAS analysis. In addition, the 
influence of the ionic strength and the pH of the washing solution was evaluated.  
By calculating the ratio between the median value of the green fluorescent signal of the wild type and the 
inactive population respectively, the extent of the fluorescence intensity change between the two popula-
tions was determined for each condition. The results have shown that higher ratios, and therefore best 
washing conditions to reduce the fluorescence background, are obtained with Triton X-100 or Zwittergent 
3:14 at pH 10 (figure 3.42). These conditions were found optimal for both uncoated and PSS-PAH-coated 
microreactors. 
 
 
74 
 
 
 
Figure 3.42. Unreacted peptide washing analysis; microreactors expressing either Gly6-AlgQ2-SrtA or the in-
active Gly6-AlgQ2-SrtA-C184G were reacted with 50 µM FITC-LPETGE for 18 hours at 30 °C and subse-
quently washed three times with either 25 mM MES pH 6, 25 mM Tris/HCl pH 8 or 25 mM Glycine pH 10 for 
5 minutes. Washing at pH 10 was also performed in presence of either 1 M NaCl, 0.1% Zwittergent 3-14 or 0.1% 
Triton X-100. Following COPAS analysis, the ratio (R) between the median value of the green fluorescent signal 
for microreactors expressing the wild type and the inactive SaSrtA was calculated for each condition. Higher 
ratios, and therefore best washing conditions were obtained at pH 10 in presence of Triton X-100 or Zwittergent 
3:14. Shown are overlays of histograms of microreactors analyzed with COPAS.  
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3.2.7 Fluorescence normalization with Propidium Iodide 
 
With the goal to precisely screen for sortase mutants with higher activity, the green fluorescent signal 
developed by the sortase activity should be normalized for the amount of sortase assayed within each 
microreactor. Supposing that the expression of the mutant enzymes remains approximately constant, the 
amount of enzyme assayed within microreactors will be proportional to the number of lysed cells that can 
be quantified by using propidium iodide (PI), a red fluorescent DNA intercalating agent that cannot cross 
the membrane of live cells. Once bound to DNA, its fluorescence is enhanced 20-30 fold and with a 
fluorescence emission maximum at 617 nm can be used in combination with FITC to quantify the lysed 
biomass within each microreactor during COPAS analysis and sorting (figure 3.43).  
 
 
 
 
 
 
 
Figure 3.43. (A) Excitation and emission spectra simulation of Fluorescein isothiocyanate (FITC) and propid-
ium iodide (PI). FITC and PI emission spectra overlap can be corrected by COPAS through fluorescence com-
pensation (B) Bright field (upper panel) and fluorescence microscopy analysis (lower panels) of microreactors 
incubated with propidium iodide after BugBuster treatment showing that at increasing cell densities (from left 
to right) correspond increasing red fluorescence signals. The size bar corresponds to 100 µm. 
 
 
 
76 
 
3.2.8 Genotype recovery from individual microreactors 
 
The recovery of the genotype from individual microreactors was possible using two alternative strategies: 
PCR and electroporation. In both cases, microreactors were dissolved to make the plasmid accessible. 
While dissolution of uncoated microreactors was simply achieved by treatment with NaHCO3 (MA Xiao-
Jun, 2004), dissolution of PSS-PAH-coated microreactors required a short treatment with a solution of 
NaOH (pH ≥ 12) to deprotonate the polycation PAH and disassemble the polyelectrolyte complex shell 
(Déjugnat and Sukhorukov, 2004). 
As can be seen in figure 3.44, amplification of the gene of interest from the plasmid was possible from 
microreactors at each phase of the assay workflow (untreated, lysed, reacted, washed). However, no am-
plification product was observed when a dissolved empty bead, taken from the reaction mixture, was used 
as template for PCR reaction showing that microreactors do not exchange the plasmids between microre-
actors during the whole assay duration. 
Although PCR is very sensitive and would allow to amplify few DNA molecules, direct transformation 
of the plasmid into the expression strain would simplify the assay workflow. When electrocompetent 
BL21 cells were electroporated, up to 500 transformants were obtained from a single uncoated microre-
actor. Possibly, due to complexation of the plasmid with the polycation PAH, slightly lower transfor-
mation efficiencies (up to 150 CFU) were achieved by using individual PSS-PAH-coated microreactors. 
 
 
 
 
Figure 3.44. Genotype can be recovered from a single microreactor by PCR or electroporation (A) Agarose 
gel electrophoresis of PCR reactions performed using as template a single microreactor from each phase of the 
assay workflow. NC: Negative control (No template), PC: Positive control, M: DNA Ladder, U: Untreated 
microreactor, L: Lysed microreactor, R: Reacted microreactor, W1: Microreactor after 1 hour peptide washing, 
W2: Microreactor after 2 hours peptide washing, NCB: Not-colonized microreactor before treatments, NCA: 
Not-colonized microreactor after treatments. (B) LB agar plate showing transformants obtained after electro-
poration into E. coli BL21 of an aliquot of a single dissolved PSS-PAH-coated microreactor. 
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3.2.9 Validation of the microreactor-based assay 
 
Following the optimization of the various steps of the assay, the complete procedure was tested using 
uncoated microreactors expressing the Gly6-AlgQ2-SrtA and PSS-PAH-coated microreactors expressing 
the construct G-SrtA.  
 
 
3.2.9.1 Validation of the assay with Gly6-AlgQ2-wtSaSrtA 
 
To assess the functionality of the assay with Gly6-AlgQ2-SrtA, the ability of the intracellularly expressed 
fusion protein to capture exogenous fluorescent peptide within hollow-core-based microreactors was ex-
amined. To this end, individual E. coli cells, harbouring the plasmid encoding either Gly6-AlgQ2-SrtA 
wild type or the inactive Gly6-AlgQ2-SrtA-C184G were encapsulated within hollow-core chitosan-algi-
nate microcapsules and grown to generate microreactors expressing the respective fusion protein. Follow-
ing cell lysis with BugBuster, microreactors were washed to remove excess of the detergent mixture and 
the sortase-mediated conjugation initiated by the addition, in the reaction buffer, of the FITC-labeled 
peptide carrying the recognition sequence LPETG specific for SrtA (FITC-LPETGE). After removal of 
unreacted substrate peptide, microreactors were analyzed by fluorescence microscopy and COPAS to 
evaluate the extent of reaction. The workflow of the assay is schematized in figure 3.45 A. As shown in 
figure 3.45 B and C, in comparison to microreactors expressing the inactive construct Gly6-AlgQ2-SrtA-
C184G, microreactors expressing Gly6-AlgQ2-SrtA wild type exhibited high levels of fluorescence indi-
cating a substantial conjugation and capture of the fluorescent peptide.  
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Figure 3.45. (A) Workflow of the assay performed with microreactors expressing the construct Gly6-AlgQ2-SrtA. 
(B, C) Microscope and COPAS analysis showing successful conjugation and capture of the fluorescent peptide 
FITC-LPETGE within microreactors expressing Gly6-AlgQ2-SrtA wild type (WT). Microreactors expressing Gly6-
AlgQ2-SrtA-C184G were used as negative control. After encapsulation within HC-CAM, cells were grown in TB 
auto for 18 hours at 30 °C. For the reaction, microreactors were lysed in 25 mM Tris pH 8.2, 150 mM NaCl, 10 mM 
CaCl2 and incubated in the same buffer with 10 µM FITC-LPETGE for 16 hours at 30 °C. (B) Bright field (upper 
panel) and fluorescence pictures (lower panel) of reacted microreactors. Fluorescence exposure time 1/50s; the size 
bar corresponds to 100 µm. (C) Overlay of histograms of Gly6-AlgQ2-SrtA wild type (blue) and Gly6-AlgQ2-SrtA-
C184G (red) microreactors analyzed with COPAS. The ratio (R) between the median value of the green fluorescent 
signal of microreactors expressing the wild type and the inactive SaSrtA is given. 
 
 
 
To confirm that the fluorescent signal originates from the Gly6-AlgQ2-SrtA-mediated intramolecular 
capture of the fluorescent substrate peptide, microreactors were dissolved and protein samples analyzed 
by SDS-PAGE and fluorescence scanning. In addition, western blot analysis was performed to verify 
whether the construct Gly6-AlgQ2-SrtA, by interacting through the AlgQ2 moiety with the alginate in 
the microreactors, is specifically retained inside microreactors (Figure 3.46).  
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Figure 3.46. Coomassie-stained SDS-PAGE gel (left), fluorescence scan (middle) and western blot analysis (right) 
of samples of Gly6-AlgQ2-SrtA-expressing microreactors incubated without fluorescent peptide (lane2), with the 
class B specific peptide FITC-DNPNTGDE (lane3) and with the class A specific peptide FITC-LPETGE (lane4). 
The fluorescence scan shows that most of the fluorescent signal comes from unrelated E. coli proteins labeled by 
SaSrtA. The western blot analysis shows that after cell lysis and reaction (lane 2, 3, 4) the fusion protein Gly6-
AlgQ2-SrtA is not retained inside microreactors as compared to untreated microreactors (lane 1). The Coomassie-
stained gel confirmed equal protein loading. 
 
 
 
Consistent with previous results, fluorescent signals were generated with microreactors expressing Gly6-
AlgQ2-SrtA wild type incubated with the recognition peptide specific for SaSrtA (FITC-LPETGE, lane 
4) but not in absence of recognition peptide (lane 2) or with a class B specific peptide (FITC-DNPNTGDE, 
lane 3). Interestingly, despite a fluorescent protein of the size of Gly6-AlgQ2-SrtA was detected in the 
fluorescence scan, the majority of the signal arises from unrelated E. coli proteins labeled by SaSrtA 
possibly at N-terminus glycine or exposed lysine residues. Although the labeling of E. coli proteins en-
hance the total fluorescent signal intensity thereby increasing the assay sensitivity, the directed evolution 
strategy based on the use of Gly6-AlgQ2-SrtA might select for variants with a reduced specificity towards 
the oligo-glycine acceptor substrate. In addition, as indicated by western blot analysis, considerable 
amount of the Gly6-AlgQ2-SrtA was found to diffuse out from reacted microreactors (lane 2, 3, 4) as 
compared to untreated ones (lane 1). As the release of the fusion construct was also observed from gel-
core microreactors (data not shown), we thought that the release of Gly6-AlgQ2-SrtA may be independent 
of the presence of alginate in the capsule core. In the attempt to explain this observation, we found that 
the interaction between AlgQ2 and the alginate is reverted in presence of 150 mM sodium chloride nor-
mally employed during the assay. Likely, sodium ions shield the negative charges of the alginate thereby 
preventing electrostatic interaction with AlgQ2 (Figure 3.47). 
 
 
 
 
Figure 3.47. Binding analysis of AlgQ2 to alginate beads at increasing NaCl concentrations. About 2000 
alginate beads were incubated in 25 mM Tris pH 8.0, 10 mM CaCl2 with 500 nM of AlgQ2-GFP then washed 
for 30 min with the same buffer containing increasing NaCl concentrations. Shown are the alginate beads in 
bright field and as fluorescence images (Exposure time 1/500s). The size bar corresponds to 100 µm 
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In addition to the above-mentioned issues, when C-terminal fusion constructs with AlgQ2 were purified 
by affinity chromatography, a smaller protein was always co-purified (figure 3.48 A). On the basis of the 
band size, it was speculated that this second product was the result of a degradation event occurring at the 
C-terminal region of AlgQ2. As consequence, beyond the need of a second purification step to obtain 
pure fusion constructs, the putative degradation of the fusion Gly6-AlgQ2-SrtA represented an issue for 
the development of the microreactor-based assay as it could negatively affect the assay sensitivity. 
The determination of the N-terminal sequence of this protein product (EDMAN degradation service, 
FGCZ, Zurich) revealed that the putative degradation event occurs in correspondence of the two consec-
utive methionine residues Met505 and M506 located within the C-terminal helix of AlgQ2 (figure 3.48 B). 
 
 
 
Figure 3.48. (A) SDS-PAGE analysis of Gly6-AlgQ2-eSrtA purification showing the presence of an additional 
protein product in the eluate fraction (E). (B) AlgQ2 structural model generated with Chimera from the atomic 
coordinates of 1KWH (Momma et al., 2002). The C-terminal helix and the putative cleavage site are highlighted in 
cyan and magenta respectively. 
 
 
 
To assess whether degradation could be avoided by removing the putative degradation site, AlgQ2 was 
shortened at the C-terminus by 6, 12 and 18 amino acids (meaning the partial or total removal of the C-
terminal helix of AlgQ2) and the resulting AlgQ2 variants fused with eSaSrtA were purified by affinity 
chromatography. The SDS-PAGE analysis did not provide any evidence about the removal of this second 
protein product but rather showed that shortening AlgQ2 at the C-terminal impair the stability of the 
relative fusion proteins (figure 3.49).  
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Figure 3.49. SDS-PAGE analysis of the purification of Gly6-AlgQ2ΔC6, Gly6-AlgQ2ΔC12 and Gly6-AlgQ2ΔC18 fusion 
constructs with eSrtA. Shortening of the C-terminus of AlgQ2 impairs the stability of the resulting fusion proteins. 
M: Protein Ladder; WCE: whole cell extract; S: Clarified cell lysate; FT: Flow through; E: Eluate 
 
 
 
Next, to test whether this side product may originate from the messenger RNA translation starting from 
this downstream methionine, the RBS translation rate calculator (Espah Borujeni et al., 2014; Salis et al., 
2009) was employed to predict the translation rate from each putative start codon of the messenger RNA 
encoding for AlgQ2. This tool makes use of a free energy model to calculate the total binding free energy 
between the ribosome and mRNA and relate the total free energy change to the mRNA’s translation ini-
tiation. The analysis revealed for the start codon corresponding to the methionine 506 the third highest 
value of translation rate among other putative in frame start codons (the first highest being the first me-
thionine residue downstream the promoter) therefore suggesting translation from this methionine residue. 
To test this hypothesis, we employed the RBS translation rate calculator to identify which silent nucleotide 
base substitutions upstream Met505 and M507 codons caused a reduction of the translation rate from these 
residues. For instance, when codons encoding for AlgQ2 residues Gln501 and Val502 were changed from 
CAG and GTT to CAA and GTC respectively, the predicted translation rate starting from codons encoding 
for Met505 and M507 decreased from 1208 to 24 and 39 (au) respectively. When the fusion protein Gly6-
AlgQ2-eSrtA containing the above-mentioned mutations was expressed and purified using the same pro-
cedure as for the unmodified Gly6-AlgQ2-eSrtA, the presence of the small side product was drastically 
reduced (figure 3.50). Although further analysis would be required, this result clearly supported the hy-
pothesis of protein translation from an internal methionine residue.  
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Figure 3.50. Purification of the fusion protein Gly6-AlgQ2-eSrtA constructed after the RBS translation rate 
analysis. The construct contains silent mutations in the codons codifying for the residues Gln501 and Val502 of 
AlgQ2 that are predicted to reduce the translation rate from the internal methionine 506 and 507. The SDS-
PAGE analysis revealed a notable reduction of the presence of the side product. M: Protein Ladder; WCE: whole 
cell extract; S: Clarified cell lysate; FT: Flow through; E: Eluate 
 
 
 
Although a significant fluorescent change was observed for microreactor expressing Gly6-AlgQ2-SrtA 
wild type in comparison to those expressing Gly6-AlgQ2-SrtA-C184G, the results have shown that the 
fusion construct and the relative fluorescent transpeptidation products are not retained within microreac-
tors. This prevent a direct correlation between the sortase activity and the fluorescent output signal making 
the conjugation and product capture strategy based on the alginate binding protein AlgQ2 unsuitable for 
the development of the assay. 
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3.2.9.2 Validation of the assay with G-SaSrtA  
 
To assess the functionality of the assay using the single glycine-modified SrtA (G-SrtA), microreactors 
expressing either G-SrtA wild type or the inactive G-SrtA-C184G were prepared and subsequently coated 
with a single layer of PSS and PAH. Following cell lysis, incubation with FITC-LPETGE and unreacted 
peptide removal, microreactors were analysed for the fluorescence. As expected, fluorescence microscopy 
and COPAS analysis revealed higher level of fluorescence for microreactors expressing the wild type     
G-SrtA as compared to those expressing the inactive enzyme demonstrating the ability of G-SrtA to cap-
ture the fluorescent substrate peptide within PSS-PAH-coated microreactors (Figure 3.51). 
 
 
 
 
 
 
 
Figure 3.51. (A) Workflow of the assay performed with PSS-PAH-coated microreactors expressing the construct 
G-SrtA (B, C) Microscope and COPAS analysis showing successful conjugation and capture of the fluorescent 
peptide FITC-LPETGE within microreactors expressing G-SrtA wild type. Microreactors expressing G-SrtA-
C184G were used as negative control. After encapsulation within HC-CAM, cells were grown in TB auto for 
18 hours at 30 °C. Following PSS-PAH coating, microreactors were lysed in 25 mM Tris pH 8.2, 150 mM NaCl, 
10 mM CaCl2 and subsequently incubated in the same buffer with 10 µM FITC-LPETGE for 16 hours at 30 °C. (B) 
Bright field (upper panel) and fluorescence pictures (lower panel) of reacted microreactors. Fluorescence exposure 
time 1/50s; the size bar corresponds to 200 µm. (C) Histogram overlay showing fluorescence distribution of G1-
SrtA wild type (red) and G1-SrtA-C184G (blue)-expressing microreactors populations analyzed with COPAS. The 
ratio (R) between the median value of the green fluorescent signal of microreactors expressing the wild type and the 
inactive SaSrtA is given. 
84 
 
Next, to prove that PSS-PAH-coated microreactors behave as isolated reaction compartments and effi-
ciently retain G-SrtA during the whole application duration, microreactors were mixed in 1:10 ratio of 
wildtype:C184G and following PSS-PAH coating were reacted with FITC-LPETGE in the same tube. 
The same mixture of uncoated microreactors was used as control. The fluorescence microscopy analysis 
revealed that, in both mixtures, about 10% of total microreactors (those expressing G-SrtA wild type) 
exhibited higher level of fluorescence in comparison to the remaining 90%. However, coated microreac-
tors displayed greater fluorescence than uncoated microreactors indicating a better retention of G-SrtA 
within PSS-PAH-coated microreactors (Figure 3.52 A). Accordingly, when reacted PSS-PAH-coated or 
uncoated microreactors expressing G-SrtA wild type were dissolved and analyses by SDS-PAGE and gel 
fluorescence scanning, the majority of G-SrtA was found to diffuse out from uncoated microreactors. On 
the other hand, as comparable amounts of G-SrtA were detected in both untreated (U) and reacted (R) 
samples, the presence of the PSS-PAH shell efficiently prevented G-SrtA from escaping coated micro-
capsules (Figure 3.52 B) 
 
 
 
 
Figure 3.52. The PSS-PAH shell prevents the diffusion of G-SrtA. (A) Microscope analysis of reacted mixtures of 
G1-SrtA wild type (WT) and C184G-expressing microreactors in a 1 to 10 ratio. When coated, microreactors ex-
pressing G-SrtA wild type display higher level of fluorescence than uncoated microreactors demonstrating a better 
retention of G-SrtA.; the size bar corresponds to 200 µm. (B) Coomassie-stained SDS-PAGE gel and fluorescence 
scan of PSS-PAH-coated and uncoated G1-SrtA-expressing microreactors before any treatment (Untreated, U) and 
after reaction (Reacted, R). In comparison to uncoated microreactors, PSS-PAH-coated microreactors ensure the 
retaining of G-SrtA. 
 
 
 
Interestingly, while the reaction performed within uncoated microreactors expressing Gly6-AlgQ2-SrtA 
typically led to a 20-fold increase in fluorescence intensity (see figure 3.45 A), the reaction performed 
within PSS-PAH-coated microreactors expressing G-SrtA typically showed comparable or lower fluores-
cence intensities. However, comparison of the total fluorescent signal obtained by reacting whole cell 
extracts of cultures expressing either Gly6-AlgQ2-SrtA or G-SrtA with FITC-LPETGE (Figure 3.53) 
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clearly indicate that much higher levels of fluorescence are expected for PSS-PAH-coated microreactors 
expressing G-SrtA than for uncoated microreactors expressing Gly6-AlgQ2-SrtA. This observation sug-
gests that the presence of the PSS-PAH polyelectrolyte shell might hamper the proper diffusion of the 
fluorescent recognition peptide inside PSS-PAH-coated microreactors thereby reducing the catalytic ef-
ficiency of G-SrtA. Although further optimizations that allow to precisely control the diffusion of mole-
cules through the polyelectrolyte shell are required, the results have shown that the microreactor-based 
assay that rely on this strategy can be employed for the laboratory evolution of sortases. 
 
 
 
 
Figure 3.53. Comparison of Gly6-AlgQ2-SrtA and G-SrtA conjugation efficiency in whole cell extracts at different 
time points shows that much higher level of fluorescence and therefore higher sensitivity for the assay can be ob-
tained using the construct G-SrtA. For the reaction, whole cell extracts were reacted with 50 µM FITC-LPETGE in 
25 mM Tris/HCl pH 8.2, 150 mM NaCl, 10 mM CaCl2 at 30 °C.  
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3.2.10  Microreactor-based assay with sortase B from B. anthracis 
 
Once established for SaSrtA, the functionality of the microreactor-based assay was probed for sortase B 
from B. anthracis. Due to its very low activity, this sortase represents a very challenging target for directed 
evolution.  
First, as described for SaSrtA, the fusion protein Gly6-AlgQ2-SrtB was constructed, purified and analysed 
for its capability to capture intramolecularly the fluorescent recognition peptide FITC-DNPNTGDE. As 
previously described for Gly6-AlgQ2-eSrtA (section 3.2.3.1.2), when Gly6-AlgQ2-SrtB was incubated 
at three different concentrations with FITC-DNPNTGDE, comparable amounts of labeled protein were 
generated independently of the protein concentration (Figure 3.54). Even in this case, in comparison to 
the reference reaction performed with equimolar concentrations of Gly6-AlgQ2 and BaSrtB (lane Ref), 
reactions performed with Gly6-AlgQ2-SrtB displayed a much higher conjugation efficiency, indicating 
that, similar to Gly6-AlgQ2-eSrtA, Gly6-AlgQ2-SrtB labels itself through an intramolecular reaction. 
 
 
 
 
Figure 3.54. Gly6-AlgQ2-SrtB intramolecular labeling evaluation. The recombinant fusion protein Gly6-AlgQ2-
SrtB was incubated at three different concentrations (10, 1 or 0.1 µM) with an excess of FITC-DNPNTGDE (40 µM) 
in 25 mM Tris/HCl pH 8.2, 150 mM NaCl, 10 mM CaCl2 for 20 hours. The reaction performed with equimolar 
concentrations (10 µM) of Gly6-AlgQ2 and SrtB was used as reference (Ref). 3 pmol of Gly6-AlgQ2-SrtB from 
each reaction were analyzed by SDS-PAGE gel fluorescence scanning (right panel). Equal protein loading was as-
sessed by staining the gel with Coomassie (left panel). Comparable amounts of labeled protein for the three reactions 
and higher conjugation efficiency compared to the reaction performed with separate components suggest that Gly6-
AlgQ2-SrtB labels itself intramolecularly.  
 
 
 
However, when the ability of Gly6-AlgQ2-SrtB to capture the fluorescent substrate peptide was examined 
within microreactors, no increase in fluorescence intensity was detected with COPAS for microreactors 
expressing Gly6AlgQ2-SrtB wild type as compared to microreactors expressing the inactive Gly6-AlgQ2-
SrtB-C233G (Figure 3.55). 
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Figure 3.55. Histogram overlays showing fluorescence distribution of Gly6-AlgQ2-SrtB wild type (red) and Gly6-
AlgQ2-SrtB-C233G (blue)-expressing microreactors populations analyzed with COPAS after 24, 48 and 72 hours 
reaction. No fluorescence change was detected for microreactors expressing Gly6-AlgQ2-SrtB wild type as com-
pared to microreactors expressing the inactive Gly6-AlgQ2-SrtB-C233G. 
 
 
As shown for SaSrtA, in the attempt to improve the conjugation efficiency, the N-terminus of BaSrtB was 
elongated by the addition of one, two or three glycine residues and the expression-activity relationship of 
these modified sortases was analysed. Unlike SaSrtA, no significant protein expression reduction was 
observed for the modified BaSrtB. However, as observed for SaSrtA, a single glycine at the N-terminus 
was sufficient to provide a significant reaction rate improvement (Figure 3.56). Although no additional 
experiments were performed, it is likely that, as for G-SrtA, G-SrtB labels itself through an intramolecular 
conjugation reaction. 
 
 
 
 
Figure 3.56. Expression-activity relationship of wild type and N-terminally glycine-modified BaSrtB. Whole 
cell extracts (WCE) of E. coli cultures expressing SrtB variants were incubated with 50 µM FITC-DNPNTGDE 
in 25 mM Tris/HCl pH 8.2, 150 mM NaCl, 10 mM CaCl2 for 20 hours at 30 °C and subsequently analysed by 
SDS-PAGE (left) and fluorescence scanning (right). In comparison to the unmodified wild type SrtB (G0-SrtB), 
the presence of one (G1) or more glycines (G2, G3) at the N-terminus results in a significant reaction rate im-
provement. Unlike N-terminally glycine-modified SrtA, the addition of glycine residues does not cause a protein 
expression reduction. The conjugation of the fluorescent peptide to the amino-terminal glycine of sortases causes 
the upshift of the corresponding bands. 
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Despite the significant improvement in conjugation efficiency, when G-SrtB wild type was reacted with 
FITC-DNPNTGDE within PSS-PAH-coated microreactors, no change in the fluorescence intensity was 
detected for the population of microreactors expressing G-SrtB as compared to the population of those 
expressing the inactive G-SrtB-C233G (Figure 3.57). However, when whole cell extracts obtained by 
dissolving microreactors were reacted with FITC-DNPNTGDE, G-SrtB wild type appeared efficiently 
labeled (Figure 3.58). As mentioned above for the construct G-SrtA (section 3.2.9.2), it is possible that 
the low conjugation efficiency of G-SrtB within PSS-PAH-coated microreactors depends on the presence 
of the PSS-PAH shell that prevent the efficient supply by diffusion of the fluorescent substrate peptide. 
In addition, as the cell density within microreactors was calculated about 15 fold higher than in whole cell 
extracts, it is also possible that the proper diffusion of the fluorescent peptide inside microreactors is 
hampered by the high-density cell debris clump. 
 
 
 
 
Figure 3.57. Microscope and COPAS analyses of reacted microreactors expressing either G1-SrtB wild type or the 
inactive G1-SrtA-C233G. After encapsulation within HC-CAM, cells were grown in TB auto for 18 hours at 30 °C. 
Following PSS-PAH coating, microreactors were lysed in 25 mM Tris/HCl pH 8.2, 150 mM NaCl, 10 mM CaCl2 
and incubated in the same buffer with 100 µM FITC-DNPNTGDE for 40 hours at 30 °C. (A) Bright field (upper 
panel) and fluorescence pictures (lower panel) of reacted microreactors. Fluorescence exposure time 1/50s; the size 
bar corresponds to 200 µm. (B) Histogram overlay showing fluorescence distribution of G1-SrtB wild type (red) 
and G1-SrtB-233G (blue)-expressing microreactors populations analyzed with COPAS. No change in the fluores-
cence intensity was detected for the wild type population of microreactors expressing G-SrtB as compared to those 
expressing the inactive G-SrtB-C233G. 
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Figure 3.58. Conjugation efficiency of G-SrtB is much higher in whole cell extracts than in microreactors. Coo-
massie-stained SDS-PAGE gels and fluorescence scans of G1-SrtB-mediated conjugation reactions in microreactors 
(left) and in whole cell extracts obtained by sonicating about 2000 microreactors in 500 µl (right). Both microreac-
tors and whole cell extracts were reacted with 100 µM FITC-DNPNTGDE in 25 mM Tris pH 8.2, 150 mM NaCl, 
10 mM CaCl2 for 16 hours at 30 °C. G1-SrtB-C233G was used as negative control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
3.2.11  Microreactor-based assay with PaSrtF 
 
In addition to BaSrtB, the functionality of the assay was probed with the newly identified PaSrtF. 
Since PaSrtF was shown to be soluble and active only at high salt concentration and having understood 
that AlgQ2 is released from alginate in presence of salt thereby preventing efficient transpeptidation prod-
uct retention, the sortase-mediated conjugation and product capture strategy based on the use of AlgQ2 
was not investigated. Similar to SaSrtA and BaSrtB, the wild type PaSrtF was modified by the addition 
of one or more glycines at the N-terminus and the protein expression of these proteins analyzed by SDS-
PAGE. As can be seen in figure 3.59 A, the addition of one glycine caused a strong reduction of protein 
expression, which appeared almost abolished when two or more glycine residues were present. However, 
the transpeptidation activity analysis of these modified proteins revealed that only G1-SrtF is able to ef-
ficiently capture the fluorescent recognition peptide to generate acceptable readouts (Figure 3.59 B).  
 
 
 
 
Figure 3.59 (A) Expression analysis of wild type (WT) and N-terminally glycine-modified SrtF. The addition of 
one glycine residue (G1) at the N-terminus of SrtF causes a significant protein expression reduction. Addition of 
two or more glycine residues (G2-G5) almost abolish protein expression. (B) Expression-activity relationship of 
wild type (WT) and N-terminally glycine-modified SrtF. Whole cell extracts (WCE) of E. coli cultures expressing 
SrtF variants were incubated with 50 µM FITC-LPETGE in 50 mM Tris-HCl pH 7.65, 500 mM NaCl, 10 mM CaCl2 
for 20 hours at 25 °C and subsequently analysed by SDS-PAGE (left) and fluorescence scanning (right). In compar-
ison to the wild type enzyme, G1-SrtF shows improved reaction rates. Because of the very low expression yield, 
others glycine-modified SrtF variants do not show significant transpeptidation activity. 
 
 
 
When PSS-PAH-coated microreactors expressing G-SrtF wild type were reacted with FITC-LPETGE, 
they appeared more fluorescent than microreactors expressing the inactive G-SrtF homologue (C195G) 
demonstrating the suitability of the assay for directed evolution of PaSrtF (Figure 3.60).  
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Figure 3.60. Microscope and COPAS analysis showing successful conjugation and capture of the fluorescent pep-
tide FITC-LPETGE within microreactors expressing G-SrtF wild type. Microreactors expressing G-SrtF-C195G 
were used as negative control. After encapsulation within hollow-core microcapsules, cells were grown in TB me-
dium for 20 hours at 28 °C then induced for protein expression with 0.2 mM IPTG for 20 hours at 16 °C. Following 
PSS-PAH coating, microreactors were lysed and incubated with 50 µM FITC-LPETGE in 50 mM Tris-HCl pH 7.65, 
500 mM NaCl, 10 mM CaCl2 for 21 hours at 25 °C. (A) Bright field (upper panel) and fluorescence pictures of 
reacted microreactors using FITC and TRITC filters (middle and lower panel respectively). Fluorescence exposure 
time was 1/25s and 1/2000s for FITC and TRITC filter respectively; the size bar corresponds to 200 µm. (B) Histo-
gram overlays showing fluorescence distribution of G1-SrtF wild type (red) and G1-SrtF-195G (blue)-expressing 
microreactors populations before (upper panel) and after (lower panel) green signal normalization for the red fluo-
rescent signal obtained by using propidium iodide. The ratio (R) between the median value of the green fluorescent 
signal of microreactors expressing the wild type and the inactive PaSrtF is given. 
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3.3 Directed evolution of PaSrtF 
 
3.3.1 Library construction and analysis 
 
In the absence of a reliable structure-function relationship, diversification of the SrtF-Pa gene was 
achieved by error prone PCR (ep-PCR). First described by Goeddel and co-workers (Goeddel D, 1989), 
epPCR became the most used and convenient random mutagenesis technique for the diversification of a 
defined segment of DNA and has been successfully applied to evolve a large number of enzymes includ-
ing SaSrtA. 
By taking advantage of the low fidelity of some DNA polymerases under certain conditions, random point 
mutations can be introduced into the gene of interest through a simple PCR amplification reaction and the 
average number of mutations can be controlled by the number of PCR cycle performed.  
Random mutagenesis of the SrtF-Pa gene by ep-PCR was achieved by following the protocol described 
by Wilson and Keefe (Wilson and Keefe, 2000) which is based on the method of Cadwell and Joyce 
(Cadwell and Joyce, 1992). The method relies on increasing magnesium concentrations, increasing and 
unbalancing the concentration of the four nucleotides and on the addition of manganese in the PCR reac-
tion buffer to reduce base-pairing fidelity to increase the polymerase mutation rate while maintaining low 
the mutational bias.  
For this random mutagenesis protocol, Wilson and Keefe calculated the average of amino acid mutations 
per open reading frame as a function of ORF length and number of ep-PCR doublings (Figure 3.61).  
 
 
 
 
Figure 3.61. Average number of amino acid mutations per open reading frame (ORF) as a function 
of ORF length and number of ep-PCR doublings  (Wilson and Keefe, 2000).  
 
 
 
Taking this calculation as a guide, the number of doublings required to introduce the desired average of 
1.5 amino acid in PaSrtF ORF of 522 base pairs was determined to be 5.4. 
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Prior to performing the actual ep-PCR reaction, known amounts of the template (2.5, 5 and 10 ng) were 
amplified under mutagenic conditions for 10 cycles. The total yield of epPCR product after 10 cycles, 
estimated by comparing the intensity of the epPCR samples with the intensity of the gel standard loaded 
alongside on an ethidium bromide-stained agarose allowed to calculate an amplification efficiency of 1.6. 
The number of cycles required to duplicate the template DNA 5.4 times with an amplification efficiency 
of 1.6.was therefore determined to be 8. 
After the reaction, successful amplification was confirmed by DNA gel electrophoresis and the resulting 
ep-PCR products were cloned into the recipient digested expression vector to yield a full size library of 
ligation product that encode for N-terminal single glycine-modified PaSrtF mutants. By electroporating 
an aliquot of the purified ligation into electrocompetent BL21 (DE3) cells, a total library size of 107  trans-
formants was estimated.  
In order to verify the success of the epPCR and analyze the library composition, plasmid DNA was iso-
lated and sequenced from 14 clones. Alignment of each PCR product with the unmutated parental gene 
revealed the presence of point mutations randomly distributed throughout the target sequence demonstrat-
ing the positive outcome of the mutagenesis method (Table 3.3).  
 
 
                          Table 3.3. Summary of mutational events of 14 sequenced clones after ep-PCR 
 
Clone Codon Nucleotide change Amino acid change 
1 101 AAT ---> GAT Asn ---> Asp 
2 55 
126 
183 
GGT ---> GGC 
GCC ---> ACC 
ATT ---> TTT 
--- 
Ala ---> Thr 
Ile ---> Phe 
3 129 
179 
TAT ---> AAT 
CCG ---> TCG 
Tyr ---> Asn 
Pro ---> Ser 
4 74 TCC ---> TCT --- 
5 105 
124 
160 
TCT ---> CCT 
GTG ---> GTA 
CAG ---> CTG 
Ser ---> Pro 
--- 
Gln ---> Leu 
6 181 AGC ---> TGC Ser ---> Cys 
7 53 
188 
AAA ---> AGA 
AAT ---> TAT 
--- 
Asn ---> Tyr 
8              --- --- --- 
9 160 CAG ---> CGG Gln ---> Arg 
10 74 
79 
92 
160 
TCC ---> ACC 
AAA ---> TAA 
ACC---> -CC 
CAG ---> TAG 
Ser ---> Thr 
Lys ---> STOP 
Frameshift 
Gln ---> STOP 
11 54 
175 
AAA---> GAA 
AAA ---> TAA 
Lys ---> Glu 
Lys  --->STOP 
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12 --- --- --- 
13 151 ATT ---> ACT Ile --->Thr 
14 --- --- --- 
 
 
 
Although the total number of these mutations was low for a significant statistical analysis, the average 
number of mutations introduced in the SrtF gene was in agreement with the expected value of 1.5. How-
ever, the calculated ratio of transitions (purine-to-purine and pyrimidine-to-pyrimidine mutations) to 
transversions (purine-to-pyrimidine and pyrimidine-to-purine mutations) of 1.6, revealed a notable bias 
towards transitions over transvertions.  
Moreover, the analysis of the library compositions with the web program PEDEL-AA (Firth and Patrick, 
2008) allowed to estimate that the library will contain about 94% of variants without additional stop co-
dons or insertion and deletions and that about the 66% of the library will contain at least one mutation. 
 
 
 
3.3.2 Library encapsulation  
 
For library encapsulation, an aliquot of the purified library ligation was electroporated into an aliquot of 
electrocompetent BL21 and the total number of viable clones was estimated by counting the number of 
transformants achieved after plating on a LB agar plate an aliquot of the recovery.  
As the encapsulation of randomly dispersed cells follows the Poisson distribution, the average number of 
cells per bead was controlled by adjusting the number of cells added to the alginate solution prior to 
microbeads formation. To reduce the probability that multiple cells are encapsulated and avoid ambiguous 
results during analysis, the number of viable transformants was therefore used to calculate the volume of 
the recovery culture to disperse in the alginate solution to achieve a satisfactory degree of monoclonality. 
For instance, when a dilution of one cell per five beads was made (0.2 cells/bead), 16% of the alginate 
beads were expected to harbor a single cell while only 1% of them were expected to harbor more than one 
cell. On the other hand, 82% of beads do not contain cells and are expected to generate empty microcap-
sules. Analysis of microreactor after cell proliferation showed that about 20% of the total were colonized 
demonstrating the reliability of the method used for the encapsulation of the library and confirming that 
the procedure to prepare microreactors have a minimal effect on cell viability. 
Although the low degree of cell occupancy allows to increase the fraction of monoclonal microreactors, 
the higher the degree of dilution the higher will be the number of empty microcapsules meaning larger 
production volumes and longer sorting and analysis times. To overcome this problem, in a previous study 
(Walser et al., 2008), a COPAS-based technology was developed to enrich microcompartments colonized 
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by green fluorescent E. coli from empty ones. However, in this work, the use of hollow-core microcap-
sules for library encapsulation offers the great advantage to provide a fast and efficient gravity-driven 
separation of colonized microcapsules from empty microcapsules. In fact, due the high specific weight, 
colonized microreactors sediment faster than the not-colonized ones and can be easily separated from the 
latter (see section 3.2.2, figure 3.25). 
 
 
 
3.3.3 Preliminary library screening  
 
To validate the assay workflow a preliminary library screening was performed.  
Starting from 25 ml alginate that generate about 106 compartments, 2 x 105 transformants were encapsu-
lated to achieve a cell/droplet ratio of 1:5. As expected, after cell proliferation about 20% of total micro-
capsules were colonized by cells. Following separation from empty microcapsules through gravity sepa-
ration, microreactors were coated with a layer of PSS and a layer of PAH and after cell lysis incubated 
with the 50 µM FITC-LPETGE for 20 hours at 25 °C. After unreacted peptide removal, the brightest 3% 
of the microreactors were separated on the basis of the green fluorescent signal and following the addition 
of propidium iodide microreactor were re-sorted on the basis of the green: red fluorescence ratio. Best 
hits were subsequently dispensed into a microtiter plate. Two of the selected microreactors were dissolved 
and plasmid recovered by electroporation. Sequencing analysis performed in triplicate confirmed the pres-
ence of one or three point mutations. Interestingly, both isolated clones contained a point mutation at the 
same position that resulted in the conversion of the threonine residue 213 (T213) into either a serine or an 
alanine residue. (figure 6.3 A). 
To assess whether the two isolated G1-SrtF mutants showed improved catalytic properties, their ability to 
conjugate the fluorescent recognition peptide FITC-LPETGE to Gly6-AlgQ2 in comparison to the wild 
type G1-SrtF was investigated in whole cell extracts through a gel-based conjugation assay.  
As can be seen in figure 6.3 B the assay did not reveal any significant catalytic improvement for the two 
SrtF mutants as compared to the wild type variant. Although the library screening efforts described are 
only preliminary, the successful execution of the whole assay workflow proof the validity of the directed 
evolution strategy developed. 
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Figure 6.3. (A) Amino acid mutations found in the two isolated SrtF clones. (B) Analysis of the conjugation 
efficiency of G1-SrtF mutants and G1-SrtF wild type. Whole cell extracts of E. coli cultures expressing SrtF wild 
type or SrtF mutants were mixed with 10 µM Gly6-AlgQ2 and 50 µM of fluorescent peptide FITC-LPQTGE in 
50 mM sodium phosphate pH 8.5, 500 mM NaCl and incubated for 1 or 3 three hours at 25 °C. The extent of the 
transpeptidation reaction was analyzed by SDS-PAGE gel fluorescence scanning (right panel) and quantified 
with imageJ. Equal protein loading was assessed by staining the gel with Coomassie (left panel). Lane M desig-
nates the protein ladder; Mut1 and Mut2 indicate the G1-SrtF mutants (as in A) while WT the wild type variant. 
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4      Conclusions and outlook 
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In recent years, sortase enzymes have emerged as powerful tools for protein engineering applications. 
Sortase-mediated ligation methods have proven effective for building a diverse range of peptide and pro-
tein conjugates in a site-specific fashion and can now be considered a valuable alternative to chemical 
ligation methods. Sortase-mediated ligations proceed under physiological conditions and require only two 
short motifs, the C-terminal sortase recognition sequence (i.e. LPXTG) and an N-terminal glycine tag, 
which can easily be introduced into proteins or other molecular probes, either by genetic engineering or 
by chemical synthesis. A major shortcoming of sortase enzymes concerns their general poor reaction rates. 
The most active naturally occurring sortase enzyme identified so far, as well as the best characterized, is 
the class A member from the Gram-positive Staphylococcus aureus (SaSrtA). An evolved pentamutant 
variant of SaSrtA (eSaSrtA) exhibiting more than 2 orders of magnitude increase in activity was identified 
in a yeast-display-based directed evolution screen (I. Chen et al., 2011). At present, the majority of the 
sortase-mediated ligation protocols rely on the use of the wild type SaSrtA and its evolved variant 
eSaSrtA. The industrial partner of this work, NBE therapeutics AG, designed and developed a new plat-
form known as SMAC-technology (sortase-mediated antibody conjugation technology) for the site-spe-
cific conjugation of drugs to antibodies using sortase enzymes (Beerli et al., 2015). Antibody-drug con-
jugates (ADCs) generated using eSaSrtA were found to display in vitro and in vivo potencies similar to 
ADCs prepared by conventional chemical conjugation methods. One promising feature of the SMAC-
technology concerns the possibility to conjugate different drugs onto one single antibody using sortases 
with different specificities (biorthogonal conjugation) thereby increasing the cancer killing effectiveness 
of ADCs. In order to identify novel sortase enzymes that can be used, for instance, in combination with 
eSaSrtA for biorthogonal conjugation, seven naturally occurring sortases were selected as targets for ac-
tivity and specificity characterization. Focus was laid on sortases from classes with a predicted specific-
ity orthogonal to the LPXTG-specificity of SaSrtA. 
Among sortases investigated in this work, sortase B from B. anthracis (BaSrtB) yielded sufficient trans-
peptidation products that enabled for the first time the detailed sequence specificity analysis of a non-
class A sortase (Puorger et al., 2017). By recognizing the consensus sequence NPNTG, BaSrtB exhibits 
sequence specificity orthogonal to SaSrtA and could be used for dual sortagging applications. However, 
the disappointingly catalytic activity of BaSrtB (estimated 104-fold lower than eSaSrtA) precludes its use 
for biorthogonal sortagging but makes this sortase an ideal target for directed evolution. 
Unlike BaSrtB, the member of the not-yet-characterized class F from Propionibacterium acnes (PaSrtF) 
exhibits excellent catalytic features and set itself to become a valid alternative to the most thoroughly 
employed SaSrtA. With an activity comparable to SaSrtA, PaSrtF proved to tolerate high salt concentra-
tions which would enable broader applicability for sortagging approaches. Determination of the substrate 
specificity showed that, similar to eSaSrtA, PaSrtF prefers substrates carrying the consensus recognition 
sequence LPXTG. Although the overlap of the substrate spectrum prevents the use of PaSrtF in combi-
nation with eSaSrtA for biorthogonal sortagging, PaSrtF was successfully used for generation of highly 
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homogeneous ADCs displaying target-specific cell killing activity and potency similar to eSaSrtA-conju-
gated ADCs (Di Girolamo et al., 2019). The use of SrtF for sortagging was patent protected by NBE 
Therapeutics AG.  
Apart from the use of PaSrtF for protein engineering, the characterization of PaSrtF paves the way for the 
discovery of drugs targeting Propionibacterium acnes. This organism, which is an oportunistic pathogen 
of the skin, is, among other factors, responsible for the occurrence of acne vulgaris. As PaSrtF is the sole 
sortase expressed in P. acnes, it is most likely the housekeeping sortase that attachs proteins bearing the 
LPXTG motif to the cell wall such as CAMP factor, DsA1 and other proteins known to be important 
virulence factors. Consequently, the identification of molecules inhibiting PaSrtF represents a promising 
route for the prevention and the treatment of P. acnes-related diseases. In this context, the structure 
determination of PaSrtF, in combination with in silico modeling and docking approaches, would allow to 
identify structures which are most likely to bind PaSrtF, threby facilitating the selection of the most 
promising candidates for PaSrtF inhibition. 
Other sortase enzymes investigated in this work either showed very low solubility and could not be 
purified or displayed only marginal activities and could not be further characterized. Besides sampling 
natural diversity of sortases, a chimeric enzyme that ideally displayed an altered sequence specificity was 
also constructed and investigated but without success. 
In the second part of the work, a novel assay that allows for the directed evolution of sortases with in-
creased activity and/or altered specificity was developed. The assay, conceived to provide enough sensi-
tivity for the detection of low active sortases, relies on the use of alginate bead-based microreactors as 
individual evolutionary units that are suitable for high-throughput screening using the large particle flow 
cytometer COPAS (Complex Object Parametric Analyzer and Sorter). 
The assay consists of different steps individually optimized to achieve the best outcome. First, three types 
of alginate-beads based microcapsules were investigated as miniature size culture and reaction vessels. 
Among them, hollow-core chitosan-coated alginate microcapsule (HC-CAM) were recognized as the best 
choice as they enable E. coli colonies to grow and occupy the whole capsule core without affecting capsule 
stability. Colonies as big as the capsules allow to maximize the amount of enzyme that can be assayed in 
a single microreactor thereby increasing the chance to detect the activity of poorly active enzymes. Due 
to their high specific weight, HC-CAM-based microreactors can be easily separated from empty micro-
capsules allowing a considerable reduction of working volumes and sorting analysis times. In addition, 
the homogeneity in colony size and shape enables an accurate optical readout during sorting increasing 
the chance to isolate sortase variants with the improved properties. 
Using the highly active SaSrtA, two different strategies were investigated for the optimal sortase-mediated 
conjugation reaction and for the efficient retention of the fluorescent transpeptidation products within 
microreactors. The first strategy relied on the use of an N-terminally oligo-glycine-modified alginate 
binding protein (Gly6-AlgQ2) as the nucleophilic component of the sortase-mediated conjugation reac-
tion that, by interacting with alginate, would enable the fluorescent transpeptidation product FITC-
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LPETG6-AlgQ2 to be specifically retained within alginate bead-based microreactors. In this context, the 
sortase moiety in the fusion protein Gly6-AlgQ2-SrtA was found to attach the fluorescent-labeled sub-
strate peptide to the glycine stretch at its N-terminus in an intramolecular fashion that results in improved 
reaction rate as compared to the reaction performed with separate SaSrtA and AlgQ2. Although signifi-
cant fluorescence change was observed with microreactors expressing Gly6-AlgQ2-SrtA wild type in 
comparison to those expressing the fusion construct with the inactive sortase A (Gly6-AlgQ2-SrtA-
C184G), protein release analysis from microreactors have shown that the fusion protein and the relative 
fluorescent transpeptidation products are not specifically retained within microreactors thereby compro-
mising the faithful measurement of the sortase activity. To overcome this limitation and ensure a direct 
correlation between the sortase activity and the fluorescent output signal, a second strategy was therefore 
investigated. The second strategy also relied on an intramolecular transpeptidation reaction catalyzed by 
a sortase A modified at the N-terminus by the addition of a single glycine residue (G-SrtA). In comparison 
to the fusion protein Gly6-AlgQ2-SrtA, G-SrtA showed higher expression yields that resulted in higher 
levels of fluorescence and therefore higher sensitivity. In this case, experiments with mixtures of micro-
reactors expressing G-SrtA wild type and the relative inactive version G-SrtA-C184G and protein release 
analysis from microreactors have shown that coating microreactors with a size selective shell made of the 
polyelectrolyte pair PSS and PAH ensure an efficient retention of the enzyme and of the relative trans-
peptidation products. Following the development of the strategy with SaSrtA, the functionality of the 
microreactor-based assay in this format was optimized and validated with the newly characterized PaSrtF. 
The results demonstrated the suitability of the assay for its directed evolution. A preliminary screening of 
a random mutagenized library of PaSrtF was performed.  
Although the validity of the microreactor-based assay could not be demonstrated with the very low active 
sortase B from B. anthracis (BaSrtB), the results have shown that the assay has the potential to be sensitive 
enough to enable BaSrtB and other sortases with very low catalytic efficiency to become accessible for 
directed evolution.  
The microreactor-based assay developed in this work enables the completion of a whole screening cycle 
in 4-5 days with an effective hands-on time of about 20 hours and can easily be scaled up without any 
substantial change in the procedure. Compared to microtiter plate screening approaches, the microreactor-
based assay, in combination with the large particle flow cytometer COPAS, enables a considerable reduc-
tion of reaction volume and allows the screening of clones about one order of magnitude faster than the 
maximum screening capacity achievable using advanced robotic systems (105 clones per day). However, 
compared to single cell and microfluidics-based screening systems which make use of FACS (up to 104 
clones per second), our system has significantly lower throughput. Producing hydrogel-based microreac-
tors with a diameter size compatible with FACS, for instance through microfluidics techniques, would 
allow to increase the throughput and therefore reduce the time required to identify sortase variants with 
desired properties.  
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5      Experimental procedures 
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5.1 General information 
 
Unless otherwise specified in the following experimental procedures, all commercial products used in this 
work were of analytical grade and purchased from Applichem, Fluka, Invitrogen, Merck, Promega, Roth 
Sigma-Aldrich, ThermoFisher. All the cloning procedures reported in this work were performed by using 
the FX cloning strategy (Geertsma, 2013). Primer design, PCRs and DNA ligations methods followed the 
FX cloning manual’s instructions. After cloning sequences of interest were analyzed by restriction anal-
ysis and verified by DNA sequencing with universal primers T7 promoter or T7 terminal. Unless other-
wise specified, competent cells preparation, bacterial transformations, DNA restriction reactions and 
DNA gel electrophoresis were performed following standard protocols as described in the laboratory 
methods collection of Prof. Georg Lipps. Small scale plasmid preparation and DNA gel purification were 
performed using commercial kits according to the manufacturer’s instructions. Unless otherwise speci-
fied, all the E. coli cultures were performed in growth media containing 50 µg/ml kanamycin. FITC-
labeled peptides and peptide mixtures were purchased from Genscript and dissolved in DMF or DMSO 
to a final concentration of about 20 mM. Dilutions were performed in the buffer used for the sortase-
mediated reaction. FITC-labeled peptides and protein concentration was calculated from the measured 
absorbance at 495 nm and 280 nm respectively using the relative extinction coefficients. All the SDS-
PAGE and western blot analysis reported in this work were performed using the standard Laemmli SDS-
PAGE method as described in the laboratory methods collection of Prof. Georg Lipps. After gel electro-
phoresis, proteins bands were stained with a colloidal Coomassie staining solution and destained with 
water. Alternatively, following electroblotting of proteins onto a nitrocellulose membrane, proteins were 
detected by using a primary antibody against the histidine tag (1:1000 dilutions of anti-His mouse anti-
body; ThermoFisher, MA1-21315) and a secondary antibody linked to alkaline phosphatase for colori-
metric detection (1:8000 dilutions of anti-mouse antibody-AP; Roth, 4760.1). 
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5.2 PCR oligonucleotide primers, vectors and strains 
 
 
       List of oligo deoxyribonucleotides used in this work  
 
 
Name                         Sequence (5'→ 3') 
 
F1 ATATATGCTCTTCTAGTGGGACTATTGGTATCCTGAAAATTCCG 
R2 GGCTCGTATGTTGTGTGGAA 
F2 ATATATGCTCTTCTAGTGGACAAGGGTTTGCCCTCTTGC 
R2 GGCTCGTATGTTGTGTGGAA 
F3 ATATATGCTCTTCTAGTGCGGCGAAAAAAGGTCCG 
R3 TATATAGCTCTTCATGCGGCAACCGGATAGGTATAGAAGATG 
F4 ATATATGCTCTTCTAGTACCCCGAAACCGATTGTGC 
R4 TATATAGCTCTTCATGCGGCAACCGGATAGGTATAGAAGATG 
F5 ATATATGCTCTTCTAGTCAGGCCAAACCGCAAATTCC 
R5 TATATAGCTCTTCATGCCTTGACTTCCGTTGCAACAAAGATC 
F6 ATATATGCTCTTCTAGTCAAGCTAAACCTCAAATTCCG 
R6 TATATAGCTCTTCATGCTTCCAGTTTGACTTCTGTAGC 
F7 GGAGATATACATATGGGTGGTGGTGGCGGTGG     
R7 CCACCGCCACCACCACCCATATGTATATCTCC 
F8 ATATATGCTCTTCTGCACACCATCATCATCACCATCATCATC 
R8 TATATAGCTCTTCAACTTGAGCCTGAGCCGTTCTTGTATTGTCTGTCATAAGCCTGC 
F9 TATATAAGTTGAAGAGCGACCTGCAGACTGGCTGTGTATAA  
R9 ATATATTGCAGAAGAGCTGAACTAGTGGATCCCCAAAAAAG 
F10 ATATATGCTCTTCTGCACACCATCATCATCACCATCATCATC 
R10 TATATAGCTCTTCAACTTGAGCCTGAGCCATAAGCCTGCTGCATCATTTGTAAAACC 
F11 ATATATGCTCTTCTGCACACCATCATCATCACCATCATCATC 
R11 TATATAGCTCTTCAACTTGAGCCTGAGCCTTGTAAAACCTGGTATAAGCCTCTCAG 
F12 ATATATGCTCTTCTGCACACCATCATCATCACCATCATCATC 
R12 TATATAGCTCTTCAACTTGAGCCTGAGCCGCCTCTCAGTTTCAACTGACGTTG 
F13 ATATATGCTCTTCTGCATTAGAAGTTTTGTTTCAAGGTCC 
R13 TATATAGCTCTTCAACTACCACCGCCGCCACCCATATGTATATCTCCTTCTTAAAGTTAAAC 
F14 ATATATGCTCTTCTGCAGGTAGTTGGTCCCACCCG 
R14 TATATAGCTCTTCAACTACCACCGCCGCCACCCATATGTATATCTCCTTCTTAAAGTTAAAC 
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F15 ATATATGCTCTTCTGCATTAGAAGTTTTGTTTCAAGGTCC 
R15 TATATAGCTCTTCAACTACCCATATGTATATCTCCTTCTTAAAGTTAAAC 
F16 ATATATGCTCTTCTGCATTAGAAGTTTTGTTTCAAGGTCC 
R16 TATATAGCTCTTCAACTGCCACCCATATGTATATCTCCTTCTTAAAGTTAAAC 
F17 ATATATGCTCTTCTGCATTAGAAGTTTTGTTTCAAGGTCC 
R17 TATATAGCTCTTCAACTGCCGCCACCCATATGTATATCTCCTTCTTAAAGTTAAAC 
F18 GGAGATATACATATGGGCAGTACCACCACGTCAAGCACG 
R18 CGTGCTTGACGTGGTGGTACTGCCCATATGTATATCTCC 
F19 GGAGATATACATATGGGCGGCAGTACCACCACGTCAAGCACG 
R19 CGTGCTTGACGTGGTGGTACTGCCGCCCATATGTATATCTCC 
F20 GGAGATATACATATGGGCGGCGGCAGTACCACCACGTCAAGCACG 
R20 CGTGCTTGACGTGGTGGTACTGCCGCCGCCCATATGTATATCTCC 
F21 CTGACCCTGATTACGGGCGATGACTATAACG 
R21 CGTTATAGTCATCGCCCGTAATCAGGGTCAG 
F22 GTAACCCTGTCTACTGGTGATTACGCATTG 
R22 CAATGCGTAATCACCAGTAGACAGGGTTAC 
F23 AGCTATTGTGATTGCCTGGGATTACGTG 
R23 CACGTAATCCCAGGCAATCACAATAGCT 
F24 ATATATGCTCTTCTAGTCAATTCAGCAAAGGAGAAGAACTTTTCACTGG 
R24 TATATAGCTCTTCATGCACTAGTTTTGTAGAGCTCATCCGTGCC 
F25 ATATATGCTCTTCTAGTCATATGACTACCACCGCCAG 
R25 TATATAGCTCTTCATGCCTTATTGGTGTCCAAAGGTAGCTTAG 
F26 GAGAGGCTTATACCAAGTCTTACAAATGATGC 
R26 GCATCATTTGTAAGACTTGGTATAAGCCTCTC 
F27 ATATATGCTCTTCTAGTACCACCACGTCAAGCACGAG 
R27 TATATAGCTCTTCATGCTTATTATTTTTCAAACTGCGGATGGG 
F28 CATCTGTTGTCAAAGACAGCATCC 
R28 GCCTTCTGCTTAATTTGATGCCTG 
T7 promoter TAATACGACTCACTATAGGG 
T7 terminator GCTAGTTATTGCTCAGCGG 
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List of vectors used in this work 
 
 
Vector name Source Application 
pUC57-BaSrtBΔ34 Genscript Subcloning 
pUC57-BaSrtDΔ24 Genscript Subcloning 
pUC57-MkSrtEΔ24 Genscript Subcloning 
pEX-A2-CaSrtDΔ23 Eurofins Subcloning 
pEX-A2-CpSrtDΔ22 Eurofins Subcloning 
pEX-A2-ScSrtEΔ157 Eurofins Subcloning 
pEX-A2-PaSrtFΔ34 Eurofins Subcloning 
pEX-A2-Chimeric eSaSrtA/D Eurofins Subcloning 
pUC57-Gly5-AlgQ2 Genscript Subcloning 
pEX-A2-AlgX-C Eurofins Subcloning 
pEX-A2-CBM Eurofins Subcloning 
pUC57-eSaSrtA Kindly provided by NBE 
therapeutics 
    Subcloning 
p7XC3H Geertsma 2013 FX recipient expression vector 
p7XC3GH Geertsma 2013 FX recipient expression vector 
pINITIAL Geertsma 2013 FX recipient cloning vector 
p7X-Ccdb-Cat-Streptag Constructed in this work FX recipient expression vector 
p7X-Gly6-AlgQ2-GSGS-CcdB-Cat-
His10 
Constructed in this work FX recipient expression vector 
p7X-Gly6-AlgQ2ΔC6-GSGS-CcdB-Cat-
His10 
Constructed in this work FX recipient expression vector 
p7X-Gly6-AlgQ2ΔC12-GSGS-CcdB-
Cat-His10 
Constructed in this work FX recipient expression vector 
p7X-Gly6-AlgQ2ΔC18-GSGS-CcdB-
Cat-His10 
Constructed in this work FX recipient expression vector 
p7X-G1-CcdB-Cat-His10 Constructed in this work FX recipient expression vector 
p7X-G2-CcdB-Cat-His10 Constructed in this work FX recipient expression vector 
p7X-G3-CcdB-Cat-His10 Constructed in this work FX recipient expression vector 
p7X-G5-CcdB-Cat-His10 Constructed in this work FX recipient expression vector 
p7X-G1-CcdB-Cat-Streptag Constructed in this work FX recipient expression vector 
p7X-G5-CcdB-Cat-Streptag Constructed in this work FX recipient expression vector 
p7X-BaSrtBΔ34-His10 Constructed in this work Expression of BaSrtBΔ34-His10 
p7X-BaSrtDΔ24-His10 Constructed in this work Expression of BaSrtDΔ24-His10 
p7X-CpSrtDΔ22-His10 Constructed in this work Expression of CpSrtDΔ22-His10 
p7X-CaSrtDΔ23-His10 Constructed in this work Expression of CaSrtDΔ23-His10 
p7X-CaSrtDΔ66-His10 Constructed in this work Expression of CaSrtDΔ66-His10 
p7X-ScSrtEΔ157-His10 Constructed in this work Expression of ScSrtEΔ157-His10 
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p7X-ScSrtEΔ193-His10 Constructed in this work Expression of ScSrtEΔ193-His10 
p7X-MkSrtEΔ24-His10 Constructed in this work Expression of MkSrtEΔ24-His10 
p7X-PaSrtFΔ34-His10 Constructed in this work Expression of PaSrtFΔ34-His10 
p7X-PaSrtFΔ34-Streptag Constructed in this work Expression of PaSrtFΔ34-Streptag 
p7X-PaSrtFΔ47-Streptag Constructed in this work Expression of PaSrtFΔ47-Streptag 
p7X-PaSrtFΔ60-Streptag Constructed in this work Expression of PaSrtFΔ60-Streptag 
p7X-Chimeric eSrtA/D-His10 Constructed in this work Expression of Chimeric eSrtA/D-His10 
p7X-Ser-Gly5-AlgQ2-His10 Constructed in this work Expression of Ser-Gly5-AlgQ2-His10 
p7X-Gly6-AlgQ2-His10 Constructed in this work Expression of Gly6-AlgQ2-His10 
p7X-Gly6-AlgQ2-GFP-His10 Constructed in this work Expression of Gly6-AlgQ2-GFP-His10 
p7X-AlgX-C-GFP-His10 Constructed in this work Expression of AlgX-C-GFP-His10 
p7X-CBM-GFP-His10 Constructed in this work Expression of CBM-GFP-His10 
p7X-GFP-His10 Constructed in this work Expression of GFP-His10 
p7X-VvGT5-GFP-His10 Constructed in this work Expression of VvGT5-GFP-His10 
p7X-Gly6-AlgQ2-wtSaSrtA-His10 Constructed in this work Expression of Gly6AlgQ2-SaSrtA-His10 
p7X-Gly6-AlgQ2-eSaSrtA-His10 Constructed in this work Expression of Gly6-AlgQ2-eSaSrtA-His10 
p7X-Gly6-AlgQ2-BaSrtB-His10 Constructed in this work Expression of Gly6-AlgQ2-BaSrtB-His10 
p7X-Gly6-AlgQ2ΔC6-eSrtA-His10 Constructed in this work Expression of Gly6-AlgQ2ΔC6-eSrtA-His10 
p7X-Gly6-AlgQ2ΔC12-eSrtA-His10 Constructed in this work Expression of Gly6-AlgQ2ΔC12-eSrtA-His10 
p7X-Gly6-AlgQ2ΔC18-eSrtA-His10 Constructed in this work Expression of Gly6-AlgQ2ΔC18-eSrtA-His10 
p7X-G1-wtSaSrtA-His10 Constructed in this work Expression of G1-SaSrtA-His10 
p7X-G2-wtSaSrtA-His10 Constructed in this work Expression of G2-wtSaSrtA-His10 
p7X-G3-wtSaSrtA-His10 Constructed in this work Expression of G3-wtSaSrtA-His10 
p7X-G5-wtSaSrtA-His10 Constructed in this work Expression of G5-wtSaSrtA-His10 
p7X-G1-BaSrtB-His10 Constructed in this work Expression of G1-BaSrtB-His10 
p7X-G2-BaSrtB-His10 Constructed in this work Expression of G2-BaSrtB-His10 
p7X-G3-BaSrtB-His10 Constructed in this work Expression of G3-BaSrtB-His10 
p7X-G1-PaSrtFΔ34-Streptag Constructed in this work Expression of G1-PaSrtFΔ34-Streptag 
p7X-G2-PaSrtFΔ34-Streptag Constructed in this work Expression of G2-PaSrtFΔ34-Streptag 
p7X-G3-PaSrtFΔ34-Streptag Constructed in this work Expression of G3-PaSrtFΔ34-Streptag 
p7X-Gly6-AlgQ2-SaSrtAC184G-His10 Constructed in this work Expression of Gly6-AlgQ2-SaSrtAC184G-His10 
p7X -G1-SaSrtAC184G-His10 Constructed in this work Expression of G1-SaSrtAC184G-His10 
p7X-Gly6-AlgQ2-BaSrtBC233G-His10 Constructed in this work Expression of Gly6-AlgQ2-BaSrtBC233G-His10 
p7X-G1-BaSrtBC233G-His10 Constructed in this work Expression of G1-BaSrtBC233G-His10 
p7X-G1-PaSrtFC195G-Streptag Constructed in this work Expression of G1-PaSrtFC195G-Streptag 
p7X-GFP-His10 Constructed in this work Expression of GFP-His10 
p7X-VvGT5-GFP-His10 Constructed in this work Expression of VvGT5-GFP-His10 
p7X-Gly6-AlgQ2-eSaSrtA(RBS) Constructed in this work Expression of Gly6-AlgQ2-eSaSrtA(RBS) 
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 List of bacterial strains used in this work 
 
 
Strain Genotype Application 
Escherichia coli BL21 (DE3) F-, ompT, gal, dcm, lon, hsdSB (rB⁻mBᶧ), λ(DE3 [lacI la-
cUV5-T7 gene 1 ind1 sam7 nin5]). 
Protein expression 
XJb autolysis (DE3) 
(Zymo research) 
F- ompT hsdSB(rB- mB-) gal dcm ΔaraB::λR, cat (CmR), 
λ(DE3) 
Protein expression 
Escherichia coli DB3.1 F-, gyrA462, endA1, glnV44, Δ(sr1-recA), mcrB, mrr, 
hsdS20(rB-, mB-), ara14, galK2, lacY1, proA2, 
rpsL20(Smr), xyl5, Δleu mtl1. 
FX cloning 
Escherichia coli Top10 F-, mcrA, Δ(mrr-hsdRMS-mcrBC), φ80lacZΔM15, 
ΔlacX74, nupG, recA1, araD139, Δ(ara-leu)7697, galE15, 
galK16, rpsL(StrR), endA1, λ-. 
FX Cloning 
Escherichia coli XL1-Blue endA1, gyrA96(nalᴿ), thi-1, recA1, relA1, lac, glnV44, 
F’[Tn10 pro ABᶧ lacIq Δ(lacZ)M15], hsdR17(rK⁻mKᶧ). 
Cloning 
 
 
 
5.3 Molecular biology 
 
5.3.1 Gene synthesis and cloning 
 
Cloning of selected sortases 
 
Sequences of selected sortases were subjected to an in silico analysis using the bioinformatics tools 
TMpred, PredictProtein, SignalP and Phobius to delineate signal peptides and identify transmembrane 
regions. Sequences encoding for the putative soluble domains were codon optimized for E. coli expression 
and custom-synthesized by GenScript or Eurofins with FX cloning-compatible SapI sites at each end. 
Synthetic genes from GenScript or Eurofins were delivered in pUC57 or in pEX-A2 vectors respectively. 
For protein expression, sortases sequences were transferred in the FX expression vector p7XC3H to pro-
duce sortases with a 3C cleavage site and a histidine tag (10xHis) at the C-terminus under control of T7 
RNA polymerase promoter. To produce variants of CaSrtDΔ23 and ScSrtEΔ157 with a shorter N-terminal 
region (CaSrtDΔ66 and ScSrtEΔ193 respectively) sequences were amplified from the relative pEX-A2 vec-
tors with primer pairs F1/R1 and F2/R2 respectively and subsequently cloned in the expression vector 
p7XC3H. Sequence encoding for PaSrtFΔ34 was also transferred from the vector pEX-A2 in the FX ex-
pression vector p7X-CcdB-Cat-Streptag to produce the C-terminal twin-strep-tagged PaSrtF. Sequences 
encoding for the PaSrtFΔ34 length variants PaSrtFΔ47 and PaSrtFΔ60 flanked by SapI restriction sites were 
amplified from p7X-PaSrtFΔ34-Streptag with primer pairs F3/R3 and F4/R4 respectively. The resulting 
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PCR products were cloned in the expression vector p7X-CcdB-Cat-Streptag yielding p7X-PaSrtFΔ47-
Streptag and p7X-PaSrtFΔ60-Streptag.  
 
Cloning of SaSrtA variants 
 
Sequences encoding for the wild type SaSrtA (wtSaSrtA) or for the enhanced SaSrtA (eSaSrtA) flanked 
by SapI restriction sites were amplified from the vector pBX-SaSrtA-EstA (vector number 1013 from 
Prof. Georg Lipps plasmid collection) or pUC57-eSaSrtA (kindly provided by NBE Therapeutics) using 
primer pairs F5/R5 or F6/R6 for the wild type and the enhanced SaSrtA respectively. Resulting PCR 
products were cloned in the intermediate FX vector pINITIAL to obtain pINITIAL-wtSaSrtA and pIN-
ITIAL-eSaSrtA which were used for subsequent subcloning.  
 
Gene synthesis and cloning of the chimeric sortase eSrtA/D 
 
Following the identification of putative recombination sites through the SCHEMA algorithm, the se-
quence of the chimeric sortase that consists of the N-terminal region of eSaSrtA (residues Gln59-Arg151) 
fused to the C-terminal region of BaSrtD (Thr 143-Lys 198) was codon optimized for expression in E. coli 
and custom-synthesized by Eurofins. Sequence encoding for the chimeric enzyme, delivered in the clon-
ing vector pEX-A2, was transferred into the expression vector p7XC3H to obtain p7X-Chimeric 
eSaSrtA/BaSrtD-His10 for the production of a C-terminal His-tagged protein. 
 
Gene synthesis and cloning of the putative alginate binding proteins  
 
The amino acid sequence of the periplasmic protein AlgQ2 from Sphingomonas species (GI: 9501762) 
was analysed with Signal P. In agreement with a previous study (Momma et al., 2002) the in silico analysis 
of the protein sequence allowed to delineate a 24 amino acids long signal. Sequences encoding for 
AlgQ2Δ24, for the conserved C-terminal carbohydrate-binding domain of AlgX (AlgX-C) from Pseudo-
monas aeruginosa (GI: 15598742; residue 337-461), and for the carbohydrate-binding motif (CBM) of 
the sugar binding protein from Bacteroides thetaiotamicron (WP_032841246.1; residues 505-635) were 
codon optimized for E. coli expression and custom-synthesized by Genscript or Eurofins with 5 glycine 
codifying codons at the 5’end. Synthetic genes were flanked by FX cloning-compatible SapI sites. To 
investigate the alginate binding ability of the selected putative alginate binding proteins, synthetic genes 
from delivered in pUC57 or in pEX-A2 vectors (from Genscript and Eurofins respectively) were trans-
ferred in the FX expression vector p7XC3GH to yield p7X-Gly6-AlgQ2-GFP-His10, p7X-AlgX-C-GFP-
His10 and p7X-CBM-GFP-His10 for the production of proteins fused at their C-terminus with the green 
fluorescent protein (GFP). To investigate whether AlgQ2 works as nucleophile in a sortase-mediated con-
jugation reaction, sequence encoding for Gly5-AlgQ2 was first transferred in the expression vector 
p7XC3H to obtain the vector p7X-Ser-Gly5-AlgQ2 that encodes for AlgQ2 with the N-terminus 
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SGGGGG (Ser-Gly5-AlgQ2). For the expression of AlgQ2 with 6 glycines at the N-terminus (Gly6-
AlgQ2), the “cloning scar” serine codon in p7X-Ser-Gly5-AlgQ2 was changed by site-directed mutagen-
esis PCR (described below) into another glycine residue by using primer pair F7/R7 yielding p7X- Gly6-
AlgQ2. 
 
Construction of Gly6-AlgQ2-sortases fusion proteins 
 
For the production of the fusion proteins Gly6-AlgQ2-sortases, SapI restriction sites were introduced into 
the expression vector p7X-Gly6-AlgQ2 by PCR with primer pair F8/R8. R8 was designed so that a GSGS 
linker is introduced between the two components of the fusion. The resulting PCR product was ligated 
with the Ccdb-Cat cassette previously amplified from the FX cloning vector pINITIAL with primer pair 
F9/R9 yielding the FX vector p7X-Gly6-AlgQ2-GSGS-CcdB-Cat. Sequences encoding for wtSaSrtA, 
eSaSrtA and BaSrtB were then transferred from pINITIAL or pUC57 in the vector p7X-Gly6-AlgQ2-
GSGS-CcdB-Cat obtaining the expression vectors p7X-Gly6-AlgQ2-wtSaSrtA-His10, p7X-Gly6-
AlgQ2-eSaSrtA-His10 and p7X-Gly6-AlgQ2-BaSrtB-His10 respectively. 
 
Shortening of the C-terminal region of AlgQ2 
 
For the production of the fusions Gly6-AlgQ2-eSrtA in which the C-terminal region of AlgQ2 was short-
ened by 6, 12 and 18 amino acids, SapI restriction sites were first introduced into the vector p7X-Gly6-
AlgQ2-GSGS-CcdB-Cat by PCR with primer pairs F10/R10, F11/R11 and F12/R12 respectively. Reverse 
primers were designed so that a GSGS linker is introduced between the AlgQ2 variants and eSaSrtA. The 
resulting PCR products were ligated with the Ccdb-Cat cassette (obtained as described above) yielding 
the FX expression vectors p7X-Gly6-AlgQ2ΔC6-GSGS-CcdB-Cat, p7X-Gly6-AlgQ2ΔC12-GSGS-
CcdB-Cat and p7X-Gly6-AlgQ2ΔC18-GSGS-CcdB-Cat. Sequence encoding for eSaSrtA was transferred 
from pUC57 in these vectors to obtain the expression vectors p7X-Gly6-AlgQ2ΔC6-eSrtA-His10, p7X-
Gly6-AlgQ2ΔC12-eSaSrtA-His10 and p7X-Gly6-AlgQ2ΔC18-eSrtA-His10. 
 
Construction of N-terminal glycine-modified sortases 
 
For the construction of sortases with 5 glycine residues at the N-terminus, SapI restriction sites were 
introduced in the vector p7XC3H with primer pair F13/R13 or in the vector p7X-CcdB-Cat-Streptag with 
primer pair F14/R14. The resulting PCR products were ligated with the Ccdb-Cat cassette (obtained as 
described above) yielding the FX expression vectors p7X-G5-CcdB-Cat-His10 and p7X-G5-CcdB-Cat-
Streptag respectively. Sequence encoding for the wild type SaSrtA was then transferred from pINITIAL 
in the expression vector p7X-G5-CcdB-Cat-His10 to yield p7X-G5-wtSaSrtA-His10. Sequence encoding 
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for PaSrtF was transferred from the cloning vector pEX-A2-PaSrtFΔ34 in the expression vector p7X-G5-
CcdB-Cat-Streptag yielding p7X-G5-PaSrtF-Streptag.  
For the construction of the wild type SaSrtA and BaSrtB with either 1, 2 or 3 glycine residues at the N-
terminus, SapI restriction sites and glycine codifying codons were introduced in the expression vector 
p7XC3H with primer pairs F15/R15, F16/R16 and F17/R17 respectively. The resulting PCR products 
were ligated with the Ccdb-Cat cassette (obtained as described above) yielding the expression vectors 
p7X-G1-CcdB-Cat-His10, p7X-G2-CcdB-Cat-His10 and p7X-G3-CcdB-Cat-His10. Sequences encoding 
for the wild type SaSrtA and BaSrtB were therefore transferred in the latter vectors to produce p7X-G1-
wtSaSrtA-His10, p7X-G2-wtSaSrtA-His10, p7X-G3-wtSaSrtA-His10, p7X-G1-BaSrtB-His10, p7X-G2-
BaSrtB-His10 and p7X-G3-BaSrtB-His10. For the construction of PaSrtF with either 1, 2 or 3 glycine 
residues at the N-terminus, site-directed mutagenesis PCR (described below) of the vector p7X-
PaSrtFΔ34-Streptag was performed with primer pairs F18/R18, F19/R19 and F20/R20 respectively yield-
ing p7X-G1-PaSrtFΔ34-Streptag, p7X-G2-PaSrtFΔ34-Streptag and p7X-G3-PaSrtFΔ34-Streptag. 
 
Inactivation of sortases  
 
Inactive sortases were obtained by replacing the cysteine in the active site with glycine by site-directed 
mutagenesis PCR. Expression vectors encoding for Gly6-AlgQ2-SaSrtAC184G (p7X-Gly6-AlgQ2-
SaSrtAC184G-His10) and G1-SaSrtAC184G (p7X -G1-SaSrtAC184G-His10) were obtained by mutating 
the vector p7X-Gly6-AlgQ2-wtSaSrtA-His10 and p7X-G1-wtSaSrtA-His10 with the primer pair F21/R21 
respectively. Similarly, expression vectors encoding for Gly6-AlgQ2-BaSrtBC233G (p7X-Gly6-AlgQ2-
BaSrtBC233G-His10) and G1-BaSrtBC233G (p7X-G1-BaSrtBC233G-His10) were obtained by mutating 
the vector p7X-Gly6-AlgQ2-BaSrtB and p7X-G1-BaSrtB respectively with the primer pair F22/R22. The 
expression vector encoding for G1-PaSrtFC195G (p7X-G1-PaSrtFC195G-Streptag) was obtained by mu-
tating the vector p7X-G1-PaSrtF-Streptag using the primer pair F23/R23. 
 
Construction of the expression vectors encoding for GFP and VvGT5-GFP 
 
For the expression of the green fluorescence protein (GFP), sequence encoding for GFP flanked by SapI 
restriction sites was amplified from the FX vector p7XC3GH with the primer pair F24/R24.The resulting 
PCR product was cloned in the expression vector p7XC3H yielding p7X-GFP-His10. 
For the production of the fusion protein VvGT5-GFP, sequence encoding VvGT5 flanked by SapI re-
striction sites was amplified from the vector pET-VvGT5 (vector number 571 from Prof. Georg Lipps 
plasmid collection) with the primer pair F25/R25 and the resulting PCR product cloned in the expression 
vector p7XC3GH yielding p7X-VvGT5-GFP-His10. 
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 Modification of Gly6-AlgQ2-eSrtA upon RBS translation rate analysis 
 
For the production of the fusion protein Gly6-AlgQ2-eSrtA in which codons encoding for AlgQ2 residues 
Gln501 and Val502 were changed from CAG and GTT to CAA and GTC respectively, site-directed mu-
tagenesis PCR (described below) of the vector p7X-Gly6-AlgQ2-eSaSrtA was performed with primer 
pair F26/R26 yielding p7X-Gly6-AlgQ2-eSaSrtA(RBS). 
 
5.3.2 Site-directed mutagenesis 
 
Site-directed mutagenesis PCR reactions were carried out with 0.5 μM of each primer, 3 units Phusion 
HF DNA Polymerase (NEB), 1 X Phusion HF Buffer (NEB), 200 μM of each dNTP and 15 ng of template 
in a total volume of 30 μl. The PCR program employed consisted of 95 °C for 5 minutes as initial step, 
followed by 16 cycles of denaturation at 95 °C for 30 seconds, annealing at 55 °C for 30 seconds, elon-
gation at 72 °C for 1 minute/kilobase. A final elongation step of 5 minutes at 72 °C was performed. 
Following digestion of parental template with 3 units of DpnI for 1 hour at 37 °C, an aliquot of XL1blue 
chemical competent cells was transformed with 5 μl of the PCR reaction mix. Cells were plated on LB 
agar plates supplemented with 50 μg/ml kanamycin for selection of positive clones. The resulting muta-
genized vectors were purified from a 10 ml overnight culture in LB medium by using a plasmid extraction 
kit (Peqlab) according to manufacturer’s instructions. Vectors concentration was measured with the 
NanoDrop 2000c spectrophotometer (ThermoFisher) and sequences verified by DNA sequencing  
 
 
5.4 Biochemistry 
 
5.4.1 Protein expression and purification  
 
 
Expression and purification of BaSrtB, BaSrtD and CpSrtD 
 
With the exception of PaSrtF, selected sortases were expressed and purified using the same following 
procedure. E. coli BL21 (DE3) cells carrying the relative expression vector were inoculated in 20 ml LB 
medium and incubated for about 16 hours at 37 °C. The overnight culture was inoculated in 4 liters LB 
medium within a 4 liters’ flask. Proper shaking was ensured by blowing air at 0.6 Bar. The culture was 
grown until an OD600 of 0.6 was reached. Protein expression was induced by adding 1 mM IPTG followed 
by 3 additional hours of growth. Cells were harvested by centrifugation (4,500g for 15 minutes at 4 °C) 
and resuspended in 20 ml of 300 mM KCl, 100 mM KH2PO4, pH 8.0. Cells suspensions were incubated 
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on ice with 1 mg/ml lysozyme, 20 mM MgCl2 and 50 units Super Nuclease (Sino Biological) for 30 
minutes and then sonicated 6-8 cycles for 60 seconds (followed by intervals of 30 seconds for cooling) 
with 80% amplitude and 70% cycle duty. Cell lysates were centrifuged at 12,000g for 20 minutes at 4 °C 
and the cleared lysates were applied to a column filled with 5 ml TALON Superflow (GE Healthcare) 
metal affinity resin connected to the protein purification system Profinia (Biorad). Column was pre-equil-
ibrated in 300 mM KCl, 100 mM KH2PO4, 10 mM imidazole pH 8.0 and after lysate loading washed 
twice with the same buffer containing 10 and 20 mM imidazole respectively. Bound proteins were eluted 
with 300 mM KCl, 100 mM KH2PO4, 250 mM imidazole pH 8.0. The purification progress was analyzed 
with SDS-PAGE and elution fractions dialyzed against 50 mM Tris/HCl, 200 mM NaCl pH 8.0, 60 % 
glycerol and stored at -20 °C. 
 
 
Expression and purification of PaSrtF variants 
 
E. coli BL21 (DE3) cells transformed with the specific expression vector were inoculated in 5 ml of LB 
medium and allowed to grow overnight at 37 °C. The overnight cultures were inoculated in 1 liter of LB 
medium (250 ml LB medium in 4 flasks of 1 liter) and allowed to grow at 37 °C until the optical density 
at 600 nm was 0.6. The cultures were cooled down and protein expression induced by the addition of 0.5 
mM IPTG for 24 hours at 16 °C. Cells were harvested by centrifugation (16.800 g for 15 minutes at 4 °C), 
washed once in 100 mM Tris/HCl pH 8.0, 300 mM NaCl, 1 mM EDTA and pelleted again for 15 minutes 
at 4,500g and resuspended in 5 ml of the same buffer. Following 30 minutes’ incubation on ice with 1 
mg/ ml lysozyme and 0.1 % Triton X-100, cells were sonicated and the lysates clarified by centrifugation 
at 31,000g for 15 minutes at 4 °C.  The cleared lysates were adjusted to a final concentration of 5 mM 
DTT and slowly applied onto a gravity flow column containing 1 ml Strep-Tactin® Superflow sepharose 
(IBA Lifesciences), pre-equilibrated with 2 column bed volume (CV) of wash buffer (100 mM Tris/HCl 
pH 8.0, 500 mM NaCl, 1mM EDTA, 5mM DTT). Following 6 column wash steps with 3 CV of wash 
buffer, proteins were eluted in 5 fractions: 1 CV elution buffer (100 mM Tris/HCl pH 8.0, 500 mM NaCl, 
1mM EDTA, 5mM DTT, 2.5 mM desthiobiotin (IBA Lifesciences)) for the first fraction, 2 CV for the 
second and third fraction and again 1 CV for the remaining 2 fractions. After SDS-PAGE analysis, frac-
tions containing PaSrtF were pooled together and diluted 10 fold with 10 mM sodium phosphate, pH 7.0 
for further purification by ion exchange chromatography. The dilution was loaded onto a 1 ml HiTrap SP 
XL column (GE Healthcare) connected to the chromatography system Äkta Explorer (GE Healthcare) 
and eluted with a linear gradient from 0 to 1 M NaCl, in 10 mM sodium phosphate pH 7.0. Fractions 
corresponding to the main peak of the chromatogram were analyzed by SDS-PAGE and fractions con-
taining PaSrtF were pooled and dialyzed against 50 mM sodium phosphate, pH 8.5, 500 mM NaCl, 1 mM 
EDTA, 10% glycerol before concentrating with an Amicon Ultra-4 (10 kDa) centrifuge filter (Millipore). 
Proteins were frozen in liquid nitrogen and stored at -20 °C. 
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Solubility studies and purification of the chimeric SaSrtA 
 
E. coli BL21 (DE3) cells transformed with the expression vector p7X-ChimericSaSrtA/BaSrtD-His10 
were inoculated in 5 ml of LB medium and grown overnight at 37 °C. The overnight culture was inocu-
lated into 25 ml LB (OD600= 0.05) and grown at 37 °C until optical density nm was about 0.6. Following 
protein expression with 1 mM IPTG for 3 hours at 37 °C, optical density at 600 nm was measured. Cells 
from 2 ml of culture were harvested by centrifugation at 5,000 rpm for 5 minutes and resuspended in one 
of the selected extraction buffer so that optical density at 600 nm was 10. Cell suspensions were sonicated 
on ice three times for 20 seconds (80% amplitude and 70% cycle duty) and then centrifuged 10 minutes 
at 16,000g. Supernatants (here referred to as soluble fractions) were taken and cell pellets resuspended in 
the same volume of 100 mM Tris/HCl pH 8, 8M Urea, 0.2 % β-mercaptoethanol. Following vortexing, 
for 1 minute samples were centrifuged 10 minutes at 16,000g and supernatants (here referred to as insol-
uble fractions) were taken. 5 µl of soluble and insoluble fractions from each sample were analyzed by 
SDS-PAGE. 
Large scale expression and purification of the chimeric SaSrtA was performed following the procedure 
described above for BaSrtB, BaSrtD and CpSrtD. In this case, cells were lysed in 50 mM Tris/HCl pH 7.5, 
150 mM NaCl, 0.5 M Urea, and cell lysate clarified by centrifugation at 50,000g for 15 minutes at 4 °C. 
The same buffer supplemented with 10 mM imidazole was used for column equilibration and for the first 
column wash. Second column wash and protein elution were performed using the same buffer supple-
mented with 20 mM and 250 mM imidazole respectively. Following SDS-PAGE analysis, the eluate was 
dialyzed against 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.5 M Urea, 50% glycerol, concentrated with 
an Amicon Ultra-4 (10 kDa) centrifuge filter (Millipore) and stored at -20 °C. 
 
 
Expression and purification of G1-SaSrtA 
 
E. coli BL21 (DE3) cells carrying the expression vector p7X-G1-SaSrtA-His10 were inoculated in 20 ml 
TB medium and incubated for about 16 hours at 37 °C. The overnight culture was diluted in 1.2 liters of 
TB medium (600 ml LB medium in 2 conical flasks of 2 liter) and cell grown until an optical density at 
600 nm was 0.6. The culture was cooled down and protein expression induced with 0.5 mM IPTG for 
22 hours at 16 °C. Cells were harvested by centrifugation (4,500g for 15 minutes at 4 °C) and resuspended 
in 50 mM Tris/HCl, 150 mM NaCl, 5 mM imidazole, pH 8.5. Cells suspensions were incubated on ice 
with 1 mg/ml lysozyme, 20 mM MgCl2 and 50 units Super Nuclease (Sino Biological) for 30 minutes and 
sonicated 6-8 cycles for 60 seconds (followed by intervals of 30 seconds for cooling) with 80% amplitude 
and 70% cycle duty. The cell lysate was centrifuged at 20,000g for 20 minutes at 4 °C and the cleared 
supernatant applied to a column filled with 5 ml TALON Superflow (GE Healthcare) metal affinity resin 
connected to the protein purification system Profinia (Biorad) pre-equilibrated in the buffer used for cell 
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lysis. Following the loading of the lysate, the column was washed twice with the same buffer supple-
mented with 10 and 20 mM imidazole and protein eluted from the column with 250 mM imidazole. The 
eluate was dialyzed against 25 mM Tris/HCl pH 8.2, 150 mM NaCl and concentrated with an Amicon 
Ultra-4 (10 kDa) centrifuge filter (Millipore). The protein was frozen in liquid nitrogen and stored at -20 
°C. 
 
Expression and purification of Gly6-AlgQ2 and Ser-Gly5-AlgQ2  
 
Gly6-AlgQ2 and Ser-Gly5-AlgQ2 were expressed and purified following the procedure described above 
for BaSrtB, BaSrtD and CpSrtD. In this case, before induction with IPTG, the culture was cooled down 
to room temperature and protein expression induced for 16 hours at 25 °C.  
 
Expression and purification of fusion proteins with AlgQ2  
 
Gly6-AlgQ2-eSrtA and variants thereof, Gly6-AlgQ2-BaSrtB and Ser-Gly6-AlgQ2-GFP were expressed 
and purified following the procedure described above for BaSrtB, BaSrtD and CpSrtD. As for Gly6-
AlgQ2 and Ser-Gly5-AlgQ2 protein expression was induced for 16 hours at 25 °C. During cell lysis a 
tablet of cOmplete EDTA-free Protease Inhibitor (Roche) was added to prevent protein degradation. For 
further purification through size exclusion chromatography, proteins were loaded onto a HiLoad 16/60 
Superdex 200 prepacked column (GE Healthcare) connected to the chromatography system Äkta Explorer 
(GE Healthcare) and eluted with 50 mM Tris/HCl, 200 mM NaCl pH 7.8. Following SDS-PAGE analysis, 
fractions containing proteins were pooled together and concentrated with an Amicon Ultra-4 (10 kDa) 
centrifuge filter (Millipore). Proteins were frozen in liquid nitrogen and stored at -20 °C. 
 
Expression and purification of GFP and VvGT5-GFP 
 
The GFP and the fusion protein VvGT5-GFP were expressed and purified following the same procedure 
described for G1-SaSrtA. In this case, the pH of the buffers used was 7.8. The eluate was dialyzed against 
25 mM Tris/HCl pH 7.8, 150 mM NaCl, 50 % glycerol and stored at -20 °C. 
 
Thioacyl intermediate formation and purification 
 
Gly6-AlgQ2-eSrtA (10 µM) were incubated with 20 µM of donor peptide FITC-LPXTGE in 25 mM 
Tris/HCl pH 8.3, 150 mM NaCl, 10 mM CaCl2 in a final volume of 1.5 ml for 90 minutes at 30 °C. The 
reaction was centrifuged at 16,000g for 5 minutes at 4 °C then applied onto a 5 ml Bio-Scale™ Mini Bio-
Gel® P-6 desalting cartridge (Biorad) using a peristaltic pump at a flow rate of 0.5 ml/minute. Fractions 
of 1 ml were collected and analyzed by SDS-PAGE. Fractions containing FITC-labeled Gly6-AlgQ2-
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eSrtA were concentrated with an Amicon Ultra-4 (10 kDa) centrifuge filter (Millipore), frozen in liquid 
nitrogen and stored at -20 °C. 
5.4.2 Sortase activity assays 
 
 
Gel-based conjugation assays 
 
To monitor the activity of sortases through the gel-based conjugation assay, purified sortases or whole 
cell extracts of sortases were mixed with the FITC-labeled substrate peptides in presence or in absence of 
the nucleophile Gly6-AlgQ2 in the specific reaction buffer. Following incubation, reactions were 
quenched by the addition of the SDS-PAGE loading buffer and separated on a 12% SDS–PAGE gel. 
Transpeptidation products were visualized by scanning the gel for FITC emission (Excitation wavelength: 
473 nm; Filter LPB ≥ 510 nm) using the FLA-9000 imager (Fujifilm) and quantified by densitometry 
using the image analysis software ImageJ. To assess equal protein loading gels were stained with Coo-
massie after the fluorescence scan.  
 
FRET-based cleavage assays 
 
To monitor the transpeptidation activity of PaSrtF in presence of different metal bivalent cations or at 
different temperatures, 5 µM of purified PaSrtF was incubated with 2 mM tryglycine and 20 µM of bac-
terial sortase substrate II Dabcyl-QALPETGEE-Edans (Anaspec). Dabcyl (4-{[4-(dimethylamino) phe-
nyl]azo}benzoic acid) is the quencher and Edans (5-[(2-aminoethyl)amino] naphthalene-1-sulfonic acid) 
the fluorophore. Fluorophore release was monitored as an increase in fluorescence for 1 hour (excitation: 
350 nm, emission 495 nm) with a plate reader (Infinite M200, TECAN) or a fluorescence spectrophotom-
eter (Clary eclipse, Agilent). Initial rates of fluorescence change were transformed to rates of concentra-
tion change by using the specific fluorescence of the product in the different buffers used. 
 
HPLC-based assays 
 
For the analysis of the activity of length variants of PaSrtF by RP-HPLC, 5 µM of each variant was 
incubated with 250 µM FITC-LPQTGE and 1 mM GGGK-biotin in 50 mM sodium phosphate, pH 8.5, 5 
mM DTT at 25 °C. For the analysis of the activity of the chimeric sortase, 20 µM of enzyme were incu-
bated with 250 µM FITC-LPQTGE and 250 µM GGGK-biotin in 25 mM Tris/HCl pH 8.2, 150 mM NaCl, 
10 mM CaCl2 at 30 °C. After different time points, 5 µl samples were taken and the reaction was stopped 
by the addition of 95 µl of 50 mM HCl. Samples were analyzed with an XBridge C18 column (Waters) 
equilibrated in 0.1% NH4OH in 5% MeOH at 30 °C. Elution was performed with a linear gradient from 
0 to 100% of 0.1% NH4OH in 95% MeOH over 10 ml at a flow rate of 0.5 ml/min. Eluted peptides were 
detected by absorbance at 497 nm and fluorescence at 522 nm (excitation at 497 nm) and peak areas were 
analyzed for quantification employing the software Unicorn. 
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Sortase-mediated conjugation within alginate beads 
 
To analyze the activity of eSaSrtA and derivatives within alginate beads, 50 µl (about 1000) of homoge-
nous alginate beads (prepared as described in section 5.5) were transferred into a 2 ml centrifuge tubes. 
For protein loading, beads were washed once with 25 mM Tris/HCl pH 8, 10 mM CaCl2 and incubated 
with specific proteins in 500 µl final volume of the same buffer for 30 minutes at 25 °C and 850 rpm 
shaking. To remove unbound proteins, beads were washed three times with 2 ml of the same buffer for 2 
minutes. The sortase-mediated reaction was initiated by incubating the beads with the specific fluorescent 
labeled peptide in a final volume of 500 µl for 1 hour at 30 °C. Beads were washed three times with 2 ml 
of the same buffer for 2 minutes for unreacted peptide removal and subsequently analyzed by fluorescence 
microscopy. For the SDS-PAGE analysis, 10 µl of beads were taken and dissolved with 5 µl of 200 mM 
EDTA. 
 
 
5.4.3 Structure determination of sortase D from C. perfringens  
 
Protein crystallization, data collection and structure determination were performed by the research group 
of Professor Tim Mayer (Biozentrum, Universiy of Basel). 
 
 
Plate-like crystals of sortase D2 form Clostridium perfringens (CpSrtD) were grown at room temperature 
in a sitting drop experiment in 25 % PEG3350, 0.1 M Bis-Tris pH 5.5, 0.2 M NaCl within one week. 
Crystals were cryo-preserved by a quick soak in a reservoir solution containing of 25 % ethylene glycol 
and flash-cooled in liquid nitrogen. Diffraction data were collected at Swiss Light source X06DA beam-
line and processed using XDS software (Kabsch, 2010a, 2010b). The crystals belong to space group P21 
with cell dimensions a = 38.8 Å, b = 67.4 Å, and c = 68.0 Å, β= 91.5° and contain two protein molecules 
per asymmetric unit. The structure of CpSrtD was determined by molecular replacement using the crystals 
structure of sortase C from Streptococcus pneumoniae (3G66.pdb) (Neiers et al., 2009) with the program 
Phaser (McCoy et al., 2007). Model building was carried out with Buccaneer (Cowtan, 2006) and Coot 
(Emsley and Cowtan, 2004). The structure was refined using PHENIX (Adams et al., 2002) and Refmac5 
(Murshudov et al., 2011) and validated with MolProbity (Chen et al., 2010).  
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5.5 Microreactors preparation, processing and analysis 
 
 
Alginate and chitosan solution preparation 
 
Alginate solutions (3% w/v) were prepared by dissolving low viscosity sodium alginate (no. A112, Sigma-
Aldrich) in 25 mM Tris/HCl pH 7.8. Solutions were clarified by centrifugation for 10 minutes at 5,000g 
then filtered-sterilized by using a vacuum filtration system equipped with a 0.22 µm membrane filter 
(steriflip, Millipore). For the preparation of chitosan solutions (0.3% w/v) low molecular weight chitosan 
(no. 448869, Sigma-Aldrich) was added to 25 mM sodium acetate pH 5, 200 mM CaCl2 and stirred for 
30 minutes. The pH was adjusted to 5 with glacial acetic acid. Following centrifugation at 15,000g for 20 
minutes the supernatant was poured in a glass bottle and autoclaved at 121 °C for 20 minutes. 
 
Alginate bead-based microcompartments production 
 
Gel-core alginate microbeads (GCABs) were prepared using the semi-automated encapsulator B-395 Pro 
(Encapsulator Biotech/Buchi). The syringe pump of the encapsulator was used to extrude 5 ml of freshly 
prepared alginate solution through a 150-µm diameter nozzle into a gently stirred beaker filled with 100 
ml hardening solution. For inhomogeneous or homogeneous beads preparation the hardening solution 
consisted of 25 mM Tris/HCl pH 7.8, 100 mM CaCl2, 0.1% Tween 20 or 25 mM Tris/HCl pH 7.8, 50 mM 
CaCl2, 200 mM NaCl, 0.1% Tween 20 respectively. Typically, uniform and monodispersed beads were 
produced at a rate of 2480 Hz (Amplitude =5) with a flow rate of 3.12 ml/ minute and an electrode tension 
of 1080 V. The resulting alginate beads were allowed to harden for 10-15 minutes and then collected at 
the bottom of a 50 ml tube by sedimentation. The hardening solution was discarded and beads washed 
twice with 40 ml of a washing solution consisting of 20 mM Tris/HCl pH 7.8, 100 mM NaCl, 10 mM 
CaCl2 and 0.05% Tween 20. To obtain gel-core chitosan-coated alginate microcapsules (GC-CAMs), 
alginate beads were transferred into a gently stirred beaker filled with 15 ml of chitosan solution for 3 
minutes. To stop the coating reaction and remove excess of chitosan, GC-CAMs were first collected by 
sedimentation into a 50 ml tube filled with 30 ml of 150 mM NaCl, 10 mM CaCl2, 0.05% Tween 20 and 
after sedimentation washed twice with the same solution. To obtain hollow-core chitosan-alginate micro-
capsules (HC-CAMs) GC-CAMs were suspended in 25 ml of 150 mM NaCl, 10 mM CaCl2, 0.05% 
Tween 20 supplemented with 20 mM sodium citrate for 1 minute with gentle agitation for alginate core 
liquefaction. Following sedimentation at the bottom of the tube, HC-CAMs were washed twice with 
20 mM Tris/HCl pH 7.8, 100 mM NaCl, 10 mM CaCl2 and 0.05% Tween 20. After preparation, alginate 
bead-based microcompartments were immediately used or stored in their washing buffers at 4 °C up to 1 
month. 
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Cell encapsulation and growth in alginate bead-based microcompartments 
 
Cultures of E. coli BL21 (DE3) harboring the plasmid of interest were grown in LB or TB medium until 
exponential phase (OD600 = 0.4-0.8), then diluted to an OD600 of 0.1 with 50 mM Tris/HCl pH 7.6, 
100 mM NaCl. Typically, an aliquot of this diluted cell suspension was added to 5 ml alginate solution to 
obtain an average of 2 encapsulated cells per microcompartment. After mixing by gentle inversion for 
1 minute, the resulting cell suspension was transferred into a 20 ml syringe and immediately used to pre-
pare alginate bead-based microcompartments as described above. Following preparation gel-core alginate 
microbeads (GCABs) or gel-core chitosan-coated alginate microcapsules (GC-CAMs) entrapping cells 
were transferred into a 100 ml conical flask filled with 25 ml LB medium supplemented with 10 mM 
CaCl2 and incubated at 28 °C for 16-18 hours, 160 rpm shaking. To grow cells in hollow-core chitosan-
alginate microcapsules (HC-CAMs) gel-core chitosan-coated alginate microcapsules (GC-CAMs) en-
capsulating cells were treated with sodium citrate (as described above) before incubation in LB or TB 
medium for 16-20 hours at 28-30 °C, 160 rpm shaking. Alternatively, dissolution of the alginate gel core 
was achieved by the addition of 20 mM sodium citrate into the growth medium. Expression of recombi-
nant proteins in the cytoplasm of encapsulated BL21 (DE3) cells was induced by the addition of 0.2-
1 mM IPTG to overnight cultures of microreactors followed by 3 hours of growth at 37 °C for GFP, 
AlgQ2-fusions, G-SrtA and G-SrtB or 20 hours at 16 °C for G-SrtF. Alternatively, protein expression was 
induced by growing encapsulated cells overnight in an auto-induction medium (TB auto). Following cell 
growth and protein expression, colonized microreactors were collected at the bottom of a 50 ml tube by 
sedimentation and washed three times with 40 ml of 20 mM Tris/HCl pH 7.8, 100 mM NaCl, 10 mM 
CaCl2 and 0.05% Tween 20. Microreactors were immediately used or stored in this buffer at 4 °C up to 
one week. 
 
Survival rates and encapsulated cell number determination 
 
Cell survival rates upon encapsulation in gel-core alginate microcompartments were determined by plat-
ing an aliquot of the alginate-cell suspension used for cell encapsulation on LB agar plates. Upon over-
night incubation at 37 °C the number of colonies on the plate was compared with the number of E. coli 
colonies detected in the microcompartments by microscopy after 18 hours of growth at 28 °C. Cell sur-
vival rates upon encapsulation in hollow-core alginate microcapsules was estimated by comparing the 
total number of colonized gel-core and hollow-core microcompartments. 
The total number of BL21 cells grown in a single gel-core or hollow-core-based microreactor was esti-
mated by using a modified MTT reduction assay as described by Wang and colleagues (Wang et al., 
2010). About 150 microreactors (10 μl) were transferred in 1.5-ml centrifuge tubes and residual buffer 
was pipetted off. Following the addition of 200 µl of LB medium pre-warmed to 37 °C the reduction 
reaction was initiated by the addition of 20 μl of 5.0 mg/ml of MTT in water pre-warmed to 37 °C. Tubes 
were incubated at 37 °C for 15 minutes and 1000 rpm shaking with the tube cap open. The medium was 
119 
 
pipetted off from microreactors and the purple formazan crystals produced by the reaction were dissolved 
with 1 ml of DMSO by vortexing for 1 minute. Samples were transferred into clean tubes and diluted four 
fold with DMSO. Absorbance values, recorded after 10 minutes at 550 nm in a spectrophotometer using 
DMSO as the blank, were used to estimate the number of cells in a single microreactor from a standard 
curve constructed as follows. 200 µl cell suspensions at OD600 values between 0.05 and 0.6 (in triplicate) 
were prepared in 1.5-ml tubes from an exponentially growing culture of BL21 in LB medium using pre-
warmed LB medium. Cell suspensions were incubated with 20 μl of 5.0 mg/ml of MTT at 37 °C for 
15 minutes. Formazan crystals were collected at the bottom of the tubes by centrifugation at 10,000g for 
1 minute and following the removal of the supernatant dissolved with 1 ml of DMSO by vortexing for 
1 minute. Suspensions were diluted four fold with DMSO and absorbance values recorded after 
10 minutes at 550 nm in a spectrophotometer using DMSO as the blank. The standard curve was obtained 
by plotting averaged values of absorbance at 550 nm against relative cell densities.  
 
Encapsulated cell lysis optimization 
Lysis of E. coli cells within microreactors was performed with detergent mixture BugBuster (10 X, 
no. 70921, Merck Millipore). The concentration of BugBuster necessary to obtain efficient cell lysis was 
determined using two different assays. The first assay consisted of determining the cell viability of en-
capsulated cells after treatment of microreactors with increasing BugBuster concentration by using the 
MTT assay described above. Samples of 100 μl of microreactors (about 2000) were transferred into 2 ml 
centrifuge tubes and incubated in 500 μl final volume of 25 mM Tris/HCl pH 8.2, 150 mM NaCl, 10 mM 
CaCl2 in presence of BugBuster (between 0.1 and 1 X) for 30 minutes at 25 °C and 850 rpm shaking. 
Following two washing steps with 2 ml of the same buffer to remove the detergent, about 150 microreac-
tors (10 μl) were transferred in 1.5 ml centrifuge tubes and the MTT assay performed. In the second assay 
efficient cell lysis was evaluated by analyzing the relative amount of GFP released from GFP-expressing 
microreactors treated with increasing BugBuster concentrations for different time points. 100 μl of GFP-
expressing microreactors were incubated in 500 μl final volume of 25 mM Tris/HCl pH 8.2, 150 mM 
NaCl, 10 mM CaCl2 in presence of 0.1-0.5 X BugBuster for 5, 15 and 30 minutes at 25 °C and 850 rpm 
shaking for cell lysis. The GFP released in solution from uncoated and coated microreactors was measured 
by using a fluorescence microplate reader (Infinite M200, TECAN) at 490 nm for excitation and 520 nm 
for emission. Relative percentage of GFP diffusion for each sample was then calculated using as reference 
the amount of GFP diffused from microreactors treated with the highest BugBuster concentration and the 
longest incubation time. The same assay was employed to analyze the lysis efficiency of the commercial 
autolytic strain XJb (DE3) in comparison to the standard expression strain BL21 (DE3).  
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Layer-by layer coating analysis 
 
Layer-by layer coating of microreactors was performed using the polyelectrolyte coating pair PSS (poly-
styrene sulfonate, no. 243051, Sigma) and PAH (poly-allylamine hydrochloride, no. 283223 Sigma).        
To find out coating conditions that enable microreactors to retain the GFP inside after cell lysis, the per-
meability of differently coated microreactors to GFP was analyzed. To this end, samples of 100 μl of 
GFP-expressing microreactors (about 2000) were transferred into 2 ml centrifuge tubes and incubated 
with 900 μl of PSS (2 mg/ml, 0.5 M NaCl, 0.1 M CaCl2) or PAH solution (2 mg/ml, 0.5 M NaCl) for 
5 minutes at 25 °C and 850 rpm shaking. Before proceeding with the deposition of the next layer of the 
opposite charged polyelectrolyte samples were washed three times with 2 ml of 150 mM NaCl, 10 mM 
CaCl2 and 0.05% Tween 20 for 1 minute and 850 rpm shaking. Three washing steps were also performed 
at the end of the coating procedure. Layer-by-layer-coated microreactors were incubated in 500 μl final 
volume of 25 mM Tris/HCl pH 8.2, 150 mM NaCl, 10 mM CaCl2 in presence of 0.5 X BugBuster for 
15 minutes at 25 °C and 850 rpm shaking for cell lysis. The GFP released in solution from uncoated and 
coated microreactors was measured by using a fluorescence microplate reader (Infinite M200, TECAN) 
at 490 nm for excitation and 520 nm for emission. Relative percentage of GFP diffusion for each sample 
was then calculated using as reference the amount of GFP diffused from uncoated microreactors. 
 
Unreacted peptide washing optimization 
 
To determine best washing conditions for the removal of unreacted fluorescent peptide, microreactors 
expressing either Gly6-AlgQ2-SrtA or the inactive Gly6-AlgQ2-SrtA-C184G were prepared and treated 
in the same manner in parallel. Samples of 100 μl of microreactors (about 2000) were transferred into 
2 ml centrifuge tubes and incubated in 500 μl final volume of 25 mM Tris/HCl pH 8.2, 150 mM NaCl, 
10 mM CaCl2 in presence of 0.5 X BugBuster for 30 minutes at 25 °C and 850 rpm shaking. Following 
cell lysis, microreactors were incubated in 500 μl of the same buffer in presence of 50 µl of FITC-
LPETGE for 18 hours at 30 °C. After the reaction, microreactors were washed three times with 2 ml of 
the selected washing buffer for 5 minutes at 25 °C and 850 rpm shaking. Microreactors were rinsed twice 
with 2 ml of 10 mM Tris/HCl pH 8.5, 10 mM CaCl2 for 1 minute and 850 rpm shaking and subsequently 
analysed by fluorescence microscopy and or COPAS. 
 
 
Recovery of the plasmid 
 
For plasmid recovery, a single microreactor was taken along with 1µl of buffer and transferred in 1.5 ml 
centrifuge tube. Uncoated microreactors were dissolved by the addition of 10 µl of 10 mM Tris HCl pH  8, 
20 mM NaHCO3 followed by vortexing for 1 minute. Differently, PSS-PAH-coated microreactors were 
121 
 
mixed with 5 µl of 50 mM NaOH for disassembly of the polyelectrolyte shell. Following 1 minute vor-
texing and 5 minutes at 1000 rpm, 5 µl of 50 mM Acetic acid were added and the sample vortexed again. 
For plasmid recovery by electroporation, 4 µl of sample were added to 40 μl of electrocompetent BL21 
(DE3) cells (Sigma) diluted 1 to 4 with sterile 10 % glycerol and incubated for 1 minute on ice. Cells were 
electroporated at 2.5 kV, 200 Ω, and 25 µF using a 2 mm electroporation cuvette in a Gene Pulser Xcell 
unit (Biorad). After the pulse, 960 µl of recovery medium (No. CMR0001, Sigma) were added to the 
cuvette and cell suspension transferred into a 15 ml tube which was incubated for 1 hour at 37 °C and 200 
rpm for cell recovery. The culture was centrifuged for 3 minutes at 3000g and the supernatant discarded. 
Cells were spread on LB agar plate and incubated overnight at 37 °C. 
For genotype recovery by PCR, 1 µl of sample was mixed with 0.5 μM of each primers (F27 and R27), 
3 units Phusion HF DNA Polymerase, 1 X Phusion HF Buffer, 200 μM of each dNTP in a total volume 
of 30 μl. The PCR program employed consisted of 95 °C for 5 minutes as initial step, 14 cycles of dena-
turation at 95 °C for 30 seconds and annealing at 61 °C for 30 seconds (decrease 0.5 °C per cycle) and 
elongation at 72 °C for 1 minute followed by 14 cycles at 95 °C for 30 seconds and annealing at 53 °C 
for 30 seconds and elongation at 72 °C for 1 minute. A final elongation step of 5 minutes at 72 °C was 
performed. 
 
 
Validation of the microreactor-based assay 
 
For the validation of the microreactor-based assay, microreactors expressing wild type sortases or deriv-
atives and the respective inactive versions were prepared and treated in the same manner in parallel. De-
tails for each experiments are reported in the captions of the figures in the “results and discussion” section. 
Following encapsulation and cell growth within hollow-core chitosan-coated alginate microcapsules (HC-
CAMs), microreactors were incubated in presence of IPTG for protein expression. Typically, samples of 
100 μl of microreactors (about 2000) were used for the assay. For cell lysis, uncoated or PSS-PAH-coated 
microreactor were transferred into 2 ml centrifuge tubes and incubated in 500 μl final volume of the 
specific buffer in presence of 0.5 X BugBuster for 30 minutes at 25 °C and 850 rpm shaking. Buffers used 
for cell lysis were always employed for the reaction. Following the removal of the detergent by washing, 
microreactors were incubated in the specific reaction buffer in presence of the specific FITC-labeled pep-
tide substrate. Fluorescent labeled peptide removal was achieved by washing microreactors three times 
with about 2 ml of 50 mM Glycine pH 9.5, 500 mM NaCl, 10 mM CaCl2, 0.1% Zwittergent 3:14 for 5 
minutes and 850 rpm shaking. For fluorescence microscopy and COPAS analysis, microreactors were 
rinsed twice with 2 ml of 10 mM Tris/HCl pH 8.5, 10 mM CaCl2 for 1 minute and 850 rpm shaking. For 
the analysis with propidium iodide, 100 μl of 1 mg/ml propidium iodide solution were added to microre-
actors samples in a final volume of 1 ml of 10 mM Tris/HCl pH 8.5, 10 mM CaCl2 in for 5 minutes and 
850 rpm shaking. Excess of Propidium iodide was removed by rinsing microreactors twice with 2 ml of 
the same buffer. 
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For the SDS-PAGE analysis, 10 μl of uncoated microreactors were transferred in a 1.5 ml tube and the 
residual buffer was removed. Microreactors were dissolved with 10 μl 1M NaHCO3 and 10 μl 0.5 M 
EDTA. Similarly, 10 μl of PSS-PAH-coated microreactors were transferred in a 1.5 ml tube and after 
removal of the residual buffer were mixed with 5 μl of 1 M NaOH and 0 μl 0.5 M EDTA. Proper disso-
lution was achieved by pipetting up and down. 
 
 
Fluorescence microscopy and COPAS analysis 
 
Microcompartments and microreactors were typically analyzed by fluorescence microscopy and by com-
plex object parametric analyzer and sorter (COPAS). Fluorescence microscopy was performed with an 
Olympus BX41 microscope. Nonfiltered white light (bright field) was used for the illumination of the 
microreactors structure. Two filter set that allows for blue excitation and green emission (excitation filter 
at 480/20; longpass emission filter at 510 nm) or green excitation and red emission (excitation filter at 
535/30; longpass emission filter at 580 nm) were used to analyze FITC and propidium iodide-based flu-
orescence respectively. Picture were taken using 10 X and 20 X magnification lens. Exposure times 
ranged from 1/25 seconds to 1/1000 seconds for FITC-based fluorescence and from 1/1000 seconds to 
1/8000 seconds for propidium iodide-based fluorescence. 
Microreactors were spectrophotometrically imaged with a COPAS Plus particle analyzer and sorter 
(1000 µm flow-cell) equipped with the Flow pilot software (Union Biometrica). Fluorescence signals 
were recorded at 510 nm, appropriate for the emission maximum of FITC and at 615 nm appropriate for 
PI [ex: 488 nm, photon multiplier settings (PMT green): 450-650 V, (PMT red): 450 V; gain factor: 1.0. 
The COPAS-device was operated at frequencies between 10 and 20 Hz; At least 600 microbeads were 
collected any time to perform statistical analysis. Data analysis was done using the FlowJo software. 
 
 
5.6 PaSrtF library preparation and screening 
 
Random mutagenesis of PaSrtF by error prone-PCR 
 
Diversification of the PaSrtF gene was performed by error prone-PCR (ep-PCR) based on the protocol 
described by Wilson and Keefe (Wilson and Keefe, 2000). The protocol was adapted in order to obtain 
the best experimental outcome. The 1.7 kb fragment obtained upon digestion of the vector carrying the 
sequence encoding for PaSrtFΔN34 (pINITIAL- PaSrtFΔN34) with KpnI and PvuI (NEB) was used as tem-
plate. The ep-PCR reaction mixture consisted of 10 mM Tris/HCl pH 8.7, 50 mM KCl, 7 mM MgCl2, 
1 mM of dCTP and dTTP, 0.2 mM dATP and dGTP, 450 ng of template, 0.5 µM of each primer 
(F28/R28), 0.4 mM MnCl2 and 50 U Firepol DNA polymerase (Solis BioDyne) in a final volume of 
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500 µl. The reaction mixture was set up on ice and subsequently spilt in 50 µl aliquots in PCR tubes. 
Cycling conditions consisted of 95° C for 5 minutes as initial step, followed by 8 cycles of denaturation 
at 94 °C for 1 minute, annealing at 56 °C for 1 minute, elongation at 72 °C for 2 minutes. A final elongation 
step of 5 minutes at 72 °C was performed. Reactions were pooled together and ep-PCR product was 
cleaned up using the NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel). Purified ep-PCR prod-
uct concentration was measured with the NanoDrop 2000c (ThermoFisher). 
 
Preparation of ep-PCR product and recipient expression vector for cloning 
 
For the construction of the library both the ep-PCR product and the recipient FX expression vector p7X-
G1-CcdB-Cat-Streptag were prepared as described below. 5 µg of the vector were digested with 15 U 
SapI (NEB), 10 U NcoI (NEB) in 1 X Cutsmart buffer (NEB) in a total volume of 200 µl for 5 hours at 
37 °C. Following heat inactivation of the restriction enzymes at 80 °C for 20 minutes, the digestion mix-
ture was run on a 0.8% (w/v) agarose gel stained with Redsafe (iNtRON). The DNA band corresponding 
to the SapI-digested vector (5.4 kb) was excised from the gel and purified by using the NucleoSpin® Gel 
and PCR Clean-up kit. DNA elution was made in 30 µl of sterile water pre-warmed to 50 °C. 6 µg of 
epPCR product were digested with 15 U SapI and 10 U DpnI (NEB) in 1 X Cutsmart Buffer in a total 
volume of 200 µl for 16 hours at 30 °C. Following heat inactivation of the restriction enzymes at 80 °C 
for 20 minutes the digestion, the mixture was run on a 2% (w/v) agarose gel stained with Redsafe (iN-
tRON). The DNA band corresponding to the SapI-digested epPCR product (552 bp) was excised from the 
gel and purified by using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel). DNA elution was 
made in 30 µl of sterile water pre-warmed to 50 °C. 
 
Test library preparation and analysis of library composition  
Before proceeding with the full-sized library construction, a series of test libraries were performed using 
different ligation and electroporation conditions in order to maximize the final size of the ep-PCR library. 
Best experimental conditions found for the test library were subsequently used for the construction of the 
full-sized library. For the preparation of test library 50 ng of the digested vector were mixed with a three-
fold molar excess of the digested ep-PCR product, 20 U of T4 DNA ligase (NEB) and 1 X T4 DNA ligase 
buffer (NEB) in a final volume of 10 μl. A control reaction containing only the digested vector but not 
the epPCR product was used to calculate the fraction of ligation products made of recircularized vector. 
Following incubation for 16 hours at 16 °C, the ligase was heat inactivated at 65 °C for 20 minutes and 
either 1 μl of the test ligation reaction or of the control reaction was added to 40 μl of electrocompetent 
BL21(DE3) cells (Sigma) diluted 1 to 1 with sterile 10 % glycerol. Electroporation was performed fol-
lowing the electrocompetent cells manufacturer’s instructions and advices. Best electroporation condi-
tions were obtained at 2.5 kV, 200 Ω, and 25 µF using a 2 mm electroporation cuvette in a Gene Pulser 
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Xcell unit (Biorad). After the pulse, 960 µl of recovery medium (No. CMR0001, Sigma) were added to 
the cuvette and cell suspension transferred into a 15 ml tube which was incubated for 1 hour at 37 °C and 
200 rpm for cell recovery. 100 μl of cell suspensions were spread on LB agar plates and incubated over-
night at 37 °C. For the analysis of library composition, small-scale plasmid preparation was performed 
from 14 clones and the mutagenized gene insert sequenced using the universal T7 promoter primer. To 
identify mutations, sequenced samples were aligned with the sequence of the unmutated PaSrtF gene by 
using the software Vector NTI. Identified mutations were used to calculate the overall mutation rate and 
to assess bias in the mutation spectrum of the library. Library analysis was also performed using the online 
program PEDEL-AA (Firth and Patrick, 2008). 
  
Full-sized library construction  
For the construction of the full-sized ep-PCR library 500 ng of digested vector was mixed with a threefold 
molar excess of digested ep-PCR product, 200 U of T4 DNA ligase (NEB) and 1 X T4 DNA ligase buffer 
(NEB) in a final volume of 100 μl. Following incubation for 16 hours at 16 °C, the ligase was heat inac-
tivated at 65 °C for 20 minutes and the ligation product was cleaned up using the NucleoSpin Gel and PCR 
Clean-up kit (Macheray-Nagel). Ligation products were eluted in 75 µl of sterile water pre-warmed to 
50 °C. After elution, the library ligation product was split into 10 µl aliquots and stored at -20 °C. The 
size of final epPCR library was estimated by counting the number of transformants obtained after elec-
troporation of 1 μl of the full-sized library ligation into electrocompetent BL21 (DE3) using the procedure 
described above for the test library. 
 
Library encapsulation and preliminary library screening 
For the encapsulation and preliminary screening of the PaSrtF library, one aliquot of the full-sized library 
ligation was thawed on ice. 1 μl was added to 40 μl of electrocompetent BL21 (DE3) cells (Sigma) diluted 
1 to 4 with sterile 10 % glycerol. After 1-minute incubation on ice, the mix was transferred into a 2 mm 
electroporation cuvette and immediately electroporated at 2.5 kV, 200 Ω, and 25 µF in a Gene Pulser 
Xcell unit (Biorad). After the pulse, 960 µl of recovery medium (No. CMR0001, Sigma) were added to 
the cuvette and cell suspension transferred into a 15 ml tube which was incubated for 1 hour at 37 °C and 
200 rpm for cell recovery. At this point, 50 µg/ml kanamycin were added to the culture which was grown 
for two additional hours to allow only transformants to replicate. Following 2 hours of growth the culture 
was chilled on ice for 15 minutes and subsequently stored overnight at 4 °C. By plating on LB agar plates 
an aliquot of cells after 1-hour recovery and after 2 additional hours of growth, a 7-fold cell number 
replication was determined. The number of transformants on the plate after 2 hour of growth was then 
used to calculate the volume of the culture to mix with the alginate solution prior to encapsulation to have 
an average number of cells per bead of 0.25. Two batches of 25 ml of alginate solution were used for 
encapsulation. Alginate beads encapsulating cells from each batch were prepared and collected into a 
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gently stirred beaker filled with 250 ml of 25 mM Tris/HCl pH 7.8, 50 mM CaCl2, 200 mM NaCl, 0.1% 
Tween 20 and allowed to harder for about 15 minutes. Beads were collected at the bottom of four 50 ml 
tube by sedimentation and subsequently washed twice with 40 ml of 20 mM Tris/HCl pH 7.8, 100 mM 
NaCl, 10 mM CaCl2 and 0.05% Tween 20. Alginate beads were transferred into a gently stirred beaker 
filled with 75 ml of chitosan solution for 2 minutes then recovered again by sedimentation into four 50 ml 
tube. The chitosan solution was discarded and beads washed twice with 40 ml of 150 mM NaCl, 10 mM 
CaCl2, 0.05% Tween 20. Chitosan-coated alginate beads were transferred into 200 ml of TB medium 
supplemented with kanamycin and 20 mM sodium citrate for 1 hour at 37 °C then for 20 hours at 28 °C 
and 160 rpm shaking. According to Poisson distribution, about 20 % of microcompartments were colo-
nized. Empty and colonized microcompartments were collected into 50 ml tubes. By exploiting the dif-
ferent specific weight, microreactors (5 ml) were gradually separated from empty microcompartments 
and incubated into 40 ml TB medium supplemented with 0.5 mM IPTG at 16 °C and 160 rpm shaking for 
protein expression. The day after, microreactors were properly washed with 150 mM NaCl, 10 mM CaCl2, 
0.05% Tween 20 to remove traces of medium and subsequently coated with PSS and PAH. For the dep-
osition of PSS, microreactors were incubated with 40 ml of 2 mg/ml PSS in 0.5 M NaCl, 100 mM CaCl2 
for 5 minutes in a rotating mixer then washed three times with 40 ml of 150 mM NaCl, 10 mM CaCl2, 
0.05% Tween 20. For the deposition of PAH, microreactors were incubated with 40 ml of 2 mg/ml PAH 
in 0.5 M NaCl for 5 minutes in a rotating mixer then washed three times with 40 ml of the same washing 
solution. After coating, microreactors were washed once with 25 mM Tris/HCl pH 7.65, 500 mM NaCl, 
10 mM CaCl2 and incubated in 25 ml of the same buffer supplemented with 0.5 X BugBuster for 
30 minutes in a rotating mixer at room temperature for cell lysis. Microreactors were washed three times 
with the same buffer without the detergent and subsequently transferred into a 100 ml conical flask con-
taining 25 ml of the same buffer supplemented with 25 µM FITC-LPQTGE and incubated at 25 °C for 
20 hours. After the reaction, microreactors were collected into a 50 ml tube and washed three times with 
40 ml of 50 mM Glycine pH 9.5, 500 mM NaCl, 10 mM CaCl2, 0.1% Zwittergent 3:14 for unreacted 
fluorescent labeled peptide removal. After washing microreactors three times with 40 ml of 10 mM 
Tris/HCl pH 8.5, 10 mM CaCl2 to remove the detergent, microreactors were analysed using the large 
particle flow cytometer COPAS (BioSorter, Union Biometrica). The device was operated with 10 mM 
Tris/HCl pH 8.5, 10 mM CaCl2 as sheath fluid. For library screening, microreactors displaying the highest 
green fluorescence intensity levels (about 3%of the total) were sorted into a 50 ml centrifugation tube 
prefilled with 10 ml of 10 mM Tris/HCl pH 8.5, 10 mM CaCl2 (‘enrichment mode’, max. 100 Hz sorting 
rate). Isolated microreactors were incubated for 5 minutes with propidium iodide (≈ 100 μl of 1 mg/ml 
for 100 μl microreactors) and two washing steps with 10 mM Tris/HCl pH 8.5, 10 mM CaCl2 subjected 
to another sorting (‘pure mode’, maximum 1 Hz sorting rate) on the basis of the green to red fluorescence 
ratio. Single microreactors were dispensed into Nunc MicroWell 96-well plates filled with 100 μl of 
10 mM Tris/HCl pH 8.5, 10 mM CaCl2. The two clones displaying the highest green to red fluorescence 
ratio were dissolved and plasmid recovered by electroporation as described above. 
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